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Abstract 
Chronic stress and anxiety disorders are placing an increasing economic burden on 
western society. The anterolateral BNST (BNSTALG) plays a key role in mediating a 
number of stress related responses. There are three neuronal populations within the 
BNSTALG: Type I, Type II and Type III neurons. This thesis examined the 
electrophysiological properties of neurons located in the BNSTALG in different 
genders, healthy aging, a mouse model of frontotemporal dementia (CHMP2B) and 
during the different stages of the oestrous cycle. Overall I found that the oestrous 
cycle had very little effect on the electrophysiological properties of these cells; the 
only trend observed was in the maximum rate of rise of Type II neurons: diestrus 
was slower than metestrus and proestrus. There were a number of intrinsic 
electrophysiological properties which were affected by gender; Type II cells showed 
a decreased excitability in the female cohort driven by changes in passive 
membrane properties. Specifically the observed change in input resistance may be 
mediated by changes in allopregnanolone, which is 8-10 fold higher in females; 
changes in allopregnanolone levels leads to changes in GABAA subunit expression 
which may mediate changes in tonic inhibition and input resistance.  
In aged female mice, Type I neurons had a more hyperpolarised resting membrane 
potential and wider action potentials, while Type II neurons from the aged cohort 
displayed an increase in excitability most likely due to a more depolarised threshold. 
Activity in Type II neurons are thought to mediate an ‘anxiety off’ switch therefore 
these increases in excitability may indicate an anxiolytic role of these more excitable 
populations. Finally I examined the BNSTALG neurons in the CHMP2B model of 
frontotemporal dementia. Type II neurons had a more hyperpolarised threshold and 
faster latency. Overall these studies show that the stress regulatory brain region is 
susceptible to changes with gender, aging and in dementia models.  
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1. Introduction 
The bed nucleus of the stria terminalis (BNST) plays a key role in stress and anxiety. 
Limbic systems such as the medial prefrontal (mPFC) and the hippocampus are 
involved in how we respond to stressors however these regions are not directly 
connected to key output pathways such as the paraventricular nucleus (PVN) of the 
hypothalamus.  The BNST acts as a relay between these regions thus regulating 
responses to various stressors.  
1.1. Stress and Anxiety  
Chronic stress, anxiety and related mood disorders have a substantial effect on the 
well-being of all global societies.  In the developed world, conditions within this 
spectrum of disorders have become a major economic burden, in terms of both 
direct healthcare costs and lost economic productivity (Kessler Greenberg 2002).  
Stress-eliciting neural drive, however, is thought typically to have its genesis in 
higher centres, in particular the circuits of the limbic system which are known to 
integrate multiple complex factors to shape emotion and mood (Herman et al., 2002, 
2005).  However many physiological manifestations of stress-related disorders are 
ultimately mediated via the hypothalamus. This includes the classical 
neuroendocrine hypothalamo-pituitary-adrenocortical (HPA) axis and hypothalamic 
control of various brainstem nuclei involved in peripheral homeostatic responses 
such as blood pressure regulation (Klimov et al., 2013; Wagner et al., 2013; 
Schneeberger et al., 2014; Kataoka et al., 2014).  
The HPA axis is responsible for the release of glucocorticoids into circulation (Figure 
1-1). Release of corticotrophin-releasing factor (CRF) in the anterior pituitary by 
neurons from the PVN leads to the release of adrenocorticotropic hormone (ATCH) 
in the adrenal cortex which in turn affects the release of glucocorticoids into 
circulation (Figure 1-1).   
The biological effects of glucocorticoids are mediated by the glucocorticoid receptor 
(GR). In the absence of a ligand the GR is located in the cytoplasm where it forms 
part of a complex with other proteins including Src; following the binding of a ligand 
the GR translocates to the nucleus where it modulates gene expression. Additionally 
a second component of GR activation is the release of Src which mediates non 
genomic effects (Cain & Cidlowski, 2015). These molecules regulate a number of 
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stress related responses including inflammatory and immune responses, 
metabolism, reproduction, growth, cell survival, cell proliferation, cognition and 
behaviour (Chrousos & Gold, 1992; Charmandari et al., 2005; Chrousos & Kino, 
2005).   
Although the mammalian limbic system unquestionably has pivotal roles in eliciting 
and modulating stress signalling, it is not extensively connected to key hypothalamic 
areas involved in stress responses, such as the paraventricular hypothalamic 
nucleus (PVN). The PVN controls the HPA axis and also exerts substantial 
influences on autonomic activity via its connections to various brainstem/spinal cord 
networks (Kc & Dick, 2010).  
Due to the above mentioned lack of direct connectivity, limbic system influences on 
hypothalamic and brain stem-dependent outcomes are necessarily relayed through 
intermediate brain areas. One area of particular interest in this regard is the 
anterolateral area of the BNST (BNSTALG). The BNSTALG receives afferent projects 
from many areas of the limbic system, including the ventral subiculum and mPFC, 
which plays a key role in HPA axis feedback. The effect of activation of the various 
populations in the BNSTALG on the HPA axis can be either inhibitory or excitatory, 
however the BNST is a primarily GABAergic population, GABAergic projections from 
the BNSTALG could inhibit HPA axis activation. The excitatory drive is believed to be 
mediated via an internal circuit in which activation of CRF cells in the oval nucleus 
inhibit Type I and Type II populations within the BNSTALG which prevents the 
inhibition of the glutamatergic population within the ventral BNST (Daniel & Rainnie, 
2016).  
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Figure 1-1 Schematic representation of the role of the anterolateral area of the BNST 
in the HPA function. Purple shapes represent the limbic system influences on the 
anterolateral BNST; the BNST is the capable of activating or inhibiting the HPA axis 
via its connections to the PVN. Abbreviations anterolateral BNST (BNSTALG), 
paraventricular nucleus (PVN), corticotrophin releasing factor (CRF), 
adrenocorticotropic hormone (ACTH). 
 
The circuit location of the BNST is suited to allow it to fulfil a gatekeeper role 
modulating the influences of the limbic system on the hypothalamus (Choi et al., 
2007; Crestani et al., 2013). Notably, the BNST has been hypothesized to mediate 
“sustained” fear and/or anxiety after repeated stressors, as well as contextual cues 
that predict aversive and/or stressful stimuli (Straube et al., 2007; Davis et al., 2010; 
Janitzky et al., 2015). This contrasts with the proposed roles of amygdala nuclei 
(such as the central amygdala amygdala (CeA) and basolateral amygdala (BLA)) 
which seemingly possess more pronounced roles in acute fear responses. (Gewirtz 
et al., 1998). While the BNST and amygdala seem to display distinct roles in fear 
processing their functions are not completely isolated from each other; they act in 
conjunction with each other to provide an accurate response to fear (Walker et al., 
2003). Furthermore, multiple functional magnetic resonance imaging (fMRI) studies 
in man have demonstrated the role of BNST in the central nervous system (CNS) 
response to fear and anxious anticipation (Straube et al., 2007; Somerville et al., 
2010; Yassa et al., 2012).   
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1.1.1. The BNST 
 
In the mammalian brain the BNST is located in the caudal pallidum, adjacent to the 
caudate putamen, and either side of the anterior commissure (Paxinos & Franklin, 
2004a; Dong & Swanson, 2004a). It is a predominantly GABAergic region, which is 
sexually dimorphic. It plays a key role in stress and anxiety where its effects can be 
both anxiolytic and anxiogenic. This complex region is comprised of several 
subregions, each of which has unique cellular populations. Here I will briefly detail 
the subregions of the BNST with specific focus on the BNSTALG and its role in 
healthy brains and disease states. 
 
1.1.2. Subdivisions of the BNST  
The BNST is a complex region made up of several sub nuclei, the number of which 
vary depending upon individual classifications. These have been better 
characterised in the rat than in the mouse where twenty subregions have been 
described based mainly upon its connectivity with the amygdala (Dong et al., 2001b). 
Two main classifications exist to describe the nuclei of the BNST, the first is based 
on detailed parcelling bundling based on intermediate, ventral, lateral and medial 
divisions. For the most part these are similar to the classifications used by Paxinos 
and Watson (Paxinos & Franklin, 2004a). In contrast, Swanson and Dong 
classifications are based more on an anterior posterior division (Dong et al., 2001b). 
The differences in these classifications are detailed in Table 1-1 (Paxinos and 
Franklin, 2004).  
The BNSTALG has been implicated in a number of anxiety related responses (Lee et 
al., 2008; Hammack et al., 2009; Davis et al., 2010; Somerville et al., 2010; Conrad 
et al., 2011a; Conrad & Winder, 2011; Yassa et al., 2012; Daniel & Rainnie, 2015; 
Daniel et al., 2017), which I will be elaborating on in section 1.1.5, I will focus on this 
classification in my thesis. In the Dong and Swanson classification (2004) the 
BNSTALG is comprised of the rhomboid (BNSTR), oval (BNSTOV), juxtacapsular 
(BNSTJC) , fusiform nuclei (BNSTFU) and an undefined area (BNSTAL) surrounding 
them referred to as the anterolateral area; although these classifications are based in 
the rat, similar classifications exist within the mouse (Dong et al., 2000; Paxinos & 
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Franklin, 2004b; Daniel et al., 2017). Figure 1-2 shows the dorsal region of the 
anterolateral BNST in the mouse and rat, this is the classification used in Daniel et 
al., 2017 where they examined the electrophysiological properties of BNST neurons 
in the mouse and the rat. Below is the same slice with the subregions denoted from 
the Paxinos and Franklin mouse atlas (Figure 1-2). 
These different subregions are populated by distinct cell types.  For example 
corticotrophin-releasing factor (CRF) positive cells in the BNST are located within the 
BNSTOV while glutamatergic neurons are primarily located in the ventral BNST 
(BNSTV) (Daniel & Rainnie, 2016). In this study I have focused on the dorsal 
component of the anterolateral group of the BNST due to its role in stress processing 
and well defined electrophysiological characterisation as described below. The 
dorsal component of the BNSTALG is comprised of the oval nucleus, the 
juxtacapsular region and the undefined anterolateral area.  
 
Figure 1-2 BNST subunits as depicted in Daniel et al., 2017, this was adopted from 
the Dong et al 2007 classification, the dorsal anterolateral area of the BNST in the a) 
mouse, Bregma 0.14 mm and b) rat, Bregma -0.12 mm. Abbreviations; anterior 
commissure (AC), Juxtacapsular nucleus of the BNST (Jc), Oval nucleus of the 
BNST (Ov), undefined anterior lateral area of the BNST (AL), anterior medial division 
of the BNST (AM).  
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Figure 1-3 The anterolateral BNST as depicted in the Paxinos and Franklin mouse 
brain atlas, 2004, Bregma 0.14 mm. abbreviations of the different subregions of the 
BNST: medial division ventral part (BSTMV),lateral division ventral part (BSTLV), 
medial division (BSTM), lateral division ventral part (BSTLV), lateral division 
posterior part (BSTLP), lateral division dorsal part (BSTLD), lateral division 
juxtacapsular part (BSTLJ).  
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BNST region in paxino  mouse atlas Corresponding breakdown Ju and 
Swanson classification (1989) 
Lateral division (BSTL) Anterolateral 
area (BNSTALG) 
 
 
 
 
Anterior division 
Lateral division, dorsal part (BSTLD) 
Lateral division, juxtacapsular part 
(BSTLJ) 
Lateral division, posterior part (BSTLP) 
Lateral division, ventral part (BSTLV) 
Medial division, ventral part (BSTMV) Medial group 
Medial division, posterolateral part 
(BSTMPL) 
Posterior division  
Medial division, posteromedial part 
(BSTMPM) 
Supracapsular part (BSTS) 
Table 1-1 Subregions of the BNST adapted from Dong et al 2001 
 
 
1.1.3. Connectivity of the anterolateral BNST with other brain regions  
 
The BNSTALG has extensive connections with the amygdala, hypothalamus and 
midbrain regions. These brain regions are associated with pain, emotional 
processing, reward and autonomic function (Daniel & Rainnie, 2016). The BNST also 
displays a complex anatomical circuitry. Both the internal circuitry and the external 
efferent and afferent connections are subregion specific, briefly I will highlight the 
known connectivity of each of the dorsal BNSTALG nuclei.  
The BNSTOV has extensive connections both within the BNST and externally. Within 
the BNST, it densely projects to the BNSTFU, the caudal anterolateral area, BNSTR, 
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the subcommissural zone and the anterodorsal area. The BNSTOV also projects to a 
number of areas outside of the BNST, including the dense afferents to the central 
amygdala (CeA), moderate input to nucleus accumbens (NA) and the periaqueductal 
gray (PAG) and sparse projections to the PVN (Dong et al., 2001c) (Figure 1-6). 
Similar to the BNSTOV, the BNSTAL area projects both within the BNST and to a 
number of key nuclei outside of the BNST. Within the BNST it densely projects to the 
rhomdoid nucleus, the BNSTFU, the anteroventral nucleus and the anterodorsal area, 
it also has weaker connection to the BNSTJU and the BNSTOV. Outside of the BNST 
it projects to several key brain areas associated with stress processing and reward 
including the CeA, the PVN, the NA and the VTA. The BNSTAL also has reciprocal 
dorsal raphe (DR) connections (Dong & Swanson, 2004b) (Figure 1-4).  
The BNSTJU innervates the caudal anterolateral area of the BNST along with a 
number of regions outside of the BNST including the infralimbic (IL) and prelimbic 
(PL) cortical areas and the CA1 region of the hippocampus and the parasubthalamic 
and subthalamic nuclei of the hypothalamus (Dong et al., 2001c) (Figure 1-5).  
Afferent projections into the BNST also exhibit a subregion specificity. Thus, 
afferents from the IL cortex innervate the BNSTJU, BNSTOV and BNSTAL. The PL 
cortex sends moderate connections to the BNSTAL. The ventral subiculum (VS) of 
the hippocampus has light connections to the BNSTAL (McDonald et al., 1999). The 
CeA projects to the BNSTOV and the BNSTAL. The strongest connections to both the 
BNSTOV and the BNSTAL originate from the amydalopiriform transitional area (APir) 
(McDonald et al., 1999). The APir is a region in the temporal lobe involved in 
olfactory processing (Jolkkonen et al., 2001) (Figure 1-4, Figure 1-5, Figure 1-6).  
Recent brain imaging-based analysis of BNST connectivity in humans indicates a 
very similar connectivity to that described in rodents, indicating that functional 
studies in rodents are likely to reflect largely human neural physiology (Lebow & 
Chen, 2016). 
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Figure 1-4 Connectivity of the BNSTAL to key brain regions outside of the BNST. 
Dark green locations represent afferent projections, yellow shapes represent efferent 
projections and the light green represent reciprocal connections. Abbreviations; 
amydalopiriform transitional area (Apir), infralimbic cortex (IL), Prelimbic cortex (PL), 
ventral subiculum (VS), central amygdala (CeA), dorsal raphe (DR), ventral 
tegmental area (VTA), nucleus accumbens (NA), paraventricular nucleus (PVN).  
 
 
Figure 1-5 Connectivity of the BNSTJc to key brain regions outside of the BNST. Dark 
green locations represent afferent projections, yellow shapes represent efferent 
projections and the light green represent reciprocal connections. Abbreviations; 
amydalopiriform transitional area (Apir), infralimbic cortex (IL), Prelimbic cortex (PL), 
the CA1 region of the hippocampus (CA1).  
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Figure 1-6 Connectivity of the BNSTOv to key brain regions outside of the BNST. 
Dark green locations represent afferent projections, yellow shapes represent efferent 
projections and the light green represent reciprocal connections. Abbreviations; 
amydalopiriform transitional area (Apir), infralimbic cortex (IL), central amygdala 
(CeA), nucleus accumbens (NA), paraventricular nucleus (PVN), periaqueductal gray 
(PAG). 
 
 
1.1.4. Electrophysiological characterisation of neurons located in the 
anterolateral area of the BNST  
The original classification of neurons in the BNSTALG  of the rat identified 3 distinct 
population of neurons which can be characterised based on their 
electrophysiological properties (Hammack et al., 2007a). Type I cells sometimes 
called regular spiking cells, exhibit sag in response to hyperpolarising current 
injections and are regular spiking in response to depolarising current injection. Type 
II cells also display a degree of sag in response to a hyperpolarising pulse but they 
also exhibit a nonlinear response to depolarising stimuli referred to as a ‘hump’, 
thought to be driven by T-type calcium channels. Type III cells display no sag in 
response to hyperpolarising current injection. Another key characteristic of these 
cells is the presence of inwardly rectifying K+ channel (Hammack et al., 2007a).  
These neuronal classification described above were based on 24-48 day old male 
Sprague-Dawley rats. In 2017 Daniel et al expanded this classification to include the 
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C57BL/6 male mice and Macaca mulatta monkeys. Similar populations of cells were 
observed across the three species, however ~ 7% of the cells recorded in the mouse 
did not match the criteria for the three populations previously described. Of the cells 
which did not fit the Hammock classification 4/6 of these cells were regular spiking 
but displayed no sag in response to hyperpolarising current injections. the other 2 
cells had an inward rectifying current indicating Type III but also had sag which 
would indicate Type I or Type II, this prevented them from fitting into any of the 
classifications. This would indicate that while the populations are similar there are 
potentially some discrepancies in their use in species other than rat (Daniel et al., 
2017).  
A review by Daniel et al 2016 has hypothesised the role that each of these cell types 
play in downstream physiological effects; CRF-expressing cells are primarily located 
in the BNSTOV and the BNSTFU, their physiological properties of these CRF-
expressing cells correlate with type III neurons, since 95 % of type III neurons 
express CRF mRNA (Dabrowska et al., 2013). As selective activation of CRF-
expressing cells in the BNSTOV leads to increased anxiety behaviours (Sahuque et 
al., 2006) this population is believed to represents an ‘anxiety on’ switch. In an 
unpublished observation from the Rainnie lab (Daniel & Rainnie, 2015) they found 
that only type II neurons express mRNA for protein kinase c - (PKC-. In the CeA 
the PKC-+ neurons represent an ‘anxiety off’ switch through reciprocal inhibition of 
CRF-positive cells. A number of similarities exist between the BNST and the 
amygdala, the BNST is sometimes referred to as the extended amygdala (McDonald 
et al., 1999; Dong et al., 2001b; Janitzky et al., 2014; Pleil et al., 2015). Given the 
similarities between the amygdala and the BNST this would translate to a situation in 
which type III neurons represent “anxiety on” and type II neurons represent “anxiety 
off” switch. The role of Type I neurons is less clear; while the Daniel et al 2016 
review have proposed that type I neurons exhibit an ‘anxiety off’ switch the reasoning 
behind this is unclear (Daniel & Rainnie, 2016).  
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1.1.5. The role of the BNST in stress processing  
 
As indicated earlier, the BNST can elicit both anxiolytic and anxiogenic responses, 
mediated by a number of key modulators including CRF and serotonin. Injection of 
CRF into the ventricle enhances the startle response in rodents (Swerdlow et al., 
1986), but this effect can be blocked via lesions to the lateral BNST or microinjection 
of a CRF antagonist into the BNSTALG (Lee & Davis, 1997). A number of other 
anxiety related behaviours can be enhanced via micro infusion of CRF directly into 
the BNST, such as decreased time in the open arm on the elevated plus maze. The 
elevated plus maze is commonly used test for anxiety; a decrease in the proportion 
of time spent in the open component of the maze vs the walled area is an indicator of 
heightened anxiety. The micro infusion of CRF into the BNST also causes a 
reinstatement of drug seeking behaviour (Erb & Stewart, 1999; Liang et al., 2001). 
Chemogenetic inhibition of CRF neurons in the BNST leads to decreases in anxiety 
like behaviour (Pleil et al., 2015). The BNSTOV contains a population of CRF 
neurons, within this population, CRF mRNA increases in response to stress (Makino 
et al., 1994; Funk et al., 2006) indicating a key role of this region in stress 
processing.  
There are 2 CRF receptors, type 1 (CRFR1) and the type 2 (CRFR2) CRF receptors, 
they are plasma membrane G-protein coupled receptors (Liapakis et al., 2011). 
CRFR1 predominantly acts through the Gs pathway; this pathway leads to a 
cascade of events beginning with the activation of adenylyl cyclase causing the 
formation of cyclic AMP which phosphorylates protein kinase A (PKA) (Jedema & 
Grace, 2004). PKA mediated signalling has been implicated in in upregulation of 
BDNF in cerebral cultures (Bayatti et al., 2005), inactivation of potassium channels in 
locus ceruleus neurons (Jedema & Grace, 2004) and activation of serine threonine 
kinase (SGK-1) in primary hippocampal cultures (Sheng et al., 2008); SGK-1 is 
involved in the mediation of synaptic plasticity and cell survival. Another CRFR1 
pathway activated via cyclic AMP involves extra-cellular signal-regulated kinase-
mitogen-activated protein kinase (ERK-MAPK) which can regulate BDNF signalling 
in cultured neurons from the LC (Jedema & Grace, 2004). To my knowledge no one 
has examined the signalling cascades of CRFR1 in the BNST. 
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While CRFR1 is expressed solely in the CNS, CRFR2 is expressed both in the CNS 
and peripheral tissue. The CRFR2 differs from the CRFR1 in its endogenous ligands. 
It has a lower affinity for CFR in comparison to CRFR1 but unlike CRFR1 it has a 
high affinity for urocortin (Ucn), specifically Ucn2 and Ucn3. Urocortins play a key 
role in stress responses, cardiovascular responses and metabolism (Pal et al., 
2010). CRFR2 also mediates its downstream effects via adenyl cyclase and the 
formation of cAMP (Lewis et al., 2001).  
Within the BNSTALG, CRF acts presynaptically to enhance glutamatergic 
transmission and increases the frequency of spontaneous excitatory post synaptic 
potential (sEPSCs) in a CRF receptor (CRFR1) dependent manner (Kash et al., 
2008). This would indicate that glutamatergic input into the BNST is modulated in a 
stress dependent manner by a CRF population; however it is currently unknown 
which glutamatergic inputs are being modulated. This could be addressed using 
optogenetic targeting of the different afferent projections; however to my knowledge 
this has not been carried out. The BNST also receives CRF afferents from the 
amygdala (Sakanaka et al., 1986; Day et al., 1999) so it is difficult to attribute these 
actions solely to the CRF population within the BNST.  
Within the BNST, CRF neurons send inhibitory afferents to the BNSTAL. The 
BNSTALG is predominantly GABAergic therefore inhibition of it may lead to decreased 
inhibition in other key circuits in the stress pathway (Turesson et al., 2013). BNST 
CRF-expressing neurons also innervate a number of nuclei outside of the BNST 
including the DR, PVN, VTA, PAG and LC (Dabrowska et al., 2016). These circuits 
play a key role in stress modulation therefore it is highly probable that the anxiogenic 
effects of CRF are being mediated within a combination of these regions (Daniel & 
Rainnie, 2016). More specific targeting would be required to address the 
downstream effects of the CRF population within the BNST.  
Another key neurotransmitter system involved in the modulation of stress in the 
BNST is that of serotonin. Serotonin (or 5-hydroxytryptamine (5-HT)) is a 
monoamine neurotransmitter; there are seven families of 5-HT receptors in the CNS 
(Liapakis et al., 2011). One of the most commonly used classes of drugs for the 
treatment of both anxiety related disorders and depression are selective serotonin 
reuptake inhibitors (SSRIs) (Stokes & Holtz, n.d.; Kent et al., 1998). SSRIs do not act 
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directly on 5-HT receptors, rather they increase the amount of serotonin in the 
synaptic cleft by limiting its reabsorption into the presynaptic cell. This is mediated 
via inhibition of the serotonin transporter. There are a number of clinically available 
SSRIs, these include Fluoxetine, Fluvoxamine, Paroxetine, Ciitalopram and 
Sertraline (Rang et al., 2007).  
In the BNST availability of serotonin transporter (5-HTT) positively correlates with 
anxiety-like behaviour in monkeys (Oler et al., 2009). The BNSTALG receives dense 
inputs from serotonergic dorsal raphe cells, which can act in an anxiolytic or 
anxiogenic manner depending upon the receptor which it innervates. Presynaptically, 
activation of 5-HT1B receptors causes increases in glutamatergic transmission in the 
BNSTALG (Guo & Rainnie, 2010). While the effects of specific activation of the 5-HT1B 
receptor within the BNST are unknown, activation of this receptor in the wider CNS 
leads to increased aggression and impulsivity (Saudou et al., 1994; Nautiyal et al., 
2015). Postsynaptically, 5-HT1A hyperpolarises cells, producing an anxiolytic effect 
(Levita et al., 2004). When activated 5-HT2c depolarises cells in the BNST, 
contributing to an anxiogenic state, albeit this study found these changes in the 
ventral part of the BNST (Marcinkiewcz et al., 2015). From this we can see that the 
serotonergic circuitry has opposing action on BNST populations.  
Serotoninergic cells within the DR are subject to modulation by CRF in a dose 
dependent manner; at low doses CRF is inhibitory acting primarily via CRFR1 due to 
its higher affinity for this receptor, at higher doses CRF becomes excitatory most 
likely through its actions on CRFR2 (Kirby et al., 2000; Amat et al., 2004; Hale et al., 
2010). As CRF neurons innervate the BNST, stress related changes in CRF 
expression may lead to increased activation of DR serotonergic neurons. The 
primary action of serotonergic inputs into the BNST is inhibitory (Daniel & Rainnie, 
2016). A negative feedback loop has been hypothesised by Hammack et al 2009, in 
which stress induced CRF release from BNSTALG neurons leads to activation of DR 
serotonergic neurons. These DR neurons innervates the CRF-expressing neurons 
within the BNSTALG where they block stress induced CRF release. (Hammack et al., 
2009).  
Due to the central role of the BNST in stress and anxiety it has been implicated in a 
number of different anxiety-related disorders including general anxiety disorder 
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(GAD)(Pigott, 2003; Conrad et al., 2011b, 2011c; Yassa et al., 2012), drug addiction 
(specifically stress-induced relapse)(Shaham et al., 2003; Dumont et al., 2005; Li et 
al., 2012; Jennings et al., 2013) and post-traumatic stress disorder (PTSD) 
(Hammack et al., 2012; Lebow et al., 2012; Janitzky et al., 2015; Rodriguez-Sierra et 
al., 2016).  
 
1.1.5.1. The role of the BNST in PTSD 
PTSD is a debilitating psychiatric disorder characterised by flashbacks, increased 
activity of HPA axis, increases in arousal and difficulty sleeping. PTSD sufferers  
often live in a hypervigilant sustained fear state (Bremner et al., 1997a; Admon et al., 
2009; Somerville et al., 2010; Brinkmann et al., 2017).  
While this sustained fear state alone would indicate the involvement of the BNST, a 
number of other aspects of PTSD involve processes mediated by the BNST 
(McElligott & Winder, 2008; Lebow et al., 2012). A commonly used, albeit debated, 
marker of PTSD is increased cortisol levels; HPA regulation is mediated by the 
BNST as discussed in the previous section (Klaassens et al., 2012; Zaba et al., 
2015). One of the most commonly used treatments for PTSD include SSRIs which 
mediate a number of their actions via the serotonergic system in the BNST which 
was discussed earlier (Schneier et al., 2015; MacNamara et al., 2016).  
The CRF circuit within the BNST has been implicated in aspects of PTSD-like 
behaviours in rodents; activation of the CRF circuit in the posterior area of the BNST 
either by optogenetic stimulation (Henckens et al., 2016)  or overexpression of 
CRFR2 decreased anxiety. Furthermore optogenetic activation of CRFR2 neurons in 
the posterior BNST following trauma reduces susceptibility to PTSD-like behaviour.  
Human studies have also produced similar findings, linking the CRF system within 
the BNST with PTSD. In human patients, heightened levels of CRF have been found 
in the cerebrospinal fluids of veteran’s suffering from PTSD (Bremner et al., 1997b; 
Baker et al., 1999). Human imaging studies have also found an increase in activation 
of the BNST in female PTSD patients in anticipation of aversive stimuli (Brinkmann 
et al., 2017), with these patients also displaying increased anxiety in anticipation of 
the aversive stimuli of a human scream.   
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While the BNST plays a role in PTSD it is worth noting that this is not isolated from 
other key regions such as the amygdala; Admon et al., (2009) found that increased 
activity in the amygdala increased ones susceptibility to PTSD. When an individual is 
faced with a real threat, both the BNST and the amygdala are involved in the fear 
response: exposure to an actual tarantula elicited responses in both brain regions 
(Mobbs et al., 2010). Also Münsterkötter et al., 2015 found enhanced functional 
connectivity between the amygdala and the BNST in individuals with spider phobias 
when looking at pictures of spiders.  
 
1.1.5.2. Integration of social cues and stressful stimuli   
The BNST displays connectivity to key regions associated with social interaction, 
such as the vomersonsal cavity, VTA, medial amygdala (MeA) and the 
hypothalamus including the ventromedial hypothalamus, preoptic area and anterior 
hypothalamus (Dong et al., 2001c). These circuits play a key role in behaviour and 
mood; the central role of the BNST allows it to dictate a positive or negative 
response to various inputs thereby contributing to social regulation. It is involved in 
parental attachment, mating behaviours and aggression (Lebow & Chen, 2016). 
While these behaviours are driven more by the medial and posterior parts of the 
BNST there is a complex internal network which links these systems to the 
anterolateral area (McDonald et al., 1999; Dong et al., 2001b).  
This social regulation can play a key role in fear processing; negative social 
interaction can induce anxiety in both rodents and humans, evidenced by the fact 
that a commonly used PTSD model is that of a larger intruder (Hammack et al., 
2012; Hammels et al., 2015; Huang et al., 2016). The opposing circuits discussed 
above in relation to responses to stress observed of the BNST (Daniel & Rainnie, 
2016) may play a key role in recognising social interactions from threats allowing for 
appropriate responses.  While this theory is a compelling one, the breakdown of 
these key social interactions via manipulation of various BNST circuitry has yet to be 
explored. 
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1.2. Intrinsic properties of neurons 
The central nervous system (CNS) encompasses the brain and spinal cord, it is 
composed primarily of two distinct population of cells, neurons and glial cells. Glial 
cells are comprised of three major populations; oligodendrocytes,  astrocytes and 
microglia.  
The main role of oligodendrocytes is to create a myelin sheath for axons in the CNS; 
this is similar to the function to the role of Schwann cells in the peripheral nervous 
system, these sheath play a key role in electrical propagation along the axis (Simons 
& Nave, 2016). Astrocytes are the most abundant cell type in the central nervous 
system (CNS) and constitute almost 20-40% of the total brain cell population(Khakh 
& Sofroniew, 2015).These star-like glial cells participate in many fundamental 
biological processes such as maintenance of ion homeostasis, neurovascular 
coupling, gliotransmitter release, modulating synaptic activity, metabolic support of 
neurons and immune responses(Suzuki et al., 2011; Panatier et al., 2011; Ransom & 
Ransom, 2012). During normal healthy conditions astrocytes are in a resting 
state(Sofroniew, 2009; Gallo & Deneen, 2014; Lee & MacLean, 2015). However, 
once activated, they undergo morphological changes, becoming more proliferative 
and begin releasing pro-inflammatory cytokines and growth factors, as well as nitric 
oxide (Zhao et al., 2011; Batarseh et al., 2016).  
While astrocytes are involved in immune responses the primary glial cell involved in 
immunity and inflammation in the brain are microglia. Microglia have a well 
characterised phagocytic function as well as playing a key role in both adaptive 
immune responses and non-specific inflammation. Microglia are capable of detecting 
dysfunction both within and outside of cells, CNS stimulus of microglia leads to an 
“activation” or maturation of the microglia. Following maturation these cells they 
increase expression of a number of pro-inflammatory cytokines and activation of 
immune genes such as mannose receptors and CD14 (Aloisi, 2001). Microglial 
function is not limited to immunity it also plays a role in synaptic pruning; this process 
is necessary for both development (Paolicelli et al., 2011) and synaptic plasticity 
(Clark et al., 2015).  
Dysfunction within glial populations have also been implicated in a number of 
disease states including depression, schizophrenia and Alzheimer’s disease. While 
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glial cells play a vital role in a healthy functioning brain this thesis will focus on 
neurons; however more information on glial populations and their role in neuronal 
function can be found in these reviews (Smiałowska et al., 2013; Takahashi & 
Sakurai, 2013; Öngür et al., 2014; Goldman et al., 2015).  
Neurons are electrically active cells which transmit information through electrical and 
chemical means. They are comprised of four key compartments; the cell body, the 
axon, the dendrites and the presynaptic terminal (Kandel et al., 2000). Neurons can 
conduct electrical currents across large distances, this is mediated via the movement 
of ions across the cell membrane. Here I will go into detail on mechanisms involved 
in electrical conductances of neurons including both active and passive membrane 
properties.  
 
1.2.1. Resting membrane potential  
The resting membrane potential of neurons arises from differences in the electrical 
charges on either side of the cell membrane. The concentration of certain ionic 
species in the inside and the outside of the cell differs. This difference in the 
concentration provides the foundation for the resting membrane potential. The 
electrical charge outside of the cell is arbitrarily defined at zero and so any charges 
within the membrane are subtracted leading to a determination of the membrane 
potential,  
Vm = Vin - Vout 
In a neuron there are 4 main ions which drive this electrical gradient these are Na+, 
Cl-, K+ and organic anions (A-). Na+ and Cl- have higher concentrations outside the 
cell while K+ and A- are in higher concentrations inside the cell (Table 1-2).  
Leak ion channels play a key role in maintaining the resting membrane potentials of 
cells. In nerve cells nongated channels can be selective for a number of different 
ions. In these channels the passage of ions is driven by passive diffusion; two key 
parameters play a role in this 1) the concentration gradient of the ion and 2) the 
electrical gradient which is affected by the charge of the ion. For example K+ ions will 
flow through leak channels when a cell is at its resting membrane potential. The 
concentration gradient of K+ will drive the ions out of the cell through these pores, 
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however this ion has a positive charge and as the charge outside the cell begins to 
become more positive it will drive the ion back into the cell. This balance between 
the two parameters is referred to as the equilibrium potential for any given ion. The 
Nernst equation, stated below, can be used to calculate the equilibrium potential of 
an ion (Kandel et al., 2000).  
The Nernst equation: 
𝐸𝑥 =  
𝑅𝑇
𝑧𝐹
ln
 [𝑋]𝑜
[𝑋]𝑖
 
 
Where R is the gas constant, T is temperature measured in Kelvin, Z is the valence 
of the ion, F is the Faraday constant, [X]o is the concentration of the ion outside the 
cell and [X]I is the concentration inside the cell.  
In a stereotypical neuron the equilibrium potential of each of these ions are listed 
below along with their intracellular and extracellular concentrations (Wright, 2004). 
Ion  Intracellular 
concentration (mM) 
Extracellular 
concentration (mM) 
Equilibrium 
potential (mV) 
Cl- 4 116 -88 
Na+ 12 140 +64 
K+ 135 4 -92 
Table 1-2 Concentration of ions in a typical neuron 
Leak channels allow the passive diffusion of Na+, K+ and Cl- across the membrane. 
In the case of Na+ and K+ their electrical charge means that their actions cancel out 
the electrical gradient change, however, should this process continue uninterrupted 
the concentration gradients of the ions would run down and reduce the resting 
membrane potential of the cell. In order to correct this change in concertation 
gradient the Na+-K+ pump moves these ion against their net electrochemical 
gradients; this requires energy which is provided in the form of ATP. The Na+-K+ 
pump is a transmembrane protein which has binding site for Na+ and ATP 
intracellularly and a K+ binding site extracellularly. The pump hydrolyses a single 
molecule of ATP providing it with sufficient energy to expel 3 Na+ ion and transport 2 
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K+. This discrepancy in electrical gradient is offset by the electrogenic nature of the 
pump itself (Kandel et al., 2000).  
In the case of the Cl- ion there are two possibilities, in some cells the passive 
diffusion is corrected via a Cl- pump. As the equilibrium potential of Cl- in neurons 
generally leads to an inward flow of the ion the Cl- pump is responsible for expelling 
excess Cl- from the cell. Some populations of neurons do not have these Cl- pumps 
and so in these cells passive diffusion across the membrane determines the resting 
membrane potential ie. the resting membrane potential will be equal to ECl.  
Cl-, Na+, and K+ are the main ions which flow across the membrane when the cell is 
at rest. A modified version of the Nernst equation referred to as the Goldman-
Hodgkin-Katz equation has been derived to calculate the resting membrane potential 
based on the movement of these ions.  
 
The Goldman-Hodgkin-Katz equation: 
𝑉𝑚 =  
𝑅𝑇
𝐹
ln
𝑃𝐾[𝐾
+]𝑜 +  𝑃𝑁𝑎[𝑁𝑎
+]𝑜 +  𝑃𝐶𝑙[𝐶𝑙
−]𝑖  
𝑃𝐾[𝐾+]𝑖 +  𝑃𝑁𝑎[𝑁𝑎+]𝑖 +  𝑃𝐶𝑙[𝐶𝑙−]𝑜
 
Vm is the membrane potential of the cell and P is the relative permeability of the 
different ions 
 
Current flow is defined as the direction of net movement of positive charge; this rule 
defines the way in which we describe net changes in electrical charge across the 
membrane. An influx of positive ions into the cell or an efflux of negative ions out of 
the cell, causes a net positive charge inside the cell, this is referred to as a 
depolarisation of the membrane potential. The opposite is true of hyperpolarisation of 
the membrane, where a net negative change inside the cell leads to 
hyperpolarisation of the cell.   
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1.2.2. Ion channels  
The membrane of cells is comprised of a lipid bilayer; due to the hydrophobic 
environment of the lipid bilayer charged ions are more likely to favour the hydrophilic 
environment that exists both within and outside of cells. Electrical signalling requires 
the rapid movement of ions across the membrane, as ions are unlikely to pass 
through this lipid membrane a number of pores exist within it to allow the transport of 
ions. These pores are comprised of proteins which can allow selective transport of 
different ions. Ion channels allow the passive transport of ions across the membrane 
meaning that large quantities of ions can move across the membrane without 
expending any metabolic energy (Kandel et al., 2000).  
Two forms of ion channels exist gated and non-gated. Gated channels can be further 
subdivided into voltage-gated, ligand-gated, light-gated, mechanically-gated and 
temperature-gated. Ligand gated channels open in response to activation by an 
agonist. Light gated ion channels change their conformation in repose to specific 
wavelengths of light, Channelrhodopsins are a naturally occurring example of this. 
These receptors now widely used as a tool in neuroscience to allow the activation 
and inactivation of specific populations in response to specific wavelengths of light 
and have been invaluable in enhancing our understanding of neuronal circuits 
(Boyden et al., 2005; Zhang et al., 2006; Han & Boyden, 2007; Boyden, 2015).  
Voltage gated channels open in response to changes in the membrane potential; the 
opening and closing of ion channels involves conformational changes in the protein. 
When Hodgkin and Huxley examined the electrophysiological properties of the giant 
squid axon they found voltage gated Na+ and K+ channels (Hodgkin &Huxley, 1952). 
These ion channels have since been found in neuronal populations throughout the 
brain, since these experiments voltage gated Ca2+  channels and voltage gated Cl- 
have also been identified.  
Voltage gated Na2+ channels can be classified into two families. In the first family 
there are nine subtypes have been identified, each type has specific expression 
patterns. In the CNS Nav1.1, Nav1.2, Nav1.3, Nav1.6 are expressed, Nav1.6, Nav1.7, 
Nav1.8 and Nav1.9 are expressed in the peripheral nervous system (PNS), Nav1.6 is 
expressed in skeletal muscles and Nav1.6 is expressed in cardiac muscles. In 
mammals, voltage gated sodium channels consist of the pore-forming α subunit and 
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one or two β subunits (de Lera Ruiz & Kraus, 2015). The second family, Nav2, is 
expressed in the heart, lung and Schwann cells. Its expression is restricted in the 
CNS and has been hypothesised to play a role in regulation of salt and water intake 
(Watanabe et al., 2000).  
There are twelve families of voltage gated K channels (Kv): Kv1 to Kv12. Kv are key 
regulators of excitability and the largest family of K+ channels. Their role in neuronal 
excitability is distinct to each family; Kv1, Kv4 and Kv7 are low-voltage activated 
channels and regulate threshold potential. Kv2 is a high-voltage activated slowly 
inactivating channel, which is involved in modulating firing during high frequency 
firing periods. Kv channels are also involved in regulating a number of neurological 
processes, including apoptosis, which has made it a potential target in a number of 
neurological disease (Shah & Aizenman, 2014).  
Another key example of voltage gated ion channels is the hyperpolarisation-activated 
cyclic nucleotide-gated (HCN) channels. In response to hyperpolarising stimuli, 
membranes often do not charge in a linear manner, one aspect of this is the 
presence of a ‘sag’ in response to hyperpolarising current injections. This is 
response is driven by voltage gated HCN channels which lead to an excitatory 
current in neurons referred to as Ih in response to hyperpolarising stimuli. These 
channels are involved in regulating the presynaptic release of neurotransmitters, 
dendritic excitability and initiation of rhythmic firing (He et al., 2014).  
The role of HCN channels in neuronal excitability is cell type for specific, for example 
in hippocampal pyramidal cells HCN channels are located on distal dyndrites where 
they play more of a role in functional connectivity (Lörincz et al., 2002). Ih currents 
also impact input resistance, HCN channels which are open at rest depolarise the 
membrane pushing cells closer to their threshold potential thus increasing their 
excitability (He et al., 2014). This diverse functions allows these channels to act as 
regulators of neuronal function at both the dendritic and soma level.  
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1.1.1. Passive membrane properties  
The passive electrical properties of neurons play a key role in regulating excitability 
and determining responses to synaptic inputs, these will be discussed in detail 
below. Here I will discuss how input resistance, capacitance and the membrane time 
constant can influence the behaviour of a cell.  
The input resistance of a cell is mediated by the resistance of the membrane, this is 
a reflection of the leak channels discussed above. As the membrane itself functions 
as a resistor, we can use Ohm’s law to determine the level of resistance.  It is 
measured as the amount that the membrane deflects in response to a steady state 
current injection.  
Ohm’s law: 
𝑉 =  𝐼𝑅 
Where I is current, V is voltage change and R is resistance (Ω).  
As we are interested in the resistance of the cell we can rearrange the equation to 
Ohm’s law  
𝑅 =  
𝑉
𝐼
 
The resistance of the membrane can have a large impact on spike generation in 
cells; larger input resistances will cause a larger deflection from baseline voltage in 
response to changes in current. In this manner synaptic events will generate a larger 
response in a cell with a higher input resistance increasing the likelihood of that cell 
reaching action potential threshold and generating an action potential.  
If a membrane functioned as a true resistor, then a step change in current would 
lead to an immediate step change in voltage, however there is a delay in the voltage 
deflection observed. This delay in the voltage deflection is due to the fact that 
neuronal membranes function not only as a resistor, but also as a capacitor. The 
charging of the membrane is exponential in nature, in order to quantify this curve the 
membrane time constant is examined.  
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The time constant is  
1 −
1
𝑒
 
 
This equates to ~63.2% of the final peak value reached. The membrane time 
constant can play a significant role in action potential generation, due to the fast 
nature of synaptic events slower time constants can prevent the cell from reaching 
threshold in this short period.  
A capacitor stores electrical charge in a manner proportional to the size of the 
membrane. Due to this a higher capacitance of a cell would indicate a larger 
membrane area and therefore a larger cell. A second variable can affect capacitance 
which is the size of the insulator; in the case of neurons the lipid bilayer is assumed 
to be constant at 4 nm this means the capacitance of the membrane can be 
calculated, in neuronal cells this is ~ 1µF/cm2 of membrane. The capacitance of the 
membrane is directly related to the input resistance and the membrane time constant 
of a cell. This allows the capacitance to be calculated based on these other 
parameters as described below: 
𝐶 =  
𝑇𝑎𝑢
𝑅
 
Where C is the capacitance, R is the resistance and Tau is the membrane time 
constant.  
1.2.3. Action potentials  
Large depolarising changes in the membrane potential such as those caused by 
excitatory synaptic events can lead to an action potential. Before a neuron can 
generate an action potential it must reach threshold potential; threshold is a 
membrane potential which the cell must reach to initiate the all or nothing action 
potential. Should one of these inputs reach threshold a number of voltage activated 
Na+ channels will open. Once this happens, the influx of Na+ into of the cell becomes 
larger than the K+ efflux and leads to depolarisation of the cell. This causes more 
voltage gated Na+ channels to open leading to an even greater influx of Na+ ions. 
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This process causes the rising phase of an action potential. The Na+ equilibrium 
potential in neurons is approximately +64 mV, however even on the rising phase of 
an action potential K+ is flowing preventing the cell from reaching this membrane 
potential. The downward phase of an action potential is driven by two forces, the 
inactivation of the Na+ channels and the delayed opening of voltage gated K+ 
channels. A final aspect of the action potential is the after-spike potential; there are 
two main after-spike potentials which can be either hyperpolarising ie. an 
afterhyperpolarization potential (AHP) or depolarising ie. an afterdepolarization 
potential (ADP) (Kandel et al., 2000).  
The action potential is propagated along the axon in the same manner in which it 
was generated. Voltage gated Na+ channels open along the axon followed by the 
delayed opening of the K+ channels allowing the current to flow along the axon. In 
some neuronal populations, such as those in the spinal cord the axons are 
surrounded by insulating glial cells which increase the efficiency of this propagation 
(Kandel et al., 2000).  
While the basic properties of action potential generation are generally the same for 
all CNS neurons the variety and differences in expression levels of the ion channels 
can vary greatly from cell to cell. This can have a large impact on the action potential 
of a given cell affecting a number of properties such as changes in threshold or 
action potential height and width. Changes in threshold will alter the required current 
needed to initiate an action potential. Changes the action potential width or peak 
height can have an impact on the release of neurotransmitters from the cell.  
 
1.2.4. Synapses and synaptic transmission  
Synaptic transmission is the mechanism by which nerve cells communicate. A 
synapse is comprised of a presynaptic terminal on the axon of a neuron which 
communicates with a postsynaptic terminal in the dendrite of another neuron.  
The release of neurotransmitters is mediated by an influx of Ca2+ into the cell as the 
extracellular concentration of Ca2+ is higher than the intracellular concentration this 
influx is mediated by passive diffusion through voltage-gated Ca2+ channels. Voltage 
gated Ca2+ channels are conjugated at the neuromuscular junction, the high local 
44 
 
concentration of these voltage gated Ca2+ channels in the ‘active zone’ allows for a 
rapid localised increase in Ca2+. The calcium sensors which are responsible for the 
release of the vesicle have a low binding affinity between 50-100 µM whereas most 
enzymatic reactions require only ~1 µM. The rapid influx allows high enough 
concentrations to be reached however due to passive diffusion these high 
concentrations are only maintained for ~1 ms; this mediated the speed of synaptic 
transmission. Neurotransmitters are stored in vesicles at the synaptic terminal, once 
neurotransmitter release is instigated, exocytosis of the contents of the vesicle takes 
place. This process is mediated by a protein complex involving soluble NSF-
attachment protein receptor (SNARE) and Sec1/Munc 18-like (SM) protein which 
mediate the formation of a fusion pore. The formation of a fusion pore which expels 
the neurotransmitter into the synaptic cleft (Kandel et al., 2000).  
Most neurotransmitter release is mediated via depolarisation of the cell; tetrodotoxin, 
a compound which blocks Na+ channels inhibits action potential generation 
preventing calcium induced binding of the SNARE protein thereby preventing 
neurotransmitter release. Miniature IPSCs can be observed in the presence of TTX; 
these reflect spontaneous neurotransmitter release (Ropert et al., 1990).  
These neurotransmitters then act on receptors on the post synaptic terminal. There 
are two broad classes of receptors at synapses, ionotropic and metabolic receptors. 
Ionotropic receptors contain an ion channel which opens in response to agonist 
binding allowing movement of ions across the cell membrane thereby eliciting an 
electrical response. Actions at metabotropic receptors are mediated via a second 
messenger system inside the postsynaptic cell (Kandel et al., 2000).  
Neurotransmitters can be both excitatory and inhibitory; the two most abundant 
neurotransmitters in the mammalian brain are L-Glutamate and GABA. While 
glutamate is primarily considered to be excitatory and GABA is generally inhibitory, 
the effect of any given neurotransmitter is dependent on the type of receptor on the 
postsynaptic cell and the effect that receptor has on the properties of the cell.  
Glutamate acts at 2 broad classes of receptors; these are ionotropic and 
metabotropic. The three main ionotropic receptors these are AMPA receptors, 
NMDA receptors and kainate receptors. These channels are ion permeable channels 
which allow the flow of Na+ and K+ and, in some cases, Ca2+. Opening of these 
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channels leads to a depolarisation of the cell; for this reason glutamate is seen as 
the primary excitatory neurotransmitter in the brain. The second major class of 
Glutamate receptors are metabotropic glutamate receptors (mGluR) which are G-
protein coupled receptors. mGluRs are involved in the modulation of cell excitability 
and synaptic transmission via second messengers (Niswender & Conn, 2010).  
1.1.1.1. GABA 
There are three main receptor classes at which GABA is functionally active; these 
are known as GABAA, GABAB and GABAC receptors. Briefly the GABAB receptor is a 
metabotropic receptor, activation of which causes a second messenger cascade 
mediated by G protein. The downstream effect of GABAB receptor activation is 
dependent upon the associated G protein, the effects include the opening of a K+ 
channel (Kandel et al., 2000), stimulation of adenyl cyclase (A.R Knight, 1996; 
Olianas & Onali, 1999) or inhibition of Ca2+ channels (Bowery et al., 2002; Bettler et 
al., 2004).  
GABAA and GABAC (Bormann & Feigenspan, 1995) receptors are anionic selective 
channels that are permeable to Cl-. Increased permeability of Cl- in most mature 
neurons leads to a reduction in neuronal excitability. In most mature neurons the 
external concentration of Cl- is higher than the internal concentration of Cl-, the 
opening of this channel leads to an influx of Cl- and hyperpolarisation of the cell 
(Olsen & Sieghart, 2008).  
There are 16 subunits which can combine in a variety of manners to form GABAA 
receptors, consisting of 6 α subunits, 4 β subunits and 4  subunits, a  subunit, a 
subunit, a π subunit, a ϴ subunit. There are also 3 receptors, however these 
contribute to GABAC receptors. Each of these subunits have various splice variants, 
leading to a wide array of possible subunits (Olsen & Sieghart, 2008). GABAA 
receptors are made up of 5 subunits usually comprising 2  subunits, 2 subunits 
and 1 other subunit (Chang et al., 1996); the expression of these subunits differs 
greatly throughout the brain (Lovick, 2006).This has a major impact on function of 
the receptors as subunit composition of these receptors affects the pharmacology of 
the receptor. The  subunit is necessary for the synaptic location of the GABAA 
receptor, while those lacking this subunit will often contain the  subunit and are 
extrasynaptic (Wei et al., 2003).
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Neurons will invariably receive a combination of synaptic inputs both from the 
neurotransmitters discussed here and the various other neurotransmitters in the 
brain which can be both excitatory and inhibitory in nature. A single excitatory 
synaptic input is usually not large enough to drive a cell to threshold, this often 
requires multiple synaptic events at multiple synapses. The effect of these excitatory 
inputs can be counterbalanced by the action of inhibitory synapses in the region. 
Therefore it is the balance between excitatory and inhibitory synaptic input which 
determine the impact of synaptic events on action potential generation.  
 
1.3. The oestrus cycle  
 
The oestrus cycle is regulated via the hypothalamus-pituitary-gonad axis; 
gonadotrophin-releasing hormone (GnRH) is released in the anterior pituitary by 
GnRH cells which project from the hypothalamus and septal area. This leads to the 
peripheral release of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) 
from the gonadotrophs, these hormones stimulate the ovary leading to ovulation 
(Caligioni, 2009).  
Estradiol, one of the estrogens often referred to as E2, is released by the ovaries 
prior to ovulation which provides a positive feedback loop stimulating GnRH neurons. 
This peak in E2 levels has been shown to have effects on other key processes in the 
body including cardiac (Scharfman et al., 2003) and neuronal (Walf & Frye, 2007) 
function. 
The diestrus phase of the mouse and rat oestrus cycle and the premenstrual phase 
of the human oestrus cycle are characterised by a decline in plasma levels of 
progesterone (Figure 1-7). Progesterone plays a key role in many aspects of 
pregnancy and is required to produce mammalian offspring. As this thesis has 
focused on virgin females I will not go into much detail on this; more details can be 
found in a review by Spencer et al 2002 (Spencer & Bazer, 2002). In cycling 
females, progesterone is involved in the negative feedback of the GnRH cells 
(Skinner et al., 1998). Progesterone also plays a key role in stress modulation, the 
effect of which may be partially mediated by the BNST and will be discussed in the 
following section.  
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Figure 1-7 Changes in hormone levels during the mouse estrus cycle as depicted in 
Miller and Takahashi, 2014 
 
 
 
1.4. The sexually dimorphic nature of the BNST  
The BNST is a sexually dimorphic region in both the rodent and the human. In the 
rat, the encapsulated region of the BNST is twice the size in males in comparison to 
females (Hines et al., 1992), this is driven by heightened cell death in females during 
development (Hines et al., 1992). The sexually dimorphic nature of the BNST plays a 
role not only in gender specific behaviours but also in sexual identity. In human the 
central subdivision has been found to be larger in males than females. Interestingly 
male to female transsexuals have the BNST of females, this has led to the 
hypothesis that the BNST plays a key role in sexual identity (Hines et al., 1992; 
Kruijver et al., 2000). The BNST also mediates a number of sexually distinct 
behaviours such as maternal behaviour, aggression in males and sexual behaviour. 
The BNST plays a key role in anxiety and anxiety-related disorders; the incidence of 
anxiety related disorders in the population is estimated to be ~60% higher in 
females, some estimates put levels of PTSD in females at twice that observed in 
male population (Kessler et al., 1995; Breslau & Kessler, 2001). There is debate 
within the field whether the main reason for this is down to neurological differences in 
the processing of stress within the brain or if societal effects are playing a role (Tolin 
& Foa, 2006). While societal effects are undoubtedly influencing these altered 
48 
 
susceptibilities, a number of regions associated with stress processing including the 
hippocampus, PAG and BNST are sexually dimorphic.  
A key difference between males and females is the levels of circulating hormones 
which play a role in reproduction. Females will undergo constantly changing levels of 
hormones which due to their lipophilic nature can easily cross the blood brain barrier 
and elicit significant effects at nuclear receptors and lipid bound receptors. Both 
estrogen and progesterone receptors are located throughout the brain; this would 
indicate that their function is not limited to reproduction.  
Estradiol is a key hormone involved in reproduction as discussed above, it also has a 
number of vital functions outside of the reproductive system including in bone health 
(Albright et al., 1941), and in the CNS where estrogen receptors are abundantly 
expressed. Estradiol is upregulated during stress (Shors et al., 1999) but its effects 
are anxiolytic (Walf & Frye, 2007). 
Progesterone receptors function in three major ways, through regulation of gene 
expression, activation of cell signalling cascades and modulation of neurotransmitter 
systems (Brinton et al., 2008). Progesterone has been implicated in a number of 
stress related responses; in fact progesterone levels have been found to increase 
during acute stress (Barbaccia et al., 2008). The main effect of progesterone on 
stress is thought to be mediated not by the hormone itself but by one of its key 
metabolites, Allopregnalone (ALLO) (Gulinello et al., 2003; Lovick, 2006, 2012; Shen 
et al., 2007; Nagaya et al., 2015a). Levels of ALLO and progesterone are tightly 
linked; at the end of the proestrus phase of the mouse cycle where a drop in 
progesterone is observed there is equal drop in ALLO (Lovick, 2012).  
ALLO affects excitability of neurons, both withdrawal from progesterone (Smith et al., 
1998a, 1998b; Devall et al., 2009) and increases in progesterone (Shen et al., 2005) 
induce upregulation of extra synaptic GABAA by activating the genes encoding α4, 
β1 and  subunit. As discussed earlier, the presence of the  subunit into the GABAA 
complex leads to the extrasynaptic placement of the receptor. The extrasynaptic 
placement of these receptors leads to an increase in tonic inhibition which causes a 
decrease in excitability.  
A large body of evidence has linked the anxiogenic effects of progesterone 
withdrawal to effects mediated by the periaqueductal gray matter (PAG). The PAG is 
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a key pathway in pain modulation and processing of stress, two characteristics which 
show gender specific behaviours. Cycle-specific changes in excitability have been 
observed in this region which highlights its susceptibility to fluctuations in hormones. 
Similar to a number of other brain regions characterisation of the PAG was based 
primarily in males, however recently more females are being studied due to the 
evident role of hormones in this area (Lovick, 2006, 2012; Brack & Lovick, 2007a; 
Johnson et al., 2012; Jiang et al., 2014).  
The PAG has reciprocal connections with the BNST which also has a high 
concentration of both estrogen receptors and progesterone receptors specifically 
within the anterolateral area. Similar to the PAG most of the characterisation of this 
region has focused on males especially within the rodent. However recent evident is 
starting to emerge of the central role of the BNST in gender specific responses to 
stress.  
Systemic administration of ALLO blocks CRH-enhanced startle response in female 
rats (Toufexis et al., 2004), thought to be a BNST-mediated process. Nagaya et al 
(2015) examined the gender-specific effects of ALLO on the BNST by altering levels 
of ALLO in the BNST in a gender specific manner. This was carried out firstly via 
local infusion of ALLO into the BNST of male rats and secondly either an inhibitor of 
ALLO synthesis or an ALLO antagonist into the BNST of female rats. In males, the 
attenuation of ALLO in the BNST leads to a decrease in contextual freezing while in 
females reduction of ALLO activity in the BNST elicited enhanced contextual freezing 
(Nagaya et al., 2015a). This sexually dimorphic response to changes in ALLO 
highlights the importance of gaining greater understanding of the role of this 
compound, and the pathways it triggers, in the BNST. 
At nanomolar  concentrations, ALLO acts as an allosteric modulator of the GABAA 
receptor (Shen et al., 2007). Systemic administration of ALLO has also been shown 
to change the expression levels of the delta subunit of the GABAA receptor in 
hippocampus leading to greater extra synaptic placement of the receptor (Shen et 
al., 2005). This extrasynaptic placement means its effects are not limited to 
GABAergic synapses, indeed it has been shown that ALLO can modulate glutamate 
release presynaptically via extrasynaptic GABAA (Iwata et al., 2013).  
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1.5. Health ageing  
Healthy aging is associated with a number of cognitive and behavioural changes. 
Over the lifespan of both humans and rodents there is a decrease in cognitive 
function (Disterhoft et al., 2004) along with changes in susceptibility to anxiety-like 
disorders (Garrido, 2011). The changes in cognitive function are mediated at least in 
part by changes in hippocampal function where changes in excitability of neurons 
have been observed (Wilson et al., 2005; Randall et al., 2012). Aging has been 
shown to impact intrinsic properties in a number limbic brain regions such as the 
hippocampus and prefrontal cortex (Disterhoft et al., 2004; Chang et al., 2005a; 
Wilson et al., 2005; Randall et al., 2012; Hermann et al., 2014; Prenderville et al., 
2015; Tamagnini et al., 2015; Rodríguez-Arellano et al., 2016). A number of 
underlying factors have been attributed to these changes including changes in Na+ 
channel function which leads to changes in excitability in the hippocampus (Randall 
et al., 2012), changes in GAD-67 expression in hippocampal interneurons (Stanley & 
Shetty, 2004) and AHP magnitude (Landfield & Pitler, 1984; Kumar & Foster, 2002). 
While to my knowledge no similar differences have been reported in the BNST, 
changes in other brain regions provide some basis to examine alterations in intrinsic 
electrophysiological properties within the BNST.  
Changes in stress processing across the lifespan occur in a sex specific manner, I 
have already discussed the impact of sex hormones on stress processing so it is 
unsurprising that changes in hormone levels can have an impact on various 
neurological functions. In humans females undergo menopause in approximately the 
fifth to sixth decade of life, in mice this is referred to as senescence and occurs at 
~18 months (Ehrchen et al., 2004).  
In senescence rats anxiety levels have been shown to be higher in males than in 
females when measured in the open field. The administration of 21 days of restraint 
stress, 6 h/day, reduced anxiety shown by female rats and increased the anxiety 
shown in the males (Bowman et al., 2006); producing a highly gender specific 
response. Testosterone has been shown to regulate the HPA axis function via 
vasopressin and CRF synthesis (Viau, 2002). This effect is not mediated via 
testosterone itself but rather mediated via a metabolite of testosterone, 3β-diol (Lee 
et al., 2001). Males also undergo senescence, sometimes referred to as 
hypogonadism, which can be observed in both humans (Wu et al., 2008, 2010; 
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Ahern & Wu, 2015) and rodents (Lovick, 2012; Donner & Lowry, 2013) and is 
characterised by a decrease in testosterone. The drop in testosterone could account 
for the changes in anxiety observed.  
Female menopause, or senescence, is characterised by a decline in a number of sex 
hormones including estradiol and progesterone both of which have been shown to 
have anxiolytic properties (Chen et al., 2004; Walf & Frye, 2007; Lovick, 2012). 
Progesterone has been shown to be protective against a number of age-associated 
disease such as Alzheimer’s disease and stroke (Lee et al., 2001). The key role of 
progesterone in stress processing along with the gender specific nature of its effects 
was addressed earlier. Decreases in these key hormones may lead to increased 
anxiety and increases in a number of age-associated diseases such as Alzheimer’s 
disease and osteoporosis.  
Little research has been carried out on the BNST in healthy aging and to my 
knowledge no studies have looked at the electrophysiological properties of the BNST 
in aging; however some research has been carried out in gene expression levels of 
various key mediators within the BNST. Nutsch et al 2017 examined the expression 
levels of a number of key genes associated with behaviour in the both the BNST and 
several other regions associated with hypothalamic modulation. They found a 
decrease in expression of six genes; Cyp19a1, Esr2, Kiss1r, Nos1, Oxtr and Thra 
(Nutsch et al., 2017) in male Spague-Dawley male rats at 18 months in the BNST 
compared with 5 months. While the role of these genes has often not been studied in 
great detail in the BNST some studies have touched upon the effect they may be 
playing within this circuit. Cyp19a1 is the gene associated with aromatase, a key 
enzyme in the production of estradiol. While this paper did not examine protein levels 
one could hypothesise that a decrease in expression could lead to a decrease in 
local estradiol production. The Kiss1r gene encodes the kisspeptin receptor which is 
involved in sexual behaviour (Gresham et al., 2016) and oestrogen signalling in the 
amygdala of male rats (Stephens et al., 2016).  
The decrease in expression of Nos1 and Esr2 would indicate a decrease in NO 
production in the BNST with age, this is based on observation in the PVN where 
estrogen increases NO production through interaction with ERβ (Gingerich & Krukoff, 
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2005, 2006). In the BNST, NO is anxiolytic, as such a reduction should lead to 
decrease in anxiety responses (Faria et al., 2016).  
Decreases in oxytocin binding within the BNST have previously been associated with 
increases in parental care (Perea-Rodriguez et al., 2015)  and increases in 
aggression (Calcagnoli et al., 2014). Perea-Rodriguez et al (2015) found that a 
decrease in Oxtr mRNA observed in first time fathers was associated with an 
increase in parental care in comparison to virgin males. However it is worth noting in 
this study they also observed decreases in expression of the progesterone and 
vasopressin receptors as such the behavioural observations may not be entirely 
attributable to the decrease in OXR expression. The role of the Oxytocin system in 
aggression was addressed by Calcagnoli et al (2014) where they observed 
increases in OXTR binding in the BNST and CeA were associated with highly 
aggressive rats.  
The final gene identified was the Thra gene; while the role of this gene has not been 
studied in the BNST, the knockout model displays heightened anxiety and facilitated 
sexual behaviour (Vasudevan et al., 2013). These shifts in behaviour specifically with 
regards to the increases in anxiety would implicate the involvement of the BNST to 
some extent possibly through interaction with the oxytocin system (Vasudevan et al., 
2001).  
To my knowledge, the only other study to assess the role of the BNST in healthy 
aging found a decrease in vasopressin in mRNA in aged male Fischer 344 rats 
(Dobie et al., 1991). This effect was rescued via administration of testosterone 
(Dobie et al., 1992). Vasopressin plays a key role in a number of social behaviours 
including social approach and communication, with pharmacological inhibition 
leading to anxiogenic effects (Faria et al., 2016).  
It is worth noting that both of these studies were carried out in male rats however in 
this study I plan to address the role of electrophysiological properties in female mice. 
However from the above studies I can infer that a number of key modulators of social 
behaviour change in the BNST during heathy aging, we would expect these changes 
to impact the functionality of neurons within this circuit.  
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1.6. Frontotemporal dementia  
Frontotemporal dementia is an umbrella term used to describe a group of 
neurodegenerative diseases characterised by deficits in executive function, 
behaviour or language (Bang et al., 2015). It is the leading type of early onset 
dementia, the third most common dementia following Alzheimer’s disease and 
dementia with Lewy bodies (Vieira et al., 2013) and the second most common early 
onset dementia following Alzheimer’s disease (Ratnavalli et al., 2002; Harvey et al., 
2003). There are three main forms of the disease, behavioural-variant frontotemporal 
dementia and primary progressive aphasia which is further subcategorised as non-
fluent variant primary progressive aphasia and semantic-variant primary progressive 
aphasia.  Further details on their clinical diagnosis can be found in Bang et al., 2015.  
Frontotemporal dementia is characterised by neuronal loss, microvascular changes 
and gliosis with different subtypes displaying distinct protein depositions (Mackenzie 
et al., 2010). There are three common proteins which account for nearly all cases of 
frontotemporal dementia; the microtubule-associated protein tau (MAPT), the fused –
in-sarcoma (FUS) protein and the TAR DNA-binding protein with molecular weight 
43 KDa (TDP-43). There are some rarer cases which contain no inclusions or 
ubiquitin-only positive inclusions (Mackenzie et al., 2010; Bang et al., 2015).  
An understanding of the genetic causes of disease gives researchers the ability to 
generate models, specifically mouse models. There are a number of commonly used 
mouse models for FTD, these include models with mutations in TDP-43, progranulin 
and tau. Another model to more recently emerge in the field of FTD is those 
containing mutations in CHMP2B. Briefly I will describe some of these models and 
asses how closely related to FTD they are.  
TDP-43 positive inclusions are found in most familial and sporadic cases of FTD 
indicating a key role in disease pathogenesis (Cairns et al., 2007). Mouse models 
containing the entire human TDP-43 gene or mutant TDP-43 display several features 
of FTD including neuronal inclusions and motor dysfunction (Swarup et al., 2011). 
While this captures aspects of the disease the protein levels observed in tissue was 
three times that of the endogenous protein, such an increase in protein may lead to 
other pathological functions not observed in the human brain.  
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70 mutations in the progranulin gene (GRN) have been identified in FTD, these 
mutations lead to a loss of function (Chen-Plotkin et al., 2011). Therefore a number 
of knockout models have been developed. From these mouse models progranulin 
has been implicated in neuro-inflammation (Yin et al., 2010; Ahmed et al., 2010) and 
protein mishandling (Kayasuga et al., 2007). These mice are homozygous for the 
missing gene, however, humans homozygous for GRN mutations develop another 
disease known as neuronal ceroid lipofuscinosis (Smith et al., 2012). Future 
research into the role of progranulin in FTD should focus on heterozygous mice 
(Roberson, 2012).  
Unlike a number of genes involved in other mouse models of dementia a large 
proportion of the genes involved in FTD have a high rate of conservation with those 
observed in human. In the case of the CHMP2B gene used in this study is 100% 
conserved. Inclusion of human CHMP2B into mice has no effect equally knockout 
mice display no phenotype, this has indicated a gain of function role of the mutated 
proteins. The CHMP2B gene forms part of the endosomal sorting complex required 
for transport III (ESCRT-III). Mutations within intron 5 of CHMP2B leads to a failure 
to disconnect from the ESCRT-III impairing its function (Cox et al., 2010). Insertion of 
this mutated gene into mice leads to the presence of ubiquitin positive inclusions and 
axonal swelling implicating a role in neuronal degeneration (Ghazi-Noori et al., 
2012a).  
Approximately half of patients with frontotemporal dementia will experience 
symptoms of anxiety (Cummings, 1997; Liu et al., 2004). While this heightened 
anxiety may implicate the involvement of the BNST, to my knowledge no known 
changes in HPA axis function have been reported. This is in contrast to Alzheimer’s 
disease, where the involvement of this pathway has been implicated (Hebda-Bauer 
et al., 2013). The lack of literature on the effect of frontotemporal dementia on the 
HPA axis could be caused by one of two factors, one factor being that no studies 
have been carried out to examine the effect either in mouse models or in patients, 
despite the observed changes in anxiety levels.A second possibility is that there are 
no changes in HPA axis function however I have found no literature to support this, 
potentially due to publication bias towards positive results. 
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1.7. Hypothesis 
Intrinsic properties of neurons located within the BNSTALG differ in sex, aging and in 
a model of frontotemporal dementia.  
Differences in intrinsic properties of cells will be cell type dependent and this 
unstressed model may represent susceptibility to changes in anxiety and anxiety 
disorders which may arise following stress. 
1.8. Aims 
The overall aim of this project was to characterise the electrophysiological properties 
of BNST neurons and determine the effect of gender, age and frontotemporal 
dementia pathology on these properties. A robust and information rich way to study 
the function and plasticity of CNS circuits is through direct real-time 
neurophysiological measurements of neural activity using various approaches. Such 
neurophysiological approaches have been applied to aspects of BNST function since 
the mid to late 1970s, starting with in vivo unit recording in anaesthetized animals 
(Bueno & Pfaff, 1976) and subsequently including brain slice studies performed in 
vitro (Sawada et al., 1980; Rainnie, 1999).  
Differences in gender, healthy aging and dementia including frontotemporal 
dementia display a wide variety of changes in neurological function including 
changes in anxiety and susceptibility to anxiety-related disease. In the case of aging 
and gender there are also known changes to the HPA axis, a process regulated by 
the BNST. In the case of frontotemporal dementia there is evidence of heightened 
anxiety in patients (Cummings, 1997; Liu et al., 2004). Due to the central role of the 
BNST in processing of stress it is possible that changes in anxiety levels of patients 
may be driven by functional changes in the BNST. Here we plan to address how 
changes in electrophysiological properties of neurons located in the BNSTALG  differ 
in these unstressed models to isolate possible mechanism for changes in anxiety 
and susceptibility to anxiety-related disorders.  
A key reason for the use of males over females is the unknown effect of the estrus 
cycle on neuronal properties which may lead to increased variability. Here I 
addressed this by examining the electrophysiological properties of BNST neurons in 
the different stages of estrus to determine if the circulating hormones had impacted 
intrinsic electrophysiological properties
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2. Methods 
2.1. Animals  
One transgenic line was used in this project; the CHMP2B line. This line was 
developed and breed at UCL in the lab of Dr. Adrian Isaacs (Ghazi-Noori et al., 
2012b). The cohort was transported to the University of Exeter in the weeks 
preceding the experiments. The remainder of the project focused on C57BL/6 mice; 
the aged female study the mice were bred at Charles River and transported to the 
University of Exeter a week prior to the commencement of the project. For the 
remaining studies the C57BL/6 mice were breed in house using stock from Charles 
River. All animals were housed in a 12:12 hour light-dark cycle with ad libitum 
access to food and water. All procedures were carried out in accordance with the 
Animals (Scientific procedures) act 1986.  
2.2. Behavioural tasks  
Anxiety levels were examined using the elevated zero maze (Faria et al., 2016). This 
maze comprises an elevated circular track which is covered on two sides Figure 2-1. 
Anxiety is thought to be related to the proportion of time spent in the open area. A 
light source was placed in the centre of the maze which allowed the two ‘closed’ 
components of the maze to remain dark while the ‘open’ components of the maze 
were illuminated by white light. Animals were placed in the maze for 5 minutes and 
the proportion of time spent in the open vs closed component was calculated. In the 
CHMP2B chapter 5 animals of each genotype were run over two days and the 
results were averaged. In the sex chapter the animals were run once on the morning 
of experiments prior to culling.  
The proportion of time in each component was carried out using a stop watch; the 
experimenter was blinded by to animal’s genotype or sex during visual analysis.  
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Figure 2-1 Image of the elevated zero maze taken from experimental videos.   
 
2.3. Slice preparation and electrophysiological recordings  
2.3.1. Solutions  
A number of internal and external solutions were used to prepare slices and carry 
out patch clamp recordings. Two external solutions were used (Table 2-1); a sucrose 
based solution used in slice preparation and artificial cerebrospinal fluid (aCSF) was 
used to maintain slices in both the holding chamber and the recording chamber. All 
external solutions were constantly bubbled with carbogen (95 % O2, 5 % CO2), these 
solutions had a pH of 7.3 and osmolality of 290-300 mOsm.  
 Sucrose (mM) aCSF (mM) 
Sucrose  189  
D-glucose  10 10 
NaHCO3 26 24 
KCl 3 3 
MgSO4 5 1 
CaCl2 0.1 2 
NaH2PO4 1.25 1.25 
NaCl  124 
Table 2-1 Composition of external solutions 
 
K-gluconate based internal solutions were used throughout the project. Two different 
varieties were used as detailed in Table 2-2 below. The 15 mV junction potential 
error produced by pairing this pipette solution with our aCSF was corrected for 
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during analysis. Internal solutions had an osmolality of 280 – 290 mOsm and a pH of 
7.3.  
Table 2-2 Composition of internal solutions 
 
2.3.2. Slice preparation  
 
Animals were killed by cervical dislocation, the brains were quickly removed and 
placed into ice-cold sucrose solution (Table 2-1). A Leica VT1200 vibratome was 
used to cut serial 300 m thick coronal sections. Slices containing the BNSTALG 
came from approximately Bregma -.1 to +0.3, and were identified with the aid of the 
Paxinos and Franklin mouse brain atlas (Paxinos & Franklin, 2004a) using the 
anterior commissure as a key landmark. Cells came from the dorsal portion of the 
BNSTALG Figure 2-2. Typically one or two BNST-containing coronal sections per 
animal could be used and by bisecting these along the dorsal-ventral midline I was 
able to obtain up to four usable tissue sections per mouse. 
Following their preparation slices were allowed to recover at room temperature for at 
least 60 mins in our standard aCSF (Table 2-1).  A Flaming Browning P-97 
micropipette puller was used to produce the microelectrodes used in this study. 
These electrodes had a resistance of 3-5 MΩ when filled with the K-Gluconate-
based internal solution used for all recordings..   
 
 K-Gluconate (mM) K-Gluconate with biocytin 
(mM) 
K-Gluconate 130 120 
KCl 20 20 
HEPES free acid  10 10 
EGTA 0.2 0.2 
GTP-Na salt  0.3 0.3 
ATP-Mg salt  4 4 
KOH pH to 7.3 pH to 7.3 
Biocytin   13.4  
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Figure 2-2 BNSTALG location enlarged boxes show the anterolateral area of the 
BNST as taken from the Paxino and Franklin mouse brain atlas (Paxinos & Franklin, 
2004a)abbreviations of the different subregions of the BNST: medial division ventral 
part (BSTMV),lateral division ventral part (BSTLV), medial division anterior part 
(BSTMA), medial division posteromedial part (BSTMPM),  medial division, 
posteromedial part (BSTMPL), lateral division ventral part (BSTLV), lateral division 
posterior part (BSTLP), lateral division dorsal part (BSTLD), lateral division 
juxtacapsular part (BSTLJ). Blue shaded area with in the enlarged images depict the 
anterolateral area of the BNST. Bregma -0.1 to +0.3. 
 
2.3.3. Whole cell patch clamp recordings  
The recording chamber was mounted on the stage of an upright microscope 
(Olympus BX51). Slices were placed in the recording chamber and continuously 
diffused with aCSF heated to between 32-35 oC. Cells within the BNST were visually 
identified using the microscope’s infrared differential interference contrast optics and 
a coupled IR-sensitive CMOS camera (Thor Labs) as seen in Figure 2-3. All 
recordings were made with a Multiclamp 700B amplifier (Molecular Devices) 
interfaced to a Digidata 1440A computer interface (Molecular Devices). Data was 
collected using the Clampex programme within the pClamp 10.4 software suite.  All 
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data were stored directly onto a personal computer (Hewlett-Packard) and backed-
up to a network drive.  
 
Figure 2-3 Visualisation of cell 
 
2.3.3.1. Voltage clamp recordings  
 
After forming a gigaseal and subsequently gaining whole cell access, in all 
recordings I first recorded a 60 s period in voltage clamp at a holding potential of  -70 
mV at a sampling rate of 10 kHz. From this recording the amount of holding current, 
the mean frequency and amplitude of the spontaneous inward-going synaptic events 
were measured. The holding current was taken as the mean current in the 1 minute 
trace.  
To assess the frequency and amplitude of inward-going synaptic events traces were 
bandpassed filtered using a 5 Hz highpass filter and 1000 Hz for a Gaussian 
lowpass filter. A threshold detection was used to isolate all events over 8pA. Cells 
which displayed a large quantity of noise were excluded. The event frequency 
measured in hertz was calculated by dividing the number of events by 60. The 
amplitude of all events was averaged for each cell.  
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2.3.3.2. Current clamp recordings  
 
Following the initial 60 s period in voltage clamp, the amplifier was switched to 
current clamp mode for the remainder of the recording allowing cellular voltage 
responses to be studied. Firstly, a period of activity in the absence of any injected 
current was recorded (i.e. at the resting potential).at a sampling rate of 10 kHz. The 
proportion of cells exhibiting any spontaneous action potential firing was also 
examined.  Cells were subsequently held at a prestimulus membrane potential at 
defined levels of -70 mV or -80 mV; the amount of current required to hold cells at 
these potentials was defined as Ihold (pA) and recorded for each cohort. A number of 
protocols were used to examine passive properties and firing properties of each cell. 
We began with the step protocol; this was comprised of a series of nine, 500 ms 
duration, current injections ranging from -40 to +80 pA in 15 pA increments recorded 
at a sampling rate of 100 kHz. The time between the stimuli was 10 s. This was 
followed by a rheobase protocol which examined the amount of current required to 
generate an action potential in a cell also recorded at a sampling rate of 100 kHz.  
2.3.3.2.1. Passive membrane properties  
 
The -40 pA hyperpolarizing current injections from the 9 step series were used to 
determine passive, subthreshold membrane properties as shown in Figure 2-4. Input 
resistance was calculated using ohms law (R = I/V, R = input resistance, I = current 
injection, V = voltage change); the voltage deflection was the difference between the 
pre-stimulus voltage and average voltage during the final 100 ms of the 
hyperpolarizing current stimulus. 
The rebound is the voltage change between the depolarising peak following the 
switching off of the current and the baseline. % Sag is the (((peak negative deflection 
– average voltage of last 100 ms of hyperpolarising current stimulus)/ peak negative 
deflection) *100). 
The membrane time constant is the amount of time required to charge the 
membrane to 63.2% of the peak negative deflection; this is calculated following the 
injection of -40 pA of current. Finally capacitance was calculated from the membrane 
time constant and the input resistance (capacitance = (membrane time constant/ 
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input resistance) * 1000 pF). Figure 2-4 depicts a cell at a holding potential of -80 
mV; the same measurements were made on cells held at -70 mV.  
 
Figure 2-4 Passive membrane properties isolated from a 40 pA current injection, this 
sample trace displays a prominent sag along with a rebound following the switching 
off of the current. The areas where key calculations from the voltage deflection to a -
40 pA current injection are highlighted using blue arrows.  
 
2.3.3.2.2. Active properties  
 
The action potential properties of each cell were characterised from the first action 
potential generated in response to a series of depolarising current injections. For 
each recording we measured action potential threshold, maximum rate of rise, zenith 
and action potential width as depicted in Figure 2-5. 
Threshold was measured at the first point at which the rate of rise exceeded 20 
mV/ms. AP zenith was the peak depolarisation reached; AP width was measured at 
2 points, from a set point of -20 mV and at threshold. The maximum rate of rise was 
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calculated based on the first derivative of the action potential as depicted in Figure 
2-6.  
 
Figure 2-5 Action potential properties. AP zenith is the maximum point which the 
action potential reaches (mV), AP width is the width of the action potential at a 
specific membrane potential of 20 mV (ms), threshold is the point at which the rate of 
rise goes above 20 mV/ms (mV). AP width at threshold is the width of the action 
potential at this point (ms). 
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Figure 2-6 dV/dt max plotted against the voltage change of a single cell. dV/dt max is 
taken at the maximum rate of rise reached by the cell (mV/ms). 
 
2.3.3.2.3. Firing properties 
 
The series of depolarising pulses in the step protocol were used to characterise the 
firing properties of the cells (Figure 2-7). This included the proportion of cells firing in 
response to each amplitude of depolarising injection, the frequency of action 
potentials and latency to generate an action potential. Latency to the first action 
potential was measured on 2 sweeps; the first sweep when an action potential was 
generated and the final sweep in the step protocol ie. the injection of +80 pA of 
current.  Another way to examine excitability is to look at rheobase (i.e. the amount 
of depolarizing current required to elicit any spiking). This was achieved by applying 
current injections lasting 300 ms that were increased in amplitude by 2 pA per sweep 
until a spike was observed, the time between stimuli was 1 s (Figure 2-8).  
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Figure 2-7 sample trace of step protocol. Depicts 3 out of the 9 current injections 
offset for visualisation purposes.  
 
 
Figure 2-8 Sample rheobase current injection (A) and trace (B) 
 
 
2.3.3.2.4. Pharmacological recordings  
 
Pharmacological examination of gaboxadol was carried out via injection of 
alternating hyperpolarising (-40 pA), depolarising (80 pA) pulses to examine firing 
frequencies as well as passive membrane properties in current clamp mode while 
holding the cells at -80 mV. 
The nature of inward synaptic events was determined by using agents which block 
glutamatergic synaptic transmission specifically NBQX and L689-560 in voltage 
clamp mode holding cells at -70 pA. 
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2.4. Statistics and graphs  
 
Several statistical test were carried out throughout this project dependent upon the 
dataset being examined. Comparisons between proportions of cells firing action 
potentials was examined using a chi squared test carried out in Excel. All other 
statistical tests were carried out in SPSS. Comparisons of firing frequencies on each 
step was carried out via a two-way ANOVA. For all other parameters the Shapiro-
Wilk normality test was used to address the distribution of the populations. 
Populations which were normally distributed were compared using an unpaired t-
test. Non-normally distributed populations were examined via Mann-U-Whitney test. 
Identification of statistical tests used are listed in figure legends.  
Graphs were all made in Origin 2016; for all box plots the scatter plots to the left are 
individual recordings. The small symbol within the box is the mean, the box reflects 
the Standard error of the mean (SEM) and line traversing the box is the median. 
 
 
2.5. Characterisation of cells based on their electrophysiological properties 
 
Cells were sorted into 3 different populations based on the characterisation from 
Hammack et al 2007 paper. A key component of Type I and Type II calls is a 
depolarising sag mediated by Ih current in response to a hyperpolarising current 
injection. Type I cells have a regular spiking pattern in response to depolarising 
current injection (Figure 2-9). A key characteristic of Type II cells is a depolarising 
‘hump’ peaking within 150 ms of the depolarising current being switched on. This 
‘hump’ contributes to the burst firing observed within these cells. Finally type III cells 
have no ‘sag’ in response to a hyperpolarising current injection. A sample of each of 
these cells is depicted in Figure 2-9. 
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Figure 2-9 Sample of each cell type A) sample of current injection showing 3 out of 
the 9 injections, B) sample type I cell, C) sample Type II cell and D) sample Type III 
cell.   
 
 
2.6. Oestrous cycle testing 
 
Following the cervical dislocation of female mice and the removal of the brain into ice 
cold sucrose solution as described below the stage of oestrous was examined via a 
wet smear for chapters three and four. 10 µL of PBS was inserted ~ 5mm into the 
mouse’s vagina and gently flushed two to three times.  The final flush was collected 
and placed on to a slide for visual examination. The unstained sample was examined 
under a x10 objective using a Nikon eclipse E800 microscope. Oestrous cycle stage 
was determined by the proportion of each cell type present as described in Caligioni, 
2009. During proestrus the sample is predominantly populated with nucleated 
epithelial cells, during estrus it is predominantly anucleated cornified cells, in 
metestrus it is a combination of leukocytes, cornified and nucleated epithelial cells 
and during diestrus it is predominantly leucocytes (Figure 2-10).  
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Figure 2-10 Different stages of the oestrus cycle, a) proestrus, b) estrus, c) 
metestrus, d) diestrus. N is adjacent to a nucleated epithelial cells, C di adjacent to a 
cornified cells, L is adjacent to leucocytes.  
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2.7. Pharmacology  
 
To assess spontaneous synaptic transmission cells were voltage clamped at -70 mV. 
Events were then detected and measured as described in the methods chapter. The 
receptor basis of synaptic events in Type I neurons was examined by applying the 
glutamate receptor blockers of NBQX and L689560 (both 5 µM)  
Pharmacological activation of GABAA receptors containing the  subunit was carried 
out in current clamp mode from a prestimulus potential of -80 mV in the constant 
presence of NBQX and L689-560, alternating 500 ms pulses of -40 pA and +80 pA 
were applied at 10 second intervals. Following a 5 minute baseline, 30 µM 
Gaboxadol was added, 8 minutes later the GABAA receptor antagonist GABAzine (5 
µM) was co-applied with the Gaboxadol. After another 8 minutes Gaboxadol and 
GABAzine were washed out.   
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3.  Effect of the estrus cycle on neurons located in the BNST  
3.1. Introduction   
 
The reproductive cycle in females is a key component of fertility, in humans this 
cycle is referred to as the menstrual cycle and last ~ 28 days. The premenstrual 
phase of the menstrual cycle is often associated with increase in anxiety as well 
as mood swings. Due to the central role of the BNST in anxiety-related 
behaviour, these mood changes could be at least in part mediated by the 
BNST. In the mouse, this cycle is referred to as the oestrus cycle and lasts 
approximately 4-5 days. This process leads to changes in circulating levels of a 
number of hormones that have been shown to have an effect on neurological 
function (Brack & Lovick, 2007a; Johannessen et al., 2011; Singh & Su, 2013; 
Bailey & Silver, 2014).  
One such hormone is progesterone, this hormone has been shown to have a 
number of CNS activities outside of hypothalamic function, evident by the 
widespread expression of its receptor in various brain regions. For example, 
progesterone has been shown to be involved in cognitive function as well as 
key neuronal processes, including neuronal differentiation, outgrowth, survival, 
plasticity and regeneration (Singh & Su, 2013).   
3.1.1. Effect of the oestrus cycle on neurophysiological properties  
 
A number of studies have identified changes in neuronal excitability in different 
CNS cellular populations. In the periaqueductal grey (PAG) increases in 
bicuculline-induced firing in estrus and diestrus were observed in comparison to 
proestrus and metestrus (Brack & Lovick, 2007b). In the hippocampus larger 
maximal population spikes were evoked in proestrus and estrus were observed 
in comparison with metestrus in CA1 cells following Schaffer collateral 
stimulation (Scharfman et al., 2003). 
Outside the CNS oestrus-dependent changes in intrinsic excitability of neurons 
have also been observed in the trigeminal ganglion where an increase in 
excitability in proestrus and estrus was seen in comparison to diestrus (Saleeon 
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et al., 2016). Here we plan to examine whether these hormonal fluctuations 
affect intrinsic properties of neurons located in the BNSTALG. 
1.1.1 Effect of oestrus cycle in the BNST and stress 
 
The role of the oestrus cycle in stress processing is a complex one with the role 
of fluctuating hormones sometimes having opposing effects. Estrus, the stage 
with the lowest levels of circulating E2 and progesterone, has been found to be 
protective against social isolation-induced anxiety (Ramos-Ortolaza et al., 2017) 
while also increasing susceptibility to the development of PTSD-like states in 
female rats (Mironova et al., 2015). 
The BNST plays a key role in anxiety-related disorders; these disorders also 
have higher incidence in females over males in the human population. Despite 
this there is very little research which examines the BNST in female rodents. 
One contributing factor for this bias is a lack of understanding of the effects of 
hormonal fluctuation on the intrinsic properties of BNST neurons. To address 
this, I compared the properties of BNST neurons from mice in each stage of 
oestrus to identify oestrus cycle dependent changes on intrinsic 
electrophysiological properties.  
3.2. Hypothesis 
Hormone fluctuations during oestrous cycle may lead to changes in the 
intrinsic properties of neuron located in the BNSTALG. These 
hypothesised changes may account for expected changes in anxiety 
observed at different stage of the oestrous cycle. 
 
      3.3 Aims 
 To determine if the intrinsic properties of neurons located within the 
BNSTALG are affected by the different stages of oestrous.  
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1.2 Methods 
This study focused on female mice aged 3-5 months; all mice used in this study 
were breed in house using stock from Charles River with ab libitum access to 
food and water. A proportion of animals underwent behavioural testing on the 
elevated zero maze; these tests were carried on the morning of experimental 
days. Animals were then killed by cervical dislocation, the brain was removed 
and placed into an ice cold sucrose solution. Once the brain was removed the 
stage of oestrus cycle was determined via a wet vaginal smear. 300 m coronal 
slices containing the BNSTALG were prepared and placed into aCSF. 
Whole cell patch clamp recordings were made using a K-Gluconate solution 
containing biocytin. A series of electrophysiological protocols were used as 
described in methods chapter to characterise the intrinsic properties of neurons 
located within the anterolateral area of the BNST. The compositions of all 
solutions listed here are described in detail in the methods chapter.  
Determination of statistical test used was based on normal distribution of the 
data based on a Shapiro-Wilk normality test. A number of properties were 
examined from only one membrane potential, ie. firing frequency at rest; for 
these parameters if data was normally distributed an unpaired t-test was carried 
out, if data was not normally distributed a Mann-Whitney U was carried out. Part 
of the data were examined from two prestimulus potentials; if the data was 
normally distributed at both prestimulus membrane potentials a repeated 
measure two-way ANOVA was carried out with oestrus cycle stage as the 
between subject effect and prestimulus membrane potential as the within 
subject effect. If the data was not normally distributed a Kruskal-Wallis test was 
performed at each prestimulus membrane potential. If the data was normally 
distributed at only one prestimulus membrane potential a one-way ANOVA was 
carried out on this set and a Kruskal-Wallis on the non-normally distributed set. 
Firing frequencies in response to each depolarising current injection were 
analysed via repeated measure two-way ANOVA. All statistics were carried out 
in SPSS. Proportion of cells firing was determined by chi squared; tests were 
carried out in Excel.  
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1.3 Results 
1.3.1 Behaviour 
Anxiety levels were assessed using the elevated zero maze, mice were run on 
the maze in the early stages of their lights-on stage. Average time spent in the 
open arm vs dark arm was calculated over a 5 minute time period. No 
differences in % time spend in the open vs the closed arm were detected 
between the groups (Figure 3.1.1 -1, Table 3-1).  
 
Figure 3.1.1 -1 % time spent in the open arm of the elevated zero maze.  
 
 Diestrus  Proestrus  Estrus  Metestrus  P value  Statistical 
test  
% time 
in the 
open 
arm 
21 ± 2  
(n = 12) 
28 ± 3  
(n = 10) 
23 ± 2 
(n = 13) 
27 ± 2  
(n = 11) 
0.1 One-way 
ANOVA 
Table 3-1 % time spend in the open of each cohort on the elevated zero maze 
1.3.2 Electrophysiological characterisation of neurons located in the 
anterolateral area of the BNST 
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1.3.2.1 Type I neurons  
 
A total of 66 Type I cells were recorded in this study, of these 21 were from 
mice in diestrus, 16 from mice in proestrus, 13 from mice in estrus and 16 from 
mice in metestrus. The cells in diestrus were recorded from 11 animals with a 
maximum of 3 cells per animals, the cells in proestrus were recorded from 8 
animals with a maximum of 5 cells from each animal, the cells in estrus were 
recorded from 8 animals with a maximum of 4 cells being recorded from each 
animal and the recordings in metestrus were recorded from 11 animals with a 
maximum of 3 cells being recorded from each animal.  
Initially I began by using voltage clamp to examine the synaptic properties of 
Type I neurons in the BNST. The stage of the oestrus cycle had no effect on 
either the amount of current required to hold cells at -70 mV, the frequency of 
events observed or the averaged amplitude of such events (Figure 3-2, Table 
3 -2). 
 Diestrus  Proestrus  Estrus  Metestrus  P value  Statistical 
test  
Ihold (pA) -10 ± 6 
(n = 17) 
-7 ± 6 
(n = 16) 
-4 ± 7 
(n = 7) 
-3 ± 9 
(n = 13) 
0.9 One-way 
ANOVA 
Frequency 
(Hz) 
7 ± 2 
(n = 17) 
9 ± 3 
(n = 16) 
5 ± 3 
(n = 7) 
6 ± 1 
(n = 13) 
0.6 KW 
Amplitude 
(pA) 
-14 ± 1 
(n = 18) 
-16 ± 1 
(n = 16) 
-14 ± 1 
(n = 7) 
-14 ± 1 
(n = 13) 
0.6 KW 
Table 3 -2 Properties measured from VC recordings held at -70 mV. Statistical 
tests performed Kruskal-Wallis (KW) test or one-way ANOVA. 
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Figure 3-2. Spontaneous synaptic events in Type I neurons. A) Holding current 
required to hold cells at -70 mV, B) frequency of inward-going synaptic events, 
C) average amplitude of spontaneous inward going-synaptic events, D) Sample 
trace of unfiltered cell in voltage clamp mode with a zoomed in image of a 
synaptic event in the blue box.  
 
Following this the cells were switched into current clamp mode where their 
properties at their resting membrane potential were examined. The resting 
membrane potential was not dependent on the stage of the oestrus cycle in 
Type I neurons. The proportion of cells firing action potentials in the initial 1 
minute recording was also not dependent upon the oestrus cycle (estrus 8/13 
cells firing, metestrus 7/16 cells firing, diestrus 9/21 cells firing, proestrus 6/10 
cells firing, chi squared test , p = 0.4). The firing frequency of cells which were 
firing at rest was not affected by the oestrus cycle. Of the cells which were not 
firing at rest the rheobase was examined, this was not depended on the oestrus 
cycle ( Figure 3-3, Table 3-3).  
In order to assess the intrinsic properties of these cells current was injected to 
hold cells at a prestimulus membrane potential of either -70 mV or -80 mV; the 
amount of current required to hold these cells at these potentials was not 
dependent upon the oestrus cycle (Table 3-3).  
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Parameter 
and 
prestimulus 
membrane 
potential 
Diestrus  Proestrus  Estrus  Metestrus  P 
value  
Statistical 
test  
RMP (mV) -68 ± 2  
(n = 21) 
-70 ± 2 
(n = 16) 
-64 ± 4 
(n = 13) 
-70 ± 3 
(n = 16) 
0.4 One-way 
ANOVA 
Frequency 
(Hz) 
9 ± 3 
(n = 9) 
5 ± 2 
(n = 6) 
2 ± 1 
(n = 8) 
5 ± 2 
(n = 7) 
0.2 One-way  
ANOVA 
Ihold 
(mV) 
-70 
mV 
-11  ± 7 
(n = 21) 
-1 ± 7 
(n = 16) 
-25 ± 
14 
(n = 13) 
-2 ± 7 
(n = 14) 
0.6 KW 
-80 
mV 
-32 ± 7 
(n = 21) 
-17 ± 6 
(n = 16) 
-44 ± 
16 
(n = 13) 
-22 ± 8 
(n = 14) 
0.5 KW 
Rheobase 
(pA) 
28 ± 10 
(n = 7) 
28 ± 7 
(n = 5) 
26 ± 9 
(n = 5) 
26 ± 6 
(n = 5) 
1 One-way 
ANOVA 
Table 3-3. Properties of cells at their resting membrane potential and holding 
currents, statistical tests Kruskal-Wallis (KW) test and one-way ANOVA.        
 
Figure 3-3 Properties of type I neurons at their resting membrane potential, A) 
Resting membrane potential of cells in the different stages of oestrus, B) firing 
frequency of cells which fired at rest, C) Rheobase of cells which did not fire at 
rest, D) Sample trace showing cell which was firing at rest (i) and a cell which 
was not firing at rest (ii). 
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The passive membrane properties were examined following the injection of -40 
pA of current; the averages for each cohort can be seen in Figure 3-4. Oestrus 
cycle had no effect on input resistance, membrane time constant, sag or 
capacitance (Figure 3-4, Table 3-4).  
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Figure 3-4 Passive membrane properties of Type I neurons, A) average trace 
following the injection of -40 pA of current from a prestimulus membrane 
potential of -70 mV (i) and -80 mV (ii), B, C) Input resistance measured frrm a 
prestimulus membrane potential of – 70 mV and – 80 mV respectively, D, E) 
Membrane time constant of cells from a prestimulus membrane potential of -70 
mV and -80 mV respectively, F) % sag from a prestimulus membrane potential 
of  -80 mV respectively, G, H) Capacitance from a prestimulus membrane 
potential of -70 mV and -80 mV respectively.  
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Parameter and 
holding current 
Diestrus  Proestrus  Estrus  Metestrus  P  Statistical 
test  
Rin (MΩ) -70 
mV 
473 ± 43 
(n = 21) 
544 ± 45 
(n = 16) 
510 ± 46 
(n = 13) 
536 ± 59 
(n = 16) 
0.6 KW 
-80 
mV 
391 ± 39 
(n = 21) 
446 ± 46 
(n = 16) 
427 ± 49 
(n = 13) 
446 ± 61 
(n = 16) 
0.8 KW 
Tau (ms) -70 
mV 
31 ± 4 
(n = 21) 
33 ± 3 
(n = 16) 
28 ± 3 
(n = 13) 
35 ± 3 
(n = 16) 
0.5 KW 
-80 
mV 
25 ± 3 
(n = 21) 
28 ± 3 
(n = 16) 
22 ± 2 
(n = 13) 
28 ± 3 
(n = 16) 
0.4 KW 
Sag (%) -80 
mV 
16 ± 1 
(n = 21) 
15 ± 2 
(n = 16) 
14 ± 3 
(n = 13) 
15 ± 1 
(n = 16) 
0.5 KW 
Capacitance 
(pF)  
-70 
mV 
67 ± 7 
(n = 21) 
65 ± 7 
(n = 16) 
56 ± 5 
(n = 13) 
70 ± 7 
(n = 16) 
0.4 KW 
-80 
mV 
66 ± 5 
(n = 21) 
70 ± 7 
(n = 16) 
57 ± 6 
(n = 13) 
69 ± 7 
(n = 16) 
0.8 One-way 
ANOVA 
Table 3-4 Passive membrane properties of Type I neurons, statistical test used 
were Kruskal-Wallis (KW) and one-way ANOVA.  
 
 
 Diestrus  Proestrus  Estrus  Metestrus  P Statistical 
test  
Zenith  
(mV) 
-70 
mV 
15 ± 2 
(n = 21) 
14 ± 2 
(n = 16) 
18 ± 2 
(n = 13) 
17 ± 2 
(n = 16) 
0.4 KW 
-80 
mV 
17 ± 2 
(n = 21) 
14 ± 2 
(n = 16) 
20 ± 2 
(n = 13) 
17 ± 2 
(n = 16) 
0.3 KW 
Width (ms) -70 
mV 
0.7 ± 
0.03 
(n = 21) 
0.8 ± 
0.03 
(n = 16) 
0.7 ± 
0.03 
(n = 13) 
0.8 ± 
0.04 
(n = 16) 
0.6 KW 
-80 
mV 
0.7 ± 
0.04 
(n = 21) 
0.7 ± 
0.04 
(n = 16) 
0.7 ± 
0.03 
(n = 13) 
0.7 ± 
0.05 
(n = 16) 
0.8 KW 
Threshold 
(mV) 
-70 
mV 
-52 ± 1 
(n = 21) 
-54 ± 2  
(n = 16) 
-52 ± 1 
(n = 13) 
-50 ± 2 
(n = 16) 
0.6 Repeated 
measure 
two-way 
ANOVA 
-80 
mV 
-52 ± 1 
(n = 21) 
-50 ± 1  
(n = 16) 
-50 ± 2 
(n = 13) 
-51 ± 1 
(n = 16) 
dV/dt max 
(mV/ms)  
-70 
mV 
265 ± 
16 
(n = 21) 
234 ± 12 
(n = 16) 
272 ± 
23 
(n = 13) 
282 ± 16 
(n = 16) 
0.2 KW 
-80 
mV 
294 ± 
17 
(n = 21) 
256 ± 12 
(n = 16) 
308 ± 
24 
(n = 13) 
302 ± 19 
(n = 16) 
0.2 KW 
Table 3-5 Action potential properties of Type I neurons, statistical tests used 
were Kruskal-Wallis (KW) and one –way ANOVA 
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Figure 3-5. Action potential properties of Type I neurons, A) averaged action 
potential of the first action potential generated from a prestimulus membrane 
potential of -70 mV (i) and -80 mV (ii), B, C) Action potential zenith from a 
prestimulus membrane potential of -70 mV and -80 mV respectively, D, E) 
Action potential width measured at  – 20 mV from a prestimulus membrane 
potential of -70 mV and -80 mV respectively, F, G) Threshold from prestimulus 
membrane potential of -70 mV and -80 mV respectively.  
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The action potential properties were measured from the first action potential 
generated in response to depolarising current injections, the averages of these 
are shown in Figure 3-5. The action potential zenith, width and threshold were 
examined; none of these were affected by the oestrus cycle (Figure 3-5, Table 
3-5). We also examined the first derivative of the action potential to establish 
the maximum rate of rise, this was not dependent on oestrus in type I neurons 
(Figure 3-6, Table 3-5).  
 
Figure 3-6. dV/dt of first action potential generated by Type I neurons, A, B) 
averaged dV/dt (line is the mean and shaded area is the standard error of the 
mean) plotted against the average action potential of cells from a prestimulus 
membrane potential of -70 mV and -80 mV, respectively, C, D) dV/dt maximum 
from a prestimulus membrane potential of -70 mV and -80 mV, respectively.  
 
Using the series of depolarising pulses the excitability of cells was examined; 
neither the frequency of firing (repeated measure two-way ANOVA, p = 0.6) nor 
the proportion of cells firing were affected by the oestrus cycle (Figure 3-7,Table 
3-6, Table 3-7, Table 3-8, Table 3-9). Equally rheobase was not affected by 
oestrus cycle (Figure 3-7, Table 3-10), this is unsurprising given the fact that 
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neither the resting membrane potential nor excitability on the step protocol was 
affected by oestrus.  
 
Figure 3-7 Firing properties of Type I neurons A) sample traces of cells in each 
stage of oestrus i) sample current injection, ii) diestrus, iii) proestrus, iv) estrus, 
v) metestrus, B, C) fraction of cells firing action potentials in response to various 
current injections from a prestimulus membrane potential of -70 mV and -80 mV 
respectively, D, E) frequency of firing in response to various current injections 
from a prestimulus membrane potential of -70 mV and -80 mV respectively, F, 
G) Rheobase from a prestimulus membrane potential of -70 mV and -80 mV 
respectively.  
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 Diestrus (Hz) Proestrus 
(Hz) 
Estrus (Hz)  Metestrus 
(Hz) 
5 pA 1 ± 0.4 1 ± 0.4 1 ± 1 1 ± 1 
20 pA 7 ± 1 9 ± 1 9 ± 2 9 ± 2 
35 pA 15 ± 2 18 ± 2 18 ± 3 17 ± 3 
50 pA 21 ± 3 27 ± 3 23 ± 3 25 ± 4 
65 pA 28 ± 3 32 ± 2 29 ± 4 32 ± 4 
80 pA 30 ± 3 36 ± 2 35 ± 4 40 ± 5 
Table 3-6 Firing frequency on each current injection from a prestimulus 
membrane potential of -70 mV 
 
 Diestrus  Proestrus  Estrus  Metestrus  
5 pA 0 ± 0 0 ± 0 0 ± 0 0.1 ± 0.1 
20 pA  1 ± 0.5 2 ± 1  1 ± 0.5 4 ± 2 
35 pA 5 ± 1 8 ± 2 9 ± 2 9 ± 3 
50 pA 10 ± 2 14 ± 3 16 ± 3 14 ± 4 
65 pA 16 ± 2 20 ± 3 23 ± 3 21 ± 5 
80 pA 22 ± 3 27 ± 3 28 ± 4 27 ± 5 
Table 3-7 Firing frequency on each current injection from a prestimulus 
membrane potential of -80 mV 
 
 P value  Diestrus  Proestrus  Estrus  Metestrus  
5 pA 0.9 3/21 3/16 2/13 4/16 
20 pA 0.2  16/21 16/16  10/13  14/16 
35 pA 0.6  20/21  16/16  13/13  15/16 
50 pA 0.5  20/21  16/16  13/13  16/16 
65 pA NS 21/21 16/16 13/13 16/16 
80 pA NS 21/21 16/16 13/13 16/16 
Table 3-8 Proportion of cells firing in response to current injection from a 
prestimulus membrane potential of -70 mV 
 
 
84 
 
 
 
 P value Diestrus  Proestrus  Estrus  Metestrus  
5 pA 0.4 0/21 0/16 0/13 1/16 
20 pA 0.9 6/21 5/16  5/13  5/16 
35 pA 0.4  10/21  10/16  10/13  9/16 
50 pA 0.3  15/21  15/16  11/13  13/16 
65 pA 0.5 20/21 16/16 13/13 16/16 
80 pA NS 21/21 16/16 13/13 16/16 
Table 3-9 Proportion of cells firing action potentials from a prestimulus 
membrane potential of -80 mV 
Due to the speed of synaptic events the delay between onset of current 
injection and action potential generation is a key measure. This is referred to as 
the latency, it was measured in two manners, the delay between current onset 
and the first action potential generated in response to the complete set of 
incremental depolarising current injections and the delay between injection of 
80 pA of current and the generation of an action potential, neither of these 
measurements were oestrus cycle-dependent (Figure 3-8, Table 3-10). 
 Diestrus  Proestrus  Estrus  Metestrus  P   Statistical 
test  
Rheobase 
(pA) 
-70 
mV 
12 ± 3 
(n = 17) 
10 ± 2 
(n = 15) 
12 ± 4 
(n = 9) 
11 ± 2 
(n = 15) 
0.99 KW 
-80 
mV 
28 ± 3 
(n = 17) 
24 ± 3 
(n = 15) 
29 ± 5 
(n = 9) 
32 ± 4 
(n = 15) 
0.6 KW 
Latency 
1st AP 
(ms) 
-70 
mV 
129 ± 
32  
(n = 21) 
153 ± 30  
(n = 16) 
98 ± 
32  
(n = 
13) 
98 ± 15 
(n = 16) 
0.2 KW 
-80 
mV 
109 ± 
20  
(n = 21) 
115 ± 20  
(n = 16) 
122 ± 
27  
(n = 
13) 
131 ± 24 
(n = 16) 
0.9 KW 
AP 
Latency 
last 
sweep 
(ms) 
-70 
mV 
14 ± 3 
(n = 21) 
13 ± 2 
(n = 16) 
10 ± 1 
(n = 
13) 
14 ± 2  
(n = 16) 
0.4 KW 
-80 
mV 
46 ± 14 
(n = 15) 
32 ± 8 
(n = 13) 
17 ± 2 
(n = 
16) 
35 ± 10  
(n = 9) 
0.3 KW 
Table 3-10 firing properties of Type I neurons, statistical test performed Kruskal-
Wallis (KW) 
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Figure 3-8 Latency to action potential generation in Type I cells A, B) latency to 
the first action potential generated in response to depolarising current injection 
from a prestimulus membrane potentials of -70 mV and -80 mV, respectively, C, 
D) latency to action potential generation in response to injection of 80 pA from a 
prestimulus membrane potential of -70 mV and -80 mV respectively.  
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1.3.2.2 Type II neurons  
A total of 53 Type II cells were recorded from, of these cells 15 were recorded 
from mice in diestrus, 13 were recorded from mice in proestrus, 16 were 
recorded from mice in estrus and 9 were recorded from mice in metestrus. The 
recordings made in diestrus were recoded from 10 animals with a maximum of 
3 cells recorded from each animal, the recordings made in proestrus were 
recorded from 8 animals with a maximum of 4 cells being recorded per animal, 
the recordings made in estrus were recorded from 10 animals with a maximum 
of 3 cells being recorded from each animal and the recordings carried out in 
metestrus were recorded from 7 animals with a maximum of 2 cells being 
recorded from each animal.  
When examining the cells in voltage clamp mode no differences were found in 
the frequency or average amplitude of inward-going synaptic events of Type II 
neurons, equally the amount of current required to clamp cells at -70 mv did not 
depend on oestrus (Figure 3-9, Table 3-11).  
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Figure 3-9. Spontaneous synaptic events in Type II neurons. A) Holding current 
required to hold cells at -70 mV, B) frequency of inward-going synaptic events, 
C) average amplitude of spontaneous inward going-synaptic events, D) Sample 
trace of unfiltered trace in voltage clamp mode with a zoomed in image of a 
synaptic event in the blue box.  
 
 
 
 
 Diestrus  Proestrus  Estrus  Metestrus  P value  Statistical 
test  
Ihold (pA) -2 ± 4 
(n = 10) 
0 ± 7 
(n = 11) 
-8 ± 8 
(n = 13) 
-6 ± 6 
(n = 7) 
0.8 One-way 
ANOVA 
Frequency 
(Hz) 
4 ± 1 
(n = 10) 
5 ± 2 
(n = 11) 
7 ± 2 
(n = 13) 
6 ± 1 
(n = 7) 
0.4 KW 
Amplitude 
(pA) 
-12 ± 1 
(n = 10) 
-14 ± 1 
(n = 11) 
-14 ± 1 
(n = 13) 
-14 ± 1 
(n = 7) 
0.056 KW 
Table 3-11. Synaptic properties of Type II neurons  
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Figure 3-10. Properties of type II neurons at their resting membrane potential, 
A) Resting membrane potential of cells in the different stages of estrus, B) firing 
frequency of cells which fired at rest, C) Sample trace showing cell which was 
firing at rest (i) and a cell which was not firing at rest (ii). 
 
 Diestrus  Proestrus  Estrus  Metestrus  P value  Statistical 
test  
RMP (mV) -69 ± 2  
(n = 15) 
-70 ± 2 
(n = 13) 
-67 ± 3 
(n = 16) 
-66 ± 3 
(n = 9) 
0.7 One-way 
ANOVA 
Frequency 
(Hz) 
2 ± 1 
(n = 7) 
5 ± 2 
(n = 5) 
5.5 ± 2 
(n = 7) 
6 ± 2 
(n = 4) 
0.3 One-way  
ANOVA 
Ihold 
(mV) 
-70 
mV 
-9  ± 5 
(n = 15) 
-6 ± 5 
(n = 13) 
-9 ± 6 
(n = 14) 
-7 ± 9 
(n = 9) 
0.9 KW 
-80 
mV 
-30 ± 6 
(n = 15) 
-31 ± 3 
(n = 13) 
-23 ± 7 
(n = 14) 
-38 ± 8 
(n = 9) 
0.4 KW 
Table 3-12. Properties of Type II cells at their resting membrane potential 
 
Cells were then transferred into current clamp mode where the properties of 
cells at their resting membrane potential were examined. The resting membrane 
potentials and firing frequency of firing cells which fired at rest did not differ 
between the cohorts (Figure 3-10, Table 3-12). Not enough observations were 
gathered to examine the rheobase from the resting membrane potential.  
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The passive membrane properties were measured from the injection of -40 pA 
of current: averages are shown in Figure 3-11A. Input resistance, membrane 
time constant, capacitance and sag were not dependent on estrus in Type II 
neurons (Figure 3-11, Table 3-13).  
Parameter and 
prestimulus 
potential 
Diestrus  Proestrus  Estrus  Metestrus  P 
valu
e  
Statistical 
test  
Rin (MΩ) -70 
mV 
453 ± 41 
(n = 15) 
445 ± 55 
(n = 13) 
571 ± 69 
(n = 16) 
422 ± 95 
(n = 9) 
0.2 KW 
-80 
mV 
342 ± 42 
(n = 15) 
339 ± 42 
(n = 13) 
456 ± 66 
(n = 16) 
315 ± 79 
(n = 9) 
0.2 KW 
Tau (ms) -70 
mV 
27 ± 2 
(n = 15) 
33 ± 3 
(n = 13) 
36 ± 3 
(n = 16) 
29 ± 2 
(n = 9) 
0.2 KW 
-80 
mV 
23 ± 2 
(n = 15) 
25 ± 2 
(n = 13) 
28 ± 3 
(n = 16) 
21 ± 3 
(n = 9) 
0.3 One-way 
ANOVA 
Sag (%) -80 
mV 
21 ± 2 
(n = 15) 
17 ± 1 
(n = 13) 
18 ± 2 
(n = 16) 
20 ± 3 
(n = 9) 
0.4 KW 
Capacitance 
(pF)  
-70 
mV 
65 ± 4 
(n = 15) 
78 ± 6 
(n = 13) 
69 ± 7 
(n = 16) 
85 ± 12 
(n = 9) 
0.4 KW 
-80 
mV 
77 ± 7 
(n = 15) 
78 ± 6 
(n = 13) 
70 ± 7 
(n = 16) 
81 ± 12 
(n = 9) 
0.8 One-way 
ANOVA 
Table 3-13 Passive membrane properties of Type II neurons. Statistical test 
based on Kruskal-Wallis (KW) and one-way ANOVA.  
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Figure 3-11 Passive membrane properties of Type II neurons, A) average trace 
following the injection of -40 pA of current from a prestimulus membrane 
potential of -70 mV (i) and -80 mV (ii), B, C) Input resistance from a prestimulus 
membrane potential of – 70 mV and – 80 mV respectively, D, E) Membrane 
time constant of cells from a prestimulus membrane potential of -70 mV and -80 
mV, respectively, F) % sag from a prestimulus membrane potential of -70 mV  
G, H) Capacitance from a prestimulus membrane potential of -70 mV and -80 
mV respectively.  
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Following this I examined the action potential properties; the averages are 
shown in Figure 3-12A. There were no differences observed in action potential 
zenith, width or threshold from either holding potential (Figure 3-12, Table 3-14). 
Following this the first derivative of the action potential was examined and the 
maximum rate of rise determined, averages of the rate of rise plotted against 
the average action potential are shown in Figure 3-13 A, B. No statistically 
significant differences were observed in the maximum rate of rise, however 
there was a trend towards a lower maximum rate of rise in diestrus when 
compared to metestrus (LSD post hoc analysis, p = 0.02) and proestrus (LSD 
post hoc analysis p = 0.03).  
Following this I examined the firing properties of Type II neurons, a sample 
trace from each cohort is displayed in Figure 3-14A; no changes were found in 
the proportion of cells firing (Table 3-17, Table 3-18) or the frequency of firing of 
cells (Table 3-15, Table 3-16, repeated measure two-way ANOVA, p = 0.9) in 
response to depolarising current injection, there were also no differences in 
rheobase or latency of action potentials (Figure 3-14, Figure 3-15, Table 3-19).  
 Diestrus  Proestrus  Estrus  Metestrus  P 
value  
Statistical 
test  
Zenith  (mV) -70 
mV 
10 ± 2 
(n = 15) 
16 ± 1 
(n = 13) 
14 ± 3 
(n = 16) 
16 ± 2 
(n = 9) 
0.8 KW 
-80 
mV 
11 ± 2 
(n = 15) 
16 ± 2 
(n = 13) 
16 ± 3 
(n = 16) 
17 ± 2 
(n = 9) 
0.6 KW 
Width (ms) -70 
mV 
0.75 ± 
0.03 
(n = 15) 
0.7 ± 0.03 
(n = 13) 
0.8 ± 
0.03 
(n = 16) 
0.7 ± 0.03 
(n = 9) 
0.3 Repeated 
measure 
two-way 
ANOVA -80 
mV 
0.7 ± 
0.03 
(n = 15) 
0.7 ± 0.03 
(n = 13) 
0.8 ± 
0.04 
(n = 16) 
0.7 ± 0.03 
(n = 9) 
Threshold 
(mV) 
-70 
mV 
-52 ± 1 
(n = 15) 
-54 ± 2  
(n = 13) 
-52 ± 1 
(n = 16) 
-50 ± 2 
(n = 9) 
0.7 KW 
-80 
mV 
-54 ± 1 
(n = 15) 
-53 ± 1  
(n = 13) 
-54 ± 1 
(n = 16) 
-51 ± 2 
(n = 9) 
0.8 KW 
dV/dt max 
(mV/ms)  
-70 
mV 
222 ± 13 
(n = 15) 
271 ± 15 
(n = 13) 
236 ± 
14 
(n = 16) 
279 ± 18 
(n = 9) 
0.055 Repeated 
measure 
two-way 
ANOVA 
-80 
mV 
256 ± 15 
(n = 15) 
298 ± 15 
(n = 13) 
273 ± 
16 
(n = 16) 
308 ± 19 
(n = 9) 
Table 3-14 Action potential properties of Type II neurons, statistical tests used 
Kruskal-Wallis (KW) and repeated measure two-way ANOVA.  
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Figure 3-12. Action potential properties of Type II neurons, A) averaged action 
potential of the first action potential generated, B, C) Action potential zenith from 
a prestimulus membrane potential of -70 mV and -80 mV, respectively, D, E) 
Action potential width measured from – 20 mV from a prestimulus membrane 
potential of -70 mV and -80 mV, respectively, F, G) Threshold from a 
prestimulus membrane potential of -70 mV and -80 mV, respectively.  
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Figure 3-13. dV/dt of first action potential generated by Type II neurons, A, B) 
averaged dV/dt (shaded area Standard error of the mean) plotted against the 
average action potential on cells from a prestimulus membrane potential of -70 
mV and -80 mV, respectively, C, D) dV/dt maximum from a prestimulus 
membrane potential of -70 mV and -80 mV, respectively.  
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Figure 3-14. Firing properties of Type II neurons A) sample traces of cells in 
each stage of the oestrus cycle i) Diestrus, ii) Proestrus, iii) Estrus, iv) 
Metestrus, B, C) fraction of cells firing action potentials in response to various 
current injections from prestimulus membrane potentials of -70 mV and -80 mV, 
respectively, D, E) frequency of firing in response to various current injections 
from a prestimulus membrane potential of -70 mV and -80 mV, respectively, F, 
G) Rheobase from a prestimulus membrane potential of -70 mV and -80 mV, 
respectively.   
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 Diestrus 
(n = 15) 
Proestrus 
(n = 13) 
Estrus 
(n = 16) 
Metestrus 
(n = 9) 
5 pA 1 ± 0.5 2 ± 1 2 ± 1 0.4 ± 0.4 
20 pA 7 ± 1 8 ± 2 9 ± 2  6 ± 2 
35 pA 14 ± 2 14 ± 3 15 ± 2 13 ± 2 
50 pA 20 ± 2 20 ± 4 21 ± 3 20 ± 3 
65 pA 24 ± 3 27 ± 5 24 ± 3 24 ± 4 
80 pA 27 ± 3 28 ± 4 23 ± 3 30 ± 4 
Table 3-15 Firing frequency on each current injection from a prestimulus 
membrane potential of -70 mV 
 Diestrus 
(n = 15) 
Proestrus 
(n = 13) 
Estrus 
(n = 16) 
Metestrus 
(n = 9) 
5 pA 0 ± 0 0 ± 0 0 ± 0 0 ± 0 
20 pA 0.3 ± 0.2 2 ± 1 3 ± 1 1 ± 1 
35 pA 4 ± 1 6 ± 2 7 ± 2 2 ± 1 
50 pA 9 ± 2 10 ± 3 13 ± 3 7 ± 2 
65 pA 15 ± 2 15 ± 4 18 ± 3 10 ± 3 
80 pA 20 ± 3 21 ± 5 21 ± 3 17 ± 3 
Table 3-16 Firing frequency on each current injection from a prestimulus 
membrane potential of -80 mV 
 P value Diestrus Proestrus Estrus Metestrus 
5 pA 0.5 6/15 4/13 5/16 1/9 
20 pA 0.9 11/15 10/13 13/16 6/9 
35 pA 0.2  15/15  11/13 16/16 8/9 
50 pA 0.4  15/15  12/13 16/16 9/9 
65 pA NS 15/15 13/13 16/16 9/9 
80 pA NS 15/15 13/13 16/16 9/9 
Table 3-17 Proportion of cells firing action potentials from a prestimulus 
membrane potential of -70 mV 
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 P value Diestrus Proestrus Estrus Metestrus 
5 pA NS 0/15 0/13 0/16 0/9 
20 pA 0.1 1/15 4/13  6/16  1/9 
35 pA 0.5  9/15  8/13  10/16  3/9 
50 pA 0.7  11/15  9/13  14/16  7/9 
65 pA 0.4 14/15 10/13 15/16 7/9 
80 pA NS 15/15 13/13 16/16 9/9 
Table 3-18 Proportion of cells firing action potentials from a prestimulus 
membrane potential of -80 mV 
 
 
Figure 3-15 Latency to action potential generation in Type II cells A, B) Latency 
to the first action potential generated in response to depolarising current 
injection from a prestimulus membrane potential of -70 mV and -80 mV, 
respectively, C, D) latency to action potential generation in response to injection 
of 80 pA from a prestimulus membrane potential of -70 mV and -80 mV, 
respectively.  
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 Diestrus  Proestrus  Estrus  Metestrus  P 
value  
Statistical 
test  
Rheobase 
(pA) 
-70 
mV 
12 ± 4 
(n = 11) 
21 ± 6 
(n = 10) 
11 ± 2 
(n = 
13) 
9 ± 3 
(n = 7) 
0.4 KW 
-80 
mV 
29 ± 7 
(n = 11) 
38 ± 8 
(n = 10) 
29 ± 5 
(n = 
13) 
29 ± 5 
(n = 7) 
0.6 KW 
Latency 
1st AP 
(ms) 
-70 
mV 
110 ± 
29  
(n = 15) 
106 ± 21  
(n = 13) 
96 ± 
25  
(n = 
16) 
65 ± 11 
(n = 9) 
0.6 KW 
-80 
mV 
60 ± 11  
(n = 15) 
67 ± 8  
(n = 13) 
54 ± 6  
(n = 
16) 
59 ± 9 
(n = 9) 
0.4 KW 
Latency 
last 
sweep 
(ms) 
-70 
mV 
11 ± 1 
(n = 15) 
13 ± 3 
(n = 13) 
10 ± 1 
(n = 
16) 
15 ± 3  
(n = 9) 
0.7 KW 
-80 
mV 
34 ± 14 
(n = 15) 
24 ± 5 
(n = 13) 
17 ± 2 
(n = 
16) 
28 ± 8  
(n = 9) 
0.5 KW 
Table 3-19 firing properties of Type II neurons  
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Type III neurons  
Four Type III cells were recorded from Estrus and proestrus, five Type III cells 
were recorded from Metestrus, Diestrus. No more than two Type III cells were 
recorded from each animals.  
 
 
Figure 3-16 Resting membrane potential of Type III cells in the different stages 
of estrus (A). Sample cell firing at rest (ii) and not firing at rest (ii). 
 
 Diestrus  Proestrus  Estrus  Metestrus  P value  Statistical 
test  
RMP (mV) -63 ± 2  
(n = 5) 
-62 ± 9 
(n = 4) 
-74 ± 
12 
(n = 4) 
-65 ± 5 
(n = 5) 
0.7 One-way 
ANOVA 
Ihold 
(mV) 
-70 
mV 
-37  ± 21 
(n = 4) 
-32 ± 31 
(n = 4) 
24 ± 28 
(n = 4) 
-23 ± 23 
(n = 5) 
0.4 Repeated 
measure 
two-way 
ANOVA 
-80 
mV 
-29 ± 12 
(n = 4) 
-58 ± 40 
(n = 4) 
-11 ± 
19 
(n = 4) 
-28 ± 19 
(n = 5) 
Table 3-20 Properties of Type III cells at their resting membrane potential 
 
Cells were then transferred into current clamp mode where the properties of 
cells at their resting membrane potential were examined. The resting membrane 
potentials did not differ between the cohorts or the amount of current required to 
hold cells at either holding potentials (Figure 3-10, Table 3-12). Not enough 
observations were gathered to examine the rheobase or firing frequency from 
the resting membrane potential.  
The passive membrane properties were measured from the injection of -40 pA 
of current, averages are shown in Figure 3-11A; input resistance, membrane 
time constant, capacitance were not dependent on estrus in Type II neurons 
99 
 
(Figure 3-11, Table 3-13). Sag was not examined as a lack of sag was the key 
factor in identifying these cells as Type III.  
Parameter and 
prestimulus 
potential 
Diestrus  Proestrus  Estrus  Metestrus  P 
valu
e  
Statistical 
test  
Rin (MΩ) -70 
mV 
351 ± 
137 
(n = 5) 
371 ± 47 
(n = 4) 
388 ± 98 
(n = 4) 
515 ± 83 
(n = 5) 
0.2 Repeated 
measure 
two=way
ANOVA -80 
mV 
536 ± 
130 
(n = 5) 
288 ± 39 
(n = 4) 
311 ± 56 
(n = 4) 
460 ± 53 
(n = 5) 
Tau (ms) -70 
mV 
20 ± 7 
(n = 5) 
28 ± 4 
(n = 4) 
34 ± 12 
(n = 4) 
31 ± 8 
(n = 5) 
0.8 Repeated 
measure 
two-way 
ANOVA 
-80 
mV 
28 ± 6 
(n = 5) 
24 ± 4 
(n = 4) 
33 ± 15 
(n = 4) 
25 ± 5 
(n = 5) 
Capacitance 
(pF)  
-70 
mV 
59 ± 9 
(n = 5) 
76 ± 1 
(n = 4) 
79 ± 12 
(n = 4) 
59 ± 10 
(n = 5) 
0.3 
 
Repeated 
measure 
two-way 
ANOVA -80 
mV 
60 ± 12 
(n = ) 
84 ± 4 
(n = ) 
100 ± 41 
(n = ) 
57 ± 11 
(n = ) 
Table 3-21 Passive membrane properties of Type III neurons, statistical test 
based on Kruskal-Wallis (KW) and one-way ANOVA.  
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Figure 3-17 Passive membrane properties of Type III neurons, A) average trace 
following the injection of -40 pA of current from a prestimulus membrane 
potential of -70 mV (i) and -80 mV (ii), B, C) Input resistance from a prestimulus 
membrane potential of – 70 mV and – 80 mV respectively, D, E) Membrane 
time constant of cells from a prestimulus membrane potential of -70 mV and -80 
mV, respectively, F, G) Capacitance from a prestimulus membrane potential of -
70 mV and -80 mV respectively.  
 
 
Following this I examined the action potential properties; there were no 
differences observed in action potential zenith or threshold from either holding 
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potential. Following this the first derivative of the action potential was examined 
and the maximum rate of rise was determined. No statistically significant 
differences were observed in the maximum rate of rise (Figure 3-12, Table 
3-14). There was a significant effect of oestrous cycle on AP width however 
using Bonferroni post hoc analysis no statistically significant effects were 
observed.  
Following this I examined the firing properties of Type III neurons, a sample 
trace from each cohort is displayed in Figure 3-14A; no changes were found in 
the frequency of firing of cells (Table 3-15, Table 3-16, repeated measure two-
way ANOVA, p = 0.2) in response to depolarising current injections. The 
proportion of cells firing was not examined in this cohort as this requires n 
numbers above five which were not present in this group.  
 Diestrus  Proestrus  Estrus  Metestrus  P 
value  
Statistical 
test  
Zenith  (mV) -70 
mV 
9 ± 7 
(n = 5) 
8 ± 7 
(n = 4) 
16 ± 4 
(n = 4) 
21 ± 4 
(n = 5) 
0.4 
 
Repeated 
measure 
two-way 
ANOVA 
-80 
mV 
14 ± 7 
(n = 5) 
10 ± 7 
(n = 4) 
16 ± 4 
(n = 4) 
21 ± 3 
(n = 5) 
Width (ms) -70 
mV 
0.6 ± 
0.07 
(n = 5) 
0.9 ± 0.1 
(n = 4) 
1 ± 0.1 
(n = 4) 
0.7 ± 0.01 
(n = 5) 
0.02 Repeated 
measure 
two-way 
ANOVA -80 
mV 
0.7 ± 0.1 
(n = ) 
0.9 ± 0.1 
(n = 4) 
1 ± 0.1 
(n = 4) 
0.6 ± 0.04 
(n = 5) 
Threshold 
(mV) 
-70 
mV 
-51-± 5 
(n = 5) 
-55 ± 4  
(n = 4) 
-50 ± 2 
(n = 4) 
-50 ± 3 
(n = 5) 
0.6 Repeated 
measure 
two-way 
ANOVA 
-80 
mV 
-46 ± 3 
(n = 5) 
-52 ± 3  
(n = 4) 
-53 ± 4 
(n = 4) 
-50 ± 2 
(n = 5) 
dV/dt max 
(mV/ms)  
-70 
mV 
244 ± 54 
(n = 5) 
206 ± 59 
(n = 4) 
239 ± 
39 
(n = 4) 
310 ± 17 
(n = 5) 
0.2 Repeated 
measure 
two-way 
ANOVA 
-80 
mV 
261 ± 63 
(n = 5) 
213 ± 59 
(n = 4) 
244 ± 
28 
(n = 4) 
335 ± 11 
(n = 5) 
Table 3-22 Action potential properties of Type II neurons, statistical tests used 
Kruskal-Wallis (KW) and repeated measure two-way ANOVA.  
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Figure 3-18 Action potential properties of Type III neurons, A) averaged action 
potential of the first action potential generated, B, C) Action potential zenith from 
a prestimulus membrane potential of -70 mV and -80 mV, respectively, D, E) 
Action potential width measured from – 20 mV from a prestimulus membrane 
potential of -70 mV and -80 mV, respectively, F, G) Threshold from a 
prestimulus membrane potential of -70 mV and -80 mV, respectively.  
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Figure 3-19 dV/dt of first action potential generated by Type III neurons, A, B) 
averaged dV/dt (shaded area Standard error of the mean) plotted against the 
average action potential on cells from a prestimulus membrane potential of -70 
mV and -80 mV, respectively, C, D) dV/dt maximum from a prestimulus 
membrane potential of -70 mV and -80 mV, respectively.  
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Figure 3-20 Firing properties of Type III neurons A) sample traces of cells in 
each stage of the oestrus cycle i) Diestrus, ii) Proestrus, iii) Estrus, iv) 
Metestrus, B, C) fraction of cells firing action potentials in response to various 
current injections from prestimulus membrane potentials of -70 mV and -80 mV, 
respectively, D, E) frequency of firing in response to various current injections 
from a prestimulus membrane potential of -70 mV and -80 mV respectively, F, 
G) Rheobase from a prestimulus membrane potential of -70 mV and -80 mV, 
respectively.   
 
 
 Diestrus 
(n = 5) 
Proestrus 
(n = 4) 
Estrus 
(n = 4) 
Metestrus 
(n = 5) 
5 pA 0 ± 0 0 ± 0 0 ± 0 2 ± 1 
20 pA 1 ± 1 8 ± 4 11 ± 5  10 ± 6 
35 pA 4 ± 2 18 ± 4 17 ± 6 20 ± 7 
50 pA 6 ± 3 29 ± 5 23 ± 8 28 ± 8 
65 pA 8 ± 4 36 ± 5 30 ± 10 34 ± 7 
80 pA 12 ± 6 42 ± 7 25 ± 10 40 ± 6 
Table 3-23 Firing frequency on each current injection from a prestimulus 
membrane potential of -70 mV 
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 Diestrus 
(n = 5) 
Proestrus 
(n = 4) 
Estrus 
(n = 4) 
Metestrus 
(n = 5) 
5 pA 0 ± 0 0 ± 0 0 ± 0 0 ± 0 
20 pA 0 ± 0 0 ± 0 0 ± 0 0 ± 0 
35 pA 4 ± 3 0 ± 0 0 ± 0 4 ± 2 
50 pA 8 ± 5 2 ± 1 4 ± 2 8 ± 4 
65 pA 12 ± 6 7 ± 3 11 ± 5 15 ± 6 
80 pA 16 ± 7 13 ± 4 17 ± 6 21 ± 7 
Table 3-24 Firing frequency on each current injection from a prestimulus 
membrane potential of -80 mV 
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1.4 Discussion  
This study examined neurons located within the BNSTALG across the four 
stages of oestrus to determine the effect of circulating hormones on intrinsic 
neurophysiological properties. These data would suggest that oestrus cycle has 
minimal effect on the intrinsic properties of neurons in the BNSTALG. No 
statistically significant effect was seen on any parameter examined with only 
one trend being seen in maximum rate of rise of action potentials of Type II 
neurons.  
The electrophysiological characterisation of BNST neurons was originally based 
on male rats; these have since been expanded to mice and even primates 
(Daniel et al., 2017). Here we have shown that a similar classification can also 
be applied to female mice and that the amount of variability across the stages of 
oestrus is minimal. The BNST plays a key role in a number of anxiety-related 
disorders including GAD and PTSD, as discussed in the introduction, however 
the electrophysiological characterisation of this key brain region is currently 
biased towards males, despite far higher incidences of these pertinent disorders 
being diagnosed in females. To my knowledge, only one study examining 
electrophysiological properties has contained female mice (Silberman et al., 
2013). In this study male and female mice were examined in the same cohort, 
neither the sexually dimorphic nature of this brain region nor the influences of 
oestrus cycle were addressed in the Silberman et al study perhaps due to 
limited numbers of transgenic mice.  
Drops in progesterone levels have been shown to lead to changes in plasticity 
of GABAA receptors in various brain regions. In the PAG changes in 
endogenous hormone levels lead to changes in subunit expression of the 
GABAA receptor; in diestrus mice there is an increase in expression of the  
subunit (Brack & Lovick, 2007a). The delta subunit causes extrasynaptic 
placement of the GABAA receptor leading to tonic inhibition. Through a 
decrease in input resistance (shunting inhibition) as well as a possible 
hyperpolarization of the resting potential increases in tonic inhibition would 
typically lead to decreased excitability (Kullmann et al., 2005; Marowsky & Vogt, 
2014), although this would, to some extent, depend on the nature of Cl- 
equilibrium potential. In the PAG the plastic changes in GABAA receptors 
appear to be limited to GABAergic neurons. The BNST is a primarily GABAergic 
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population making it a possible target to observe similar effects however no 
changes in excitability or input resistance were observed in either population in 
this study.  
The one observed trend was seen in the maximum rate of rise of the action 
potential which was lower in diestrus in comparison to metestrus and proestrus. 
The central role of voltage gated sodium channels in the rising phase of the 
action potential would indicate some alteration in function of these channels. 
Progesterone has been shown to act as -receptors where it inhibits 
endogenous ligands.; These endogenous ligands are capable of modulating 
voltage gated sodium channels in HEK293 cells (Johannessen et al., 2011). 
The -receptors is also found in the BNST (Lein et al., 2007) therefore similar 
actions may be taking place within the BNST. During diestrus circulating 
progesterone levels are at their lowest, the largest peak in progesterone levels 
is observed in proestrus while a smaller peak is observed in metestrus. These 
peeks in progesterone could be altering the rate of rise of these action 
potentials via indirect interactions with voltage gated sodium channels.  
Chen et al 2009 found increased neuronal activity within the BNST during 
estrus in comparison to proestrus when exposed to predator scent (Chen et al., 
2009). The Chen et al study was carried out in vivo while this study took place 
in vitro; due to the nature of in vitro slice preparation the afferent connections 
into this region are lost however the axonal projections would remain and no 
differences were observed in synaptic events or in excitability. It is possible that 
exposure to a stressor causes differences; no stressors were introduced to 
these animals.  
In the neurophysiological literature as a whole there is a distinct biased towards 
the use of male animals, a contributing reason for this is the uncertainty 
regarding the neuronal effects of the oestrus cycle. This can have detrimental 
effects especially when examining anxiety-related disorders such as general 
anxiety disorder and PTSD which have far higher incidences in the female 
population. This bias carries through to the clinic where changes in procedure to 
include more females in clinical trials has still not lead to necessary changes in 
drug development (Mazure & Jones, 2015). Here, we have shown that the 
intrinsic properties of Type I and Type II neurons in the BNST appear largely 
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unaffected by the oestrus cycle. In future studies related to the BNST I propose 
the use of both genders to ensure an accurate understanding of this key brain 
region and the circuits in which it participates.   
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4. In the BNST type II neurons show higher excitability in males than in 
females 
4.1. Introduction  
 
Despite our understanding of the sexually dimorphic properties of the brain the 
electrophysiological characterisations of various brain regions including the 
BNST are often biased toward males. A common reason for this is the 
uncertainty of the effect of the oestrus cycle on neuronal properties and the 
variability of female data due to hormone fluctuations.  In the previous chapter, I 
have addressed the effect of the oestrus cycle on the intrinsic properties of cells 
in the BNST and found no statistically significant effects; as no statistically 
significant effects were observed the cohort was grouped together for 
comparison with age matched males from the same colony. 
In humans, incidences of anxiety-related disorders are ~60% higher in females 
than males (Kessler et al., 2005), and in the case of PTSD they are twice as 
high. Some controversy still surrounds the basis for this and while a component 
of this may be down to societal effects of gender roles, eg. females are far more 
likely to experience sexual trauma, a key instigator for PTSD, the stress system 
in mammals is sexually dimorphic. In particular, as discussed in the 
introduction, the sexually dimorphic properties of the BNST are quite well 
characterised. This key circuit is also responsible for carrying out sex-specific 
behaviours such as maternal behaviours (Numan & Numan, 1995, 1996), 
heightened aggression in males (Masugi-Tokita et al., 2016) and reproductive 
behaviours  in both males and females (Emery & Sachs, 1976; Claro et al., 
1995; Liu et al., 1997; Klampfl et al., 2016).  
Circulating levels of a number of hormones greatly differ between males and 
females, for example levels of ALLO are 8 -10 fold higher in females than in 
males (Purdy et al., 1990; Corpéchot et al., 1993; Cheney et al., 1995) . ALLO 
is a neuroactive metabolite of progesterone thought to be involved in anxiety 
(Shen et al., 2007). Components of these actions are mediated via the BNST, 
for example systemic administration of ALLO blocks CRH-enhanced startle  in 
female rats (Toufexis et al., 2004), a BNST-mediated response.  
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Gaboxadol (4,5,6,7-Tetrahydroisoxazolo[5,4-c]pyridin-3-ol hydrochloride), also 
known as THIP, is a GABAA agonist with a high affinity for the GABAA receptors 
containing the delta subunit. Here we plan to address the functional properties 
of these receptors in the BNST via administration of Gaboxadol and determine if 
the effects are sex-specific. I will also examine the intrinsic neuronal properties 
of cells in the anterolateral area of the BNST in both male and female C57BL/6 
mice to determine any sex-related functional differences in Type I and/or Type II 
cells within this region.  
 
Hypothesis  
The sexually dimorphic nature of the BNST includes changes in the intrinsic 
properties of neurons located in this brain region; these changes may be related 
to changes in susceptibility to anxiety related disorders such as PTSD.  
Aim  
The aim of the current study is to address the role of sex on the intrinsic 
properties of neurons located within the BNSTALG 
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4.2. Methods  
 
All animals used in this study were breed in house using stock from Charles 
River; Male and female C57BL/6 mice aged 3-5 months were interleaved 
throughout the study, the females used in this study were the same cohort 
described in the previous chapter. A proportion of the animals underwent 
behavioural tests which were carried out on the morning of experimental days in 
the early hours of the animals’ light cycle. Following this animals were killed by 
cervical dislocation and the brain was removed and placed into ice-cold sucrose 
solution. 300 µm thick coronal slices were prepared, slices which contained the 
BNSTALG were placed into a holding chamber where they were left to recover 
for one hour prior to commencement of experiments.  
Slices were transferred into the recording chamber where whole cell patch 
clamp recordings were carried out using a K-gluconate solution containing 
biocytin as described in the methods chapter.  
To assess spontaneous synaptic transmission cells were voltage clamped at -
70 mV. Events were then detected and measured as described in the methods 
chapter. The receptor basis of synaptic events in Type I neurons was examined 
by applying the glutamate receptor blockers of NBQX and L689560 (both 5 µM)  
Pharmacological activation of GABAA receptors containing the  subunit was 
carried out in current clamp mode from a prestimulus potential of -80 mV in the 
constant presence of NBQX and L689-560, alternating 500 ms pulses of -40 pA 
and +80 pA were applied at 10 second intervals. Following a 5 minute baseline, 
30 µM Gaboxadol was added, 8 minutes later the GABAA receptor antagonist 
GABAzine (5 µM) was co-applied with the Gaboxadol (30 µM). After another 8 
minutes Gaboxadol and GABAzine were washed out.   
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4.3. Results 
 
4.3.1. Behaviour 
Anxiety levels were assessed using the elevated zero maze, mice were run on 
the maze in the early hours of their lights on stage. Anxiety is measured as the 
% of time the animals spend in the light component of the maze; while the 
females spent approximately 4% less time in the open in comparison to the 
males (Male, 28 ± 2 %, n = 20, Female 24 ± 1%, n = 46) this was not 
statistically significant (unpaired t-test, p = 0.07, Figure 4-1).  
 
Figure 4-1. % time spent in the open of the elevated zero maze 
 
4.3.2. Electrophysiological properties of neurons located in the anterolateral 
area of the BNST  
4.3.2.1. Type I neurons  
A total of 21 Type I neurons were recorded from males, these were recorded 
from 15 animals with a maximum of 3 cells being recorded from each animal. 66 
Type I neurons were recorded from females, these were recorded from 36 
animals with a maxiumum of 5 cells being recorded from each animal. I began 
by looking at the synaptic events in voltage clamp mode while holding the cells 
at -70 mV; no differences were observed in the amount of current required to 
clamp cells at -70 mV (Male -6 ± 5 pA, n = 16, female -6 ± 4 pA, n = 53, 
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unpaired t-test, p = 1, Figure 4-2), the frequency of inward-going post synaptic 
events (Male 8 ± 3 Hz, n = 16, Female 7 ± 1 Hz, n = 53 Mann-Whitney U, p = 
0.9, Figure 4-2) or the average amplitude of inward-going post synaptic events 
(Male -14 ± 0.8 pA, n = 16, female -15 ± 0.5 pA, n = 53, Mann-Whitney U, p = 
0.5, Figure 4-2).  
 
 
Figure 4-2 Synaptic properties of Type I neurons A) Amount of current required 
to hold cells at -70 mV, B) the frequency on inward-going postsynaptic events, 
C) Averaged amplitude of inward-going post-synaptic events, D) sample trace 
with an enlarged synaptic event in the blue box. 
 
 
In order to assess the nature of these synaptic events antagonists of key 
glutamate receptors were applied; NBQX, an antagonist of AMPA receptors, 
and L689560, an antagonist of NMDA receptors. The synaptic inputs to these 
cells are almost entirely blocked by the addition of these compounds (paired t-
test, p = 0.01, n = 3) indicating that they are comprised mostly of excitatory 
glutamatergic inputs (Figure 4-3).  
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Figure 4-3. % change in the frequency of 
inward going-synaptic events following the 
addition of NBQX (5µM) and L689560 
(5µM). 
 
 
 
 
Following this the cells were switched into current clamp mode where properties 
of the cells at their resting membrane potential were assessed. As suggested by 
the holding current measurements in voltage clamp, sex does not play a 
significant role in resting membrane potential with both cohorts resting at 
approximately -68 mV (Male -69 ± 2 mV, n = 21, Female -68 ± 1 mV, n = 66, 
unpaired t-test, p = 0.9, Figure 4-4). There was also no sex-specific differences 
in the proportion of cells firing with 9/21 (43%) of male cells firing action 
potentials at rest and 30/66 (45%) of the female cells firing at rest (chi squared, 
p = 0.8). The cells which were firing at rest fired at a mean of 2 ± 0.6 Hz in the 
males and 5 ± 1 Hz in the females, however, this was not significantly different 
(Mann-Whitney U, p = 0.3, Figure 4-4). Notably in the females there appeared 
to be a population of cells firing faster than 5 Hz that was absent in the males. 
Of the cells which were not firing at rest there was no difference in rheobase 
(Male 39 ± 20 pA, n = 5, Female 28 ± 5 pA, n = 16 unpaired t-test, p = 0.5).  
The intrinsic properties of the neurons were examined from two prestimulus 
potentials, -70 mV and -80 mV. The amount of current required to hold cells at 
these potentials was not dependent upon sex (-70 mV, Male -12 ± 6 pA, n =21, 
Female -9 ± 4 pA, n = 66, Mann-Whitney U, p = 0.5; -80 mV, Male -28 ± 6 pA, n 
= 21, Female -29 ± 5 pA, n = 66, Mann-Whitney U, p = 0.8).  
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Figure 4-4. Properties of Type I neurons at their resting membrane potentials. 
A) resting membrane potential of cells, B) the frequency of firing of cells which 
generated at least one action potential during a one minute epoch, C) rheobase 
of cells which were not firing at rest, D) sample cell firing at rest (i) and not firing 
at rest (ii). 
 
The passive membrane properties were examined following the injection of -40 
pA of current. the averages of these traces can be seen in Figure 4-5; no 
differences were observed in input resistance (-70 mV, Male 489 ± 43 MΩ, n = 
21, Female 513 ± 24 MΩ, n = 66, Mann-Whitney U, p = 0.5; -80 mV, Male 374 ± 
34 MΩ, n = 21, Female 425 ± 24 MΩ, n = 66, Mann-Whitney U, p = 0.4, Figure 
4-5), membrane time constant (-70 mV, Male 34 ± 3 ms, n = 21, Female 32 ± 2 
ms, n = 66, unpaired t-test, p = 0.4; -80 mV, Male 26 ± 2 ms, n = 21, Female 26 
± 1 ms, n = 66, Mann-Whitney U, p = 0.7, Figure 4-5), sag (-80 mV, Male 16 ± 1 
%, n = 21, Female 15 ± 1 %, n = 66, Mann-Whitney U, p = 0.3, Figure 4-5) and 
capacitance (-70 mV, Male 74 ± 5 pF, n = 21, Female 65 ± 3 pF, n = 66, Mann-
Whitney U, p = 0.07; -80 mV, Male 75 ± 6 pF, n = 21, Female 66 ± 3 pF, n = 66, 
Mann-Whitney U, p = 0.2, Figure 4-5).  
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Figure 4-5. Passive membrane properties of Type I neurons, A)  average 
responses to the injection of -40 pA of current, i) averaged responses from a 
prestimulus potential of -70 mV and ii) average responses from a prestimulus 
potential of -80 mV, B) Input resistance from a prestimulus potential of -70 mV 
(i) and -80 mV (ii), C) membrane time constant from a prestimulus potential of -
70 mV (i) and -80 mV (ii), D) capacitance from a prestimulus potential of -70 mV 
(i) and -80 mV (ii), E) sag from a prestimulus potential of -80 mV. 
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The action potential properties were examined from the first action potential 
generated in response to a series of depolarising stimuli. The averages of these 
action potentials can be seen in Figure 4-6. No sex-related differences were 
seen in the action potential width (-70 mV, Male 0.7 ± 0.04 ms, n = 21, Female 
0.7 ± 0.02 ms, n = 66, unpaired t-test, p = 0.4; -80 mV, Male 0.7 ± 0.03 ms, n = 
21, Female 0.7 ± 0.02 ms, n = 66, Mann-Whitney U, p = 0.7, Figure 4-6), zenith 
(-70 mV, Male 16 ± 2 mV, n = 21, Female 16 ± 1 mV, n = 66, unpaired t-test, p 
= 0.99; -80 mV, Male 17 ± 2 mV, n = 21, Female 17 ± 1 mV, n = 66, Mann-
Whitney U, p = 0.9, Figure 4-6), threshold (-70 mV, Male -51 ± 1 mV, n = 21, 
Female -51 ± 1 mV, n = 66, Mann-Whitney U, p = 0.4; -80 mV, Male -51 ± 1 
mV, n = 21, Female -51 ± 1 mV, n = 66, unpaired t-test, p = 0.9, Figure 4-6) or 
maximum rate of rise  (-70 mV, Male 262 ± 13 mV/ms, n = 21, Female 263 ± 8 
mV/ms, n = 66, unpaired t-test, p = 0.96; -80 mV, Male 289 ± 17 mV/ms, n = 21, 
Female 289 ± 9 mV/ms, n = 66, Mann-Whitney U, p = 1, Figure 4-7).  
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Figure 4-6. Action potential properties of Type I neurons, A) Averages of first 
action potential generated in response to a series of depolarising current 
injections from a  prestimulus potential of -70 mV (i) and -80 mV (ii), B) Action 
potential zenith from a  prestimulus potential of -70 mV (i) and -80 mV (ii), C) 
action potential width measured at -20 mV from a prestimulus potential of -70 
mV (i) and -80 mV (ii), Threshold of action potential from a prestimulus potential 
of -70 mV (i) and -80 mV (ii). 
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Figure 4-7. Maximum rate of rise of Type I neurons A) First derivative of action 
potentials plotted against the average action potential for each cohort, line is the 
mean and shaded area is the standard error of the mean, from a prestimulus 
potential of -70 mV (i) and -80 mV (ii), B) the maximum rate of rise of each cell 
from a prestimulus potential of -70 mV (i) and -80 mV (ii). 
 
To measure excitability a series of depolarising pulses were injected into the 
cell, the proportion of cells which fired in response to each stimulus and the 
firing frequency (repeated measure two-way ANOVA, sex p = 0.9, Figure 4-8) 
were not sex-specific in Type I neurons. Rheobase was also not sex-dependent 
(-70 mV, Male 11 ± 3 pA, n = 21, Female 11 ± 1 pA, n = 66, Mann-Whitney U, p 
= 0.8; -80 mV, Male 28 ± 6 pA, n = 21, Female 28 ± 2 pA, n = 66, Mann-
Whitney U, p = 0.4, Figure 4-8).  
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Figure 4-8. Firing properties of Type I neurons. A) Sample cell from prestimulus 
potential of -80 mV, i) sample current injection, ii) sample cell from the male 
cohort, iii) sample cell from the female cohort, B) proportion of cells firing action 
potentials in response to a series of depolarising current injections from a 
prestimulus potential of -70 mV (i) and -80 mV (ii), C) frequency of action 
potentials in response to depolarising current injections from a prestimulus 
potential of -70 mV (i) and -80 mV (ii), D) Rheobase from a prestimulus potential 
of -70 mV (i) and -80 mV (ii).  
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The delay between  the injection of current and the generation of the first action 
potential, latency, was not dependent on sex either for the first action potential 
generated in response to depolarising stimuli (-70 mV, Male 137 ± 25 ms, n = 
21, Female 121 ± 14 ms, n = 66, Mann-Whitney U, p = 0.4; -80 mV, Male 147 ± 
28 ms, n = 21, Female 118 ± 11 ms, n = 66, Mann-Whitney U, p = 0.6, Figure 
4-9) or following the injection of +80 pA of current (-70 mV, Male 11 ± 1 ms, n = 
21, Female 13 ± 1 ms, n = 66, Mann-Whitney U, p = 0.6; -80 mV, Male 25 ± 3 
ms, n = 21, Female 34 ± 5 ms, n = 66, Mann-Whitney U, p = 0.2, Figure 4-9).  
 
Figure 4-9 Latency of Type I neurons in generation of action potentials, A) 
Latency of first action potential generated in response to depolarising stimuli 
from a prestimulus potential of -70 mV (i) and -80 mV (ii).  
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In order to address the role of the different cell populations described here with 
the anxiety-like behaviours of animals, a series of correlations were examined 
between the % time spent in the open part of the maze and the intrinsic 
properties of neuronal populations in the BNST. A strong correlation was 
observed with increased frequency of synaptic events correlating with 
decreased anxiety like behaviour in the elevated zero maze in the male cohort 
(Figure 4-10, Table 4-1). A more depolarised resting membrane potential was 
also highly correlated with decreases in anxiety like-behaviour in Type I 
neurons, once again this was only in the male cohort (Figure 4-11, Table 
4-2).Given this correlation between resting membrane potential and behaviour it 
is unsurprising that a correlation was observed between holding current and 
behaviour in both voltage clamp mode (Figure 4-10, Table 4-1) and current 
clamp mode (Figure 4-11, Table 4-2). Finally higher membrane time constants 
correlated with decreased anxiety-like behaviour on the elevated zero maze 
(Figure 4-11, Table 4-3). No other correlations were observed between intrinsic 
properties and anxiety like behaviours.  
 
Figure 4-10. Correlation between % time spent in the open on the elevated zero 
maze and frequency of inward going synaptic events (A) and the amount of 
current required to hold cells at -70 mV (B). 
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Figure 4-11. Correlation between the amount of time spent in the open on the 
elevated zero maze and A) resting membrane potential, B) membrane time 
constant from a prestimulus potential of -80mV and holding current from a 
prestimulus potential of -70 mV (C) and -80 mV (D).  
 
Parameter Male Female  
 R-squared P value 
 
R-squared P value 
Holding current  0.48 0.004 0.03 0.2 
Frequency of events 0.62 0.0005 -0.007 0.4 
Average amplitude -0.07 0.7 -0.02 0.5 
Table 4-1. Correlation statistics between % time spent in the open component 
of the elevated zero maze and properties of cells examined in voltage clamp 
mode.  
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Parameter Male Female  
 R-squared P value 
 
R-squared P value 
Resting membrane 
potential 
0.4 0.001 -0.01 0.5 
Frequency at rest 0.3 0.08 -0.05 0.7 
Ihold -70 mV 0.3 0.004 0.009 0.25 
-80 mV 0.4 0.003 0.03 0.15 
Table 4-2. Correlation statistics between % time spent in the open component 
of the elevated zero maze and properties of cells at their resting membrane 
potentials and holding current required to obtain a prestimulus potential of -70 
mV and -80 mV.  
 
 
Parameter Male Female  
 R-squared P value 
 
R-squared P value 
Input 
resistance  
-70 mV 0.02 0.24 -0.004 0.4 
-80 mV 0.007 0.3 -0.01 0.4 
Membrane 
time 
constant 
-70mV -0.04 0.65 0.002 0.3 
-80 mV 0.2 0.049 -6.8 E-4 0.3 
Capacitance -70 mV 0.02 0.3 0.004 0.29 
-80 mV -0.03 0.6 -0.02 0.6 
Sag  -80 mV -0.009 0.4 0.7 -0.02 
Table 4-3. Correlation statistics between % time spent in the open component 
of the elevated zero maze and passive membrane properties. 
 
 
Parameter Male Female  
 R-squared P value 
 
R-squared P value 
AP zenith -70 mV     
-80 mV -0.05 0.97 -0.005 0.4 
AP width -70mV -0.05 0.9 -0.02 0.6 
-80 mV -0.05 0.75 -0.01 0.5 
Threshold -70 mV 0.02 0.3 -0.01 0.4 
-80 mV -0.05 0.8 -0.02 0.6 
dV/dt max -70 mV -0.05 0.9 -0.02 0.9 
-80 mV -0.03 0.5 -0.01 0.5 
Table 4-4. Correlation statistics between % time spent in the open component 
of the elevated zero maze and action potential properties.  
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Parameter Male Female  
 R-squared P value 
 
R-squared P value 
Frequency-  
injection 80 
pA 
-70 mV -0.05 0.9 -0.008 0.4 
-80 mV 0.04 0.2 -0.03 0.9 
Latency 1st 
AP 
-70mV 0.08 0.11 -0.03 0.98 
-80 mV -0.04 0.7 -0.03 0.9 
Latency 
injection 80 
pA 
-70 mV 0.01 0.3 -0.02 0.8 
-80 mV -0.05 0.8 -0.009 0.4 
Table 4-5. Correlation statistics between % time spent in the open component 
of the elevated zero maze and properties of neuronal excitability.  
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4.3.2.2. Type II neurons  
A total of 29 Type II cells were recorded from males, these were recorded from 
16 animals with a maximum of 4 cells being recorded from each animals.  53 
Type II cells were recorded from females, these recordings were made from 34 
animals with a maximum of 4 cells being recorded from each animal. Upon 
examining synaptic properties in voltage clamp mode no differences were 
observed in the amount of current required to hold cells at -70 mV (male -14 ± 7 
pA, n = 18, Female -4 ± 3 pA, n = 41, unpaired t-test, p = 0.2, Figure 4-12), the 
frequency of inward-going post synaptic events (Male 4 ± 0.8 Hz, n = 18, 
Female 6 ± 1 Hz, n = 41 Mann-Whitney U, p = 0.5, Figure 4-12) or the average 
amplitude of inward-going post synaptic events (Male -13 ± 0.5, n = 18, Female 
-13 ± 0.4, n = 41, Mann-Whitney U, p = 1, Figure 4-12). 
 
Figure 4-12 Synaptic properties of Type II neurons A) Amount of current 
required to hold cells at -70 mV, B) the frequency on inward-going post synaptic 
events, C) Averaged amplitude of inward-going post-synaptic events, D) sample 
trace with an enlarged synaptic event in the blue box.  
 
Following this the recording was switched into current clamp mode to examine 
the properties of the cells at their resting membrane potential. The resting 
membrane potentials of Type II neurons was not sex-dependent (Male -66 ± 2 
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mV, n = 29, Female -68 ± 1 mV, n =53, unpaired t-test, p = 0.3, Figure 4-13). 
Approximately half of the cells from each cohort were firing action potentials in 
the initial 1 minute recording of the cells at their resting membrane potential with 
14/29 male cells firing and 23/53 female cells firing. The firing frequency of the 
cells which were generating action potentials did not differ with sex (Male 6 ± 2 
Hz, n = 14, Female 5 ± 1 Hz, n = 23, Mann-Whitney U, p = 0.99, Figure 4-13). 
Of the cells which did not fire at rest rheobase was examined, this was not sex-
specific averaging 23.6 ± 7 pA (n = 5) in the males and 28.5 ± 5 pA (n = 16) in 
the females (unpaired t-test, p = 0.6, Figure 4-13). 
 
Figure 4-13. Properties of Type II neurons at their resting membrane potentials, 
A) resting membrane potential of cells, B) the frequency of firing of cells which 
generated at least one action potential during a one minute epoch, C) rheobase 
of cells which were not firing at rest, D) sample cell firing at rest (i) and not firing 
at rest (ii) 
 
The intrinsic properties were examined from set prestimulus membrane 
potentials of -70 mV and -80 mV. The amount of current required to hold the 
cells at the prestimulus potential of -70 mV averaged -7 pA in both male and 
female groups (Male -6 ± 4 pA, n = 24, Female -8  ± 3 pA, n =51, unpaired t-
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test, p = 0.7); whereas the depolarising current required to hold the cells at -80 
mV averaging -22 ± 4 pA (n = 24) in males and -30 ± 4 pA (n = 51) in females,  
(Mann-Whitney U, p = 0.2). 
The passive membrane properties were examined from the responses to the 
injection of -40 pA of current (averages are shown in Figure 4-14). The input 
resistance was  a mean of ~100 MΩ (~21%) higher in the male cohort from a 
prestimulus potential of -70 mV this however was not statistically significant 
(Male 581 ± 58 MΩ, n = 29, Female 482 ± 32 MΩ, n =53, Mann-Whitney U, p = 
0.14, Figure 4-14); from -80 mV the mean was also 100 MΩ (26%) higher in the 
male cohort which was statistically significant (Male 470 ± 45 MΩ, n = 29, 
Female 372 ± 29 MΩ, n =53, Mann-Whitney U, p = 0.02, Figure 4-14). 
Capacitance was ~15 pF higher in the female cohort in comparison to the male 
cohort (-70 mV, Male 56 ± 4 pF, n =29, Female 73 ± 4 pF, n = 53, Mann-
Whitney U, p = 0.006; -80 mV, Male 60 ± 4 pF, n = 29, Female 76 ± 4 pF, n = 
53, unpaired t-test, p = 0.006, Figure 4-14). No differences were observed in the 
membrane time constant (-70 mV, Male 30 ± 2 ms, n = 29, Female 32 ± 1 ms, n 
= 53, Mann-Whitney U, p = 0.6; -80 mV, Male 25 ± 1 ms, n = 29, Female 25 ± 1 
ms, n = 53, Mann-Whitney U, p = 0.4, Figure 4-14), as the influence of the 
higher capacitance of cells in females is balanced out by their lower input 
resistance. Sag was only examined from a prestimulus potential of -80 mv due 
to the voltage dependent kinetics of Ih; this was found to be significantly larger 
in the female cohort (Male 15 ± 1 %, n = 29, Female 19 ± 1 %, n = 53, Mann-
Whitney U, p = 0.02, Figure 4-14).  
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Figure 4-14 Passive membrane properties of Type II neurons, A)  average 
responses to the injection of -40 pA of current, i) sample current injection, ii) 
averaged responses from a prestimulus potential of -70 mV and iii) average 
responses from a prestimulus potential of -80 mV, B) Input resistance from a 
prestimulus potential of -70 mV (i) and -80 mV (ii), C) membrane time constant 
from a prestimulus potential of -70 mV (i) and -80 mV (ii), D) capacitance from a 
prestimulus potential of -70 mV (i) and -80 mV (ii), E) sag from a prestimulus 
potential of -80 mV. Significance indicated via *, * p<0.05, ** p <0.01. 
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Averages of action potentials, examined from the first action potential generated 
in response to depolarising stimuli, are shown in Figure 4-15. No differences 
were observed in action potential zenith (-70 mV, Male 12 ± 2 mV, n = 29, 
Female 14 ± 1 mV, n = 53, Mann-Whitney U, p = 0.3; -80 mV, Male 13 ± 2 mV, 
n = 29, Female 15 ± 1 mV, n = 53, Mann-Whitney U, p = 0.14, Figure 4-15), 
width (-70 mV, Male 0.7 ± 0.03 ms, n = 29, Female 0.7 ± 0.02 ms, n = 53, 
unpaired t-test, p = 0.4; -80 mV, Male 0.7 ± 0.02 ms, n = 29, Female 0.7 ± 0.02 
ms, n =  53, Mann-Whitney U, p = 0.14, Figure 4-15) or the threshold (-70 mV, 
Male -52 ± 1 mV, n = 29, Female -52 ± 1 mV, n = 53, Mann-Whitney U, p = 0.8; 
-80 mV, Male -54 ± 1 mV, n = 29, Female -53 ± 1 mV, n = 53, Mann-Whitney U, 
p = 0.7, Figure 4-15). The maximum rate of rise, was also not affected by sex (-
70 mV, Male 240 ± 15 mV/ms, n = 29, Female 248 ± 8 mV/ms, n = 53, unpaired 
t-test, p = 0.6; -80 mV, Male 272 ± 16 mV/ms, n = 29, Female 280 ± 8 mV/ms, n 
= 53, Mann-Whitney U, p = 0.4, Figure 4-16).  
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Figure 4-15 Action potential properties of Type II neurons, A) Averages of first 
action potential generated in response to a series of depolarising current 
injections from a  prestimulus potential of -70 mV (i) and -80 mV (ii), B) Action 
potential zenith of action potentials from a  prestimulus potential of -70 mV (i) 
and -80 mV (ii), C) action potential width measured at -20 mV from a 
prestimulus potential of -70 mV (i) and -80 mV (ii), Threshold of action potential 
from a prestimulus potential of -70 mV (i) and -80 mV (ii). 
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Figure 4-16. Maximum rate of rise of Type II neurons A) First derivative of 
action potentials plotted against the average action potential for each cohort, 
line is the mean and shaded area is the standard error of the mean, from a 
prestimulus potential of -70 mV (i) and -80 mV (ii), B) the maximum rate of rise 
of each cell from a prestimulus potential of -70 mV (i) and -80 mV (ii).  
 
Finally I measured the excitability of Type II neurons. From a prestimulus 
potential of -70 mV there were no differences in proportions of cells firing in 
response to depolarising currents (Figure 4-17B), most likely down to the high 
proportion of cells firing even in response to smaller stimuli. From a prestimulus 
potential of -80 mV the male neurons had an increased likelihood of firing in 
response to the injection of 5 pA (3/29 male cells fired while 0/59 female cells 
fired, p = 0.01) and 20 pA (15/29 male cells fired and 14/59 female cells fired, p 
= 0.009), by 35 pA a large proportion of both cohorts were firing (22/ 29 male 
cells were firing and 33/59 female cells were firing, p = 0.07, Figure 4-17B) 
which continued to increase to the point that all cells in both cohorts were firing 
by the injection of 80 pA. Male Type II neurons fired at a higher frequency than 
females in response to a series of depolarising current injections (repeated 
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measure two-way ANOVA on both prestimulus potentials, sex, p = 0.02, Figure 
4-17C). This indicated greater excitability in males compared to females. 
Rheobase of Type II neurons was not dependent on sex (-70 mV, Male 12 ± 2 
pA, n = 17, Female 13 ± 2 pA, n = 41, Mann-Whitney U, p = 0.8; -80 mV, Male 
27 ± 2 pA, n = 17, Female 31 ± 3 pA, n = 41, Mann-Whitney U, p = 0.8, Figure 
4-17). Latency between current injection and the generation of the first action 
potential was not effected by sex (-70 mV, Male 112 ± 16 ms, n = 29, Female 
97 ± 12 ms, n = 53, Mann-Whitney U, p = 0.4; -80 mV, Male 99 ± 17 ms, n = 29, 
Female 59 ± 4 ms, n = 53, Mann-Whitney U, p = 0.09, Figure 4-18), however 
following the injection of 80 pA of current the male cohort generated an action 
potential faster than the females (-70 mV, Male 8 ± 0.1 ms, n = 29, Female 12 ± 
1 ms, n = 53, Mann-Whitney U, p =0.02; -80 mV, Male 15 ± 1 ms, n = 29, 
Female 25 ± 4 ms, n = 53, Mann-Whitney U, p = 0.02, Figure 4-18).  
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Figure 4-17. Firing properties of Type II neurons A) Sample cell from 
prestimulus potential of -80 mV, i) sample current injection, ii) sample cell from 
the male cohort, iii) sample cell from the female cohort, B) proportion of cells 
firing action potentials in response to a series of depolarising current injections 
from a prestimulus potential of -70 mV (i) and -80 mV (ii), C) frequency of action 
potentials in response to depolarising current injections from a prestimulus 
potential of -70 mV (i) and -80 mV (ii), D) Rheobase from a prestimulus potential 
of -70 mV (i) and -80 mV (ii). * indicates significance * p < 0.05. 
 
* 
* 
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Figure 4-18. Latency of Type II neurons in generation of action potentials, A) 
Latency of first action potential generated in response to depolarising stimuli 
from a prestimulus potential of -70 mV (i) and -80 mV (ii).  
 
The >20% average higher input resistance observed in the males is most likely 
playing a role in the increased excitability observed within the cohort. ALLO has 
been shown to impact the extrasynaptic placement of GABAAR through 
increased expression of the  subunit; this can lead to increases in input 
resistance due to increased tonic inhibition. To determine the impact of these 
receptors on input resistance Gaboxadol (30 µM), a GABAAR agonist with a 
high affinity for the GABAAR containing the  subunit, was added. To confirm 
that the effect was mediated by GABAA GABAzine (a GABAAR agonist) was 
also added; this was examined via alternating injections of -40 pA and +80 pA. 
Frequency of cells firing following the depolarising pulse was measured and 
input resistance was assessed on the hyperpolarising current injection. Addition 
of Gaboxadol to both male (n = 5) and female (n = 6) Type II neurons caused a 
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decrease in input resistance and a decrease in firing of action potentials. 
Despite a mean larger decrease of over 100 MΩ in the Female cohort the 
difference was not statistically significant (unpaired t-test, sex, p = 0.07, Figure 
4-19), following this the decreases in action potentials were examined between 
the cohorts and no statistically significant differences were observed (Mann-
Whitney U, sex, p = 0.4, Figure 4-19). While these findings were not statistically 
significant there is a trend towards a larger effect in the female cohort.  
 
Figure 4-19 Effect of Gaboxadol on B) input resistance and C) firing frequency 
of Type II neurons. A) Sample traces of the different stages of the drug 
recording, i) sample current injection, ii) Baseline, ii) in the presence of 
Gaboxadol, iii) in the presence of Gaboxadol and GABAzine  
 
In order to address the roles of the intrinsic properties of these cells in 
behaviour correlations between % time spent in the open of the elevated zero 
maze and the intrinsic properties of cells were examined. A correlation was 
found between the firing frequency of Type II neurons following the injection of 
+80 pA and % time spent in the open, this correlation was only observed in the 
males (-70 mV, Pearson’s r = 0.43, ANOVA, p = 0.03; -80 mV, Pearson’s r = 
0.41, ANOVA, p = 0.04, Figure 4-20, Table 4-6) but not in the females (-70 mV, 
Pearson’s r = 0.29, ANOVA, p = 0.1; -80 mV, Pearson’s r = 0.03, ANOVA, p = 
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0.88, Figure 4-20, Table 4-6). No other correlations were observed between 
intrinsic properties of Type II neurons and % time spent in the open on the zero 
maze (Table 4-6, Table 4-7, Table 4-8, Table 4-9, Table 4-10).  
 
Figure 4-20. Correlation between firing frequency of Type II neurons and the % 
time spent in the open on the elevated zero maze.  
 
Parameter Male Female  
 R-squared P value 
 
R-squared P value 
Holding current  0.02 0.3 -0.04 0.6 
Frequency of events 0.19 0.057 -0.03 0.5 
Average amplitude -0.05 0.6 -0.05 0.9 
Table 4-6. Correlation statistics between % time spent in the open component 
of the elevated zero maze and properties of cells examined in voltage clamp 
mode.  
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Parameter Male Female  
 R-squared P value 
 
R-squared P value 
Resting membrane 
potential 
0.01 0.3 -0.02 0.5 
Frequency at rest -0.02 0.4 0.03 0.3 
Rheobase  0.16 0.4 -0.3 0.8 
Ihold -70 mV -0.02 0.4 -0.04 0.8 
-80 mV -0.05 0.8 -0.04 0.96 
Table 4-7. Correlation statistics between % time spent in the open component 
of the elevated zero maze and properties of cells at their resting membrane 
potentials and holding current required to obtain a prestimulus potential of -70 
mV and -80 mV. 
 
Parameter Male Female  
 R-squared P value 
 
R-squared P value 
Input 
resistance  
-70 mV 0.08 0.09 0.04 0.14 
-80 mV 0.06 0.13 -0.01 0.4 
Membrane 
time 
constant 
-70mV 0.04 0.17 0.07 0.09 
-80 mV -0.03 0.6 -0.003 0.4 
Capacitance -70 mV -0.02 0.5 -0.01 0.4 
-80 mV 0.01 0.3 -0.035 0.9 
Sag  -80 mV -0.04 0.7 0.026 0.2 
Table 4-8. Correlation statistics between % time spent in the open component 
of the elevated zero maze and passive membrane properties. 
 
Parameter Male Female  
 R-squared P value 
 
R-squared P value 
AP zenith -70 mV -0.02 0.5 -0.02 0.5 
-80 mV -0.02 0.4 -0.01 0.4 
AP width -70mV 0.02 0.2 0.01 0.3 
-80 mV 0.02 0.2 -0.02 0.6 
Threshold -70 mV -0.04 0.9 0.07 0.09 
-80 mV -0.04 0.4 -0.01 0.8 
dV/dt max -70 mV -0.04 0.9 -0.002 0.3 
-80 mV -0.04 0.9 -0.001 0.3 
Table 4-9. Correlation statistics between % time spent in the open component 
of the elevated zero maze and action potential properties. 
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Parameter Male Female  
 R-squared P value 
 
R-squared P value 
Frequency-  
injection 80 
pA 
-70 mV 0.15 0.03 0.05 0.12 
-80 mV 0.01 0.04 -0.03 0.9 
Latency 1st 
AP 
-70mV -0.04 0.9 0.003 0.3 
-80 mV -0.03 0.6 -0.003 0.3 
Latency 
injection 80 
pA 
-70 mV 0.09 0.08 0.06 0.1 
-80 mV -0.04 0.76 0.06 0.1 
Table 4-10. Correlation statistics between % time spent in the open component 
of the elevated zero maze and neuronal excitability. 
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Type III neurons  
A total of 14 type III cells were recoded from males, these recordings were 
made from 11 animals with a maximum number of 2 being recorded from each 
animal. A total of 19 type III cells were recorded from females, these were 
recorded from 16 animals with a maximum of 2 cells being recorded from each 
animal.  
I began by examining cells at their resting membrane potential of cells, there 
was no significant effect of sex on either resting membrane potential (Male, -72 
± 4 mV, n = 14, Female, -66 ± 4 mV, unpaired t-test p = 0.2) or the proportion of 
cells firing (6/14 Male cells fired while 10/19 Female cells fired, chi squared, p = 
0.6), Of the cells which were firing at rest there was no significant effect of sex 
in Type III neurons (Male 4 ± 2 Hz, n = 6, Female 4 ± 1 Hz, n = 9, unpaired t-
test p = 0.9) (Figure 4-21).  
 
Figure 4-21 Properties of cells at their resting membrane potential of Type III 
neurons, A) resting membrane potential, B) Firing frequency at rest and C) 
sample cell firing at rest (i) and not firing at rest (ii). 
  
Cells were then held at a prestimulus potential of -70 mV or -80 mV to examine 
the intrinsic properties of the neurons. I began by looking at the passive 
membrane properties. There was no significant effect of sex on the input 
resistance (-70 mV: Male, 588 ± 94 MΩ, n = 14, Female, 409 ± 49 MΩ, -80 mV: 
Male, 498 ± 72 MΩ, n = 14, Female, 410 ± 46 MΩ ,repeated measure two-way 
ANOVA p = 0.08), membrane time constant (-70 mV: Male, 38 ± 6 ms, n = 14, 
Female, 28 ± 4 ms, -80 mV: Male, 27 ± 3 ms, n = 14, Female, 27 ± 4 ms 
,repeated measure two-way ANOVA p = 0.3) or capacitance (-70 mV: Male, 70 
± 7 pF, n = 14, Female, 67 ± 5 pF, unpaired t-test, p = 0.7, -80 mV: Male, 60 ± 6 
pF, n = 14, Female, 73 ± 10 pF, Mann-Whitney U, p = 0.4) (Figure 4-22). Sag 
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was not examined as the main criteria for Type III neurons is an absence of 
sag.  
Following this the action potential properties were examined, as previously 
described this was recorded from the first action potential generated in 
response to a series of depolarising current injections. There was no effect of 
sex on the action potential width (-70 mV: Male, 0.9 ± 0.1 ms, n = 14, Female, 
0.8  ± 0.1 ms, -80 mV: Male, 0.7 ± 0.1 ms, n = 14, Female, 0.8 ± 0.1 ms, 
repeated measure two-way ANOVA p = 0.3), threshold (-70 mV: Male, -51 ± 2 
mV, n = 14, Female, -51 ± 2 mV, -80 mV: Male, -51 ± 2 mV, n = 14, Female, -50 
± 2 mV, repeated measure two-way ANOVA p = 0.9) or zenith (-70 mV: Male, 
10 ± 3 mV, n = 14, Female, 14 ± 3 mV, -80 mV: Male, 12 ± 3 mV, n = 14, 
Female, 16 ± 3 mV, repeated measure two-way ANOVA p = 0.3) (Figure 4-23). 
There was also no effect on the maximum rate of the rise of the action potential 
(-70 mV: Male, 198 ± 21 mV/ms, n = 14, Female, 253 ± 22 mV/ms, -80 mV: 
Male, 220 ± 20 mV/ms, n = 14, Female, 267 ± 24 mV/ms, repeated measure 
two-way ANOVA p = 0.1) (Figure 4-24).  
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Figure 4-22 Passive membrane properties of Type III neurons A) average 
response to the injection of -40 pA of current from a prestimulus potential of -70 
mV and -80 mV, B) input resistance from a prestimulus potential of -70 mV and 
-80 mV, C) membrane time constant from a prestimulus potential of -70 mV and 
-80 mV and D) capacitance from a prestimulus potential of -70 mV and -80 mV.  
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Figure 4-23 Action potential properties of Type III neurons, A) average action 
potential from a prestimulus potential of -70 mV and -80 mV, B) action potential 
zenith from a prestimulus potential of -70 mV and -80 mV, C) Action potential 
width from a prestimulus potential of -70 mV and -80 mV and D) action potential 
threshold from a prestimulus potential of -70 mV and -80 mV.  
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Figure 4-24 maximum rate of rise of the action potential, A) average rate of rise 
of the action potential plotted against the voltage change during the action 
potential. B) maximum rate of rise of the action potential from a prestimulus 
potential of -70 mV (i) and -80 mV (ii).  
 
Finally I examined the firing properties of Type III, there was no significant effect 
of sex on either the proportion of cells firing in response to a series of 
depolarising pulses or the firing frequencies in response to a series of 
depolarising current injections (Figure 4-25).  
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Figure 4-25 firing properties of Type III neurons A) sample trace in response to 
a current injection (i) from a male (ii) and female (iii) cell, B) fraction of cells 
firing in response to a series of depolarising stimuli (i) and C) firing frequency of 
cells n response to the injection a series of depolarising stimuli.  
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4.4. Discussion   
 
This study examined the intrinsic electrophysiological properties of Type I and 
Type II neurons in the BNSTALG in young adult male and female mice. The main 
finding in this study was a greater excitability in Type II neurons in males. 
Theoretically such a sex-associated change in excitability could result from a 
number of underlying sources, such as a negative shift in AP threshold, altered 
AHPs, or changes in input resistance. In the case of Type II neurons in the 
BNSTALG the >20% higher input resistance observed in the male cohort is a 
likely contributing factor. This difference in input resistance was only statistically 
significant from a prestimulus potential of -80 mV. However from the more 
depolarised prestimulus potential of -70 mV there was a trend towards a higher 
input resistance in the males. 
I addressed these changes in input resistance by examining the effects of 
Gaboxadol and found that Type II neurons in the females showed a trend 
towards larger changes in response to administration. While the higher levels of 
ALLO in female rats (Shen et al., 2005) have been shown to increase 
expression of the delta subunit in the hippocampus. to my knowledge no one 
has examined this in the BNST however the trend observed here would indicate 
that similar processes may be taking place in the BNST.  
The widespread expression of progesterone and estrogen receptors throughout 
the brain implies that their functions are not limited to reproduction. Indeed they 
have been shown to be involved in neuronal growth, survival, differentiation and 
plasticity (Singh & Su, 2013). Progesterones neuroprotective properties have 
also been characterised in Alzheimer’s disease, stroke and traumatic brain 
injury (Singh & Su, 2013). A key metabolite of progesterone is allopregnalone 
which may impact BNST properties. The role of ALLO in anxiety is both age and 
sex specific (Shen et al., 2007; Nagaya et al., 2015b).  
Here we have shown that Gaboxadol trends towards a higher impact on female 
Type II neurons indicating more GABAA receptor containing the  subunit may 
be present in the BNSTALG of females. ALLO is an allosteric modulator which 
enhances actions of GABA at GABAA receptors containing the  subunit, it also 
alters subunit expression of the GABAA receptor. The activation of these 
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receptors in this neuronal population reduces the input resistance of cells 
thereby reducing firing. As Type II neurons are responsible for reducing anxiety, 
a reduction in their firing could lead to an increase in activity in downstream 
targets such as the PVN thereby causing an increase in anxiety.  
The anxiolytic actions of ALLO may be mediated via other components of the 
limbic system such as the hippocampus where short term treatment with ALLO 
treatment enhances  subunit expression of GABAA receptors. However, the 
attenuation of CFR-enhanced startle by progesterone  (Toufexis et al., 2004) 
would implicate the involvement of the BNST. There is a population of CRF 
neurons within the BNST but this population was not addressed in this study 
due to low n numbers. However, if the effects seen in the Type II neurons were 
also observed in these anxiety-inducing CRF cells they may be medicating the 
effect.  
The electrophysiological characterisation of cells in the BNST was originally 
based on male rats (Hammack et al., 2007b). This characterisation was recently 
expanded to other mammals including mice and rhesus macaque; where a 
similar classification of cells appears to exist. These newer studies were also 
based solely on males (Daniel et al., 2017). While these studies have 
hypothesised a role for these different populations based mainly on similar 
populations within the amygdala, their functional role has not been fully 
addressed. The BNST is a primarily GABAergic population but other cell types 
are present in this region including CRF cells. The CRF cells are thought to be 
Type III and act as anxiety-inducing neurons. The Type I and Type II cells are 
thought to be GABAergic and function as ‘anxiety off’ cells (Daniel & Rainnie, 
2016). The correlation in behaviour of Type II cells supports this hypothesis. 
With an increase in excitability of neurons correlating with the higher percentage 
of time that was spent in the open component of the maze. The GABAergic 
nature of this population would allow it to inhibit neurons in the PVN leading to a 
reduction in anxiety-like responses.  
The correlations observed in Type I neurons in this study would indicate an 
anxiety inducing function in this unstressed model. The more hyperpolarising 
resting membrane potentials in the male cohort correlated with a decrease in 
anxiety. In theory a more hyperpolarised resting membrane potential would 
indicate a decreased likelihood of firing as larger amounts of depolarising 
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current would be required to bring the cell to threshold. A trend was also seen in 
the frequency of cells which were firing; lower firing frequencies correlated with 
lower levels of anxiety. Finally a lower frequency of inward going synaptic 
events correlated with decreases in anxiety. The synaptic input into Type I cells 
was mostly blocked by administration of NBQX and L689560 indicating that 
these events are primarily glutamatergic in nature. There are substantial 
GABAergic projections into this region (Dong et al., 2001b), however, given the 
chloride equilibrium of the solutions used (-50 mV) their detection could have 
been impaired. A higher frequency of glutamatergic input could increase the 
likelihood of spike generation. These correlations would indicate that the 
decreases in activity of Type I cells are related to decreases in the anxious 
behaviour of animals. To my knowledge this is the first study to directly compare 
anxiety like behaviour in relation to Type I and Type II cells in the BNST and 
have provided insight into the possible functionality of these different 
populations in the BNST.  
The correlation between anxiety and behaviour discussed here would provide 
support for the physiologically distinct cell types in the region. However, these 
correlations were only significant in the male cohorts. This would lead one to 
question if such classifications are physiologically relevant in females. There are 
a number of possibilities why these classifications may alter between sexes, for 
example changes in Ih, which would alter the sag of the cells, sag is one of the 
key parameters on which Type I and Type II cells are characterised. Equally 
changes in IT which is believed to be responsible for the nonlinear responses of 
cells to depolarising current injections leading to a ‘hump’, the presence of this 
‘hump’ was a key component of identifying Type II neurons. Reclassification of 
the cells may be required for an accurate representation of the roles of BNST 
cell populations in females. These discrepancies in classification highlights the 
problem of sex bias in our electrophysiological characterisation of populations, 
especially those in a sexually dimorphic brain regions such as the BNST.  
Here we have provided insight into the differences in intrinsic of neurons in the 
BNST between sexes in an unstressed model. These differences may provide a 
component of the physiological basis for changes in susceptibility to anxiety-
related disorders. An interesting advancement of this work would be to address 
the effect of stress on the electrophysiological properties of BNST neurons in 
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both males and females. One proposed model of PTSD in rodents is predator 
scent exposure which shows lasting changes in anxiety (Adamec et al., 2006), 
this model showed some sex-specific behaviours making it an ideal starting 
point to better understand responses to stressors. The electrophysiological 
characterisation of the BNST in this model would provide a key insight into 
possible changes in susceptibility of the different sexes to PTSD. 
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5. Heightened intrinsic excitability in Type II neurons of the bed nucleus of the 
stria terminalis in aged mice 
 
Having determined the sexually dimorphic nature of the intrinsic properties of 
neurons located in the BNSTALG I was next interested to determine the impact of 
age on these properties. Due to availability of tissue this study was carried out 
in female mice.  
5.1. Introduction  
 
Although seen at most ages from childhood onwards, the development and 
nature of chronic stress exhibits a complex age-related nature (Garrido, 2011; 
Prenderville et al., 2015).The glucocorticoid theory of brain aging hypothesises 
the role of these key molecules in healthy aging; chronic exposure to 
glucocorticoids leads to damage of brain structures. Indeed, in aging there is an 
impairment of the negative feedback of the HPA axis leading to chronically 
elevated glucocorticoid levels (Gupta & Morley, 2014). One key component of 
this is the downregulation of the glucocorticoid receptor within the hippocampus 
(Sapolsky et al., 1986). The role of the BNST in this feedback loop has not been 
previously addressed however, given the key position of the BNST as a relay 
between the hippocampus and the PVN, it is highly probable that the BNST 
may contribute to these observed alterations 
Little research has been carried out on the BNST in healthy aging and to my 
knowledge no one has looked at the electrophysiological properties of the 
BNST in aging, however some research has been carried out in gene 
expression levels of various key mediators within the BNST. Nutsch et al 2017 
examined the expression levels of a number of key genes associated with 
behaviour in the both the BNST and several other regions associated with 
hypothalamic modulation. They found a decrease in expression of six genes; 
Cyp19a1, Esr2, Kiss1r, Nos1, Oxtr and Thra  in male Spague-Dawley male rats 
at 18 months in comparison to 3 month olds (Nutsch et al., 2017).  
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To my knowledge the only other study to assess the role of the BNST in healthy 
aging found a decrease in vasopressin mRNA in aged male Fischer 344 rats 
(Dobie et al., 1991). This effect was rescued via administration of testosterone 
(Dobie et al., 1992). Vasopressin plays a key role in a number of social 
behaviours including social approach and communication, with pharmacological 
inhibition leading to anxiogenic effects (Faria et al., 2016).  
The above studies implicate the BNST as a key region in mediating changes in 
anxiety associated with aging, functional characterisations were not carried out 
in any of these studies but we would expect the above mentioned changes to 
impact the functionality of neurons within this circuit.  
In male C57BL/6 mice, levels of glucocorticoid were found to decrease at 16 
months however this was a circadian-dependent effect seen only in the morning 
with no changed observed in the evening (Dalm et al., 2005). I hypothesized 
that the changes to HPA activity associated with healthy aging may, at least in 
part, be driven by changes in the electrophysiological properties of neurons 
located within the BNST. To address this I performed a study in which I 
compared the neurophysiological properties of Young (3-4 month old) and Aged 
(29-30 month old) neurons in the BNSTALG in female C57BL/6 mice. This initial 
study focused on the role of aging in female mice, this was due to the 
availability of tissue, and in future it would be interesting to expand this 
characterisation to male mice. I believe this to be the first cell-level study to 
examine the effects of healthy aging on the neurophysiological function of the 
BNST.  
Hypothesis  
Sex specific changes in stress and anxiety observed in aging may be mediated 
by changes to the intrinsic properties of neuron located within the BNSTALG.   
 
Aims 
To identify changes in intrinsic properties of the different population within the 
BNSTALG.  
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5.2. Methods 
5.2.1. Animals  
All tissues for this study were harvested from female C57BL/6 mice purchased 
from Charles River. In this investigation animals aged 3-4 months (Young) were 
compared to animals aged 29-30 months (Aged). Experimental days employing 
brain slices obtained from the two different ages of mouse were interleaved 
throughout the duration of the study.  
Graphs were generated using Origin; for all box plots the symbols to the left are 
individual recordings. The small symbol within the box is the mean, the box 
reflects the Standard error of the mean (SEM) and line traversing the box is the 
median. 
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5.3. Results 
A total of 28 cells from the Aged cohort and 44 cells from the Young cohort 
were recorded in the BNSTALG.  The aged neurons consisted of 8 Type I cells 
from 4 animals with a maximum of 4 cells from any one animal, 16 Type II cells 
from 9 animals with a maximum of 4 cells from any one animal and 3 Type III 
cells, the young neurons consisted of 19 Type I cells from eight animals with a 
maximum of four cells from any one animal, 18 Type II cells from seven animals 
with a maximum of four cells from any one animal and 7 Type III neurons. Due 
to the low n numbers of Type III cells they were not included in this report.  
 
5.3.1. Type I neurons  
 
Initially, I began by examining spontaneous synaptic events while clamping the 
voltage at -70 mV. The mean holding current required to maintain cells at -70 
mV in voltage clamp mode was more positive in the aged cohort (14 ± 4 pA, n = 
14) than the Young group (-5 ± 5 pA, n = 6) (Unpaired t-test p=0.02, t = -2.5, 
Figure 5-1). Imposed upon the baseline current of both groups was a 
considerable barrage of spontaneous inward-going synaptic events (Figure 5-
1). The frequency of these events (Figure 5-1) varied considerably from cell to 
cell but did not differ with age (Young: 9 ± 2 Hz, n = 14, aged: 10 ± 3 Hz, n = 6, 
Mann-Whitney U, p = 0.7, Z = -0.5). The average amplitude of these events was 
-16 pA (Young -16 ± 1 mV, n = 14, Aged -16 ± 2 pA, n = 6, Mann-Whitney U, p = 
0.97, Z = 0.1, Figure 5-1) and was not age-dependent. 
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Figure 5-1. Spontaneous inward post-synaptic current properties of Type I 
neurons A) the holding current required to hold cells at -70 mV, B) Mean inward 
postsynaptic current frequency from 60 s voltage clamp recordings at -70 mV, 
C) Corresponding mean inward postsynaptic current averaged amplitudes, D) 
Sample trace from a typical BNST neuron showing numerous spontaneous 
inward-going postsynaptic currents and a zoomed in image of a single 
spontaneous synaptic events. For all graphs in figure - Young n= 14, Aged n = 
6.  
 
Given the significant difference in the amount of current required to hold cells at 
-70 mV in the voltage clamp recordings it is unsurprising that the mean resting 
membrane potential of the young cohort (-68 ± 3 mV, n = 18) was over 10 mV 
more depolarised than that of the Aged population (-80 ± 2 mV, n = 8), 
(unpaired t-test, p= 0.01, t = 2.6, Figure 5-2). This difference in resting 
membrane potential did not lead to a significant difference in the proportion of 
cells exhibiting any spontaneous action potential firing; 12 % fired 
spontaneously in the Aged slices (1 of 8 cells) while 50% were firing in the 
Young group (9 of 18 cells; Chi-squared test p = 0.07). Of the cells which did 
not fire spontaneously there was no difference in rheobase (Young 46 ± 11 pA, 
n = 5, Aged 34 ± 11 pA, n = 7, Mann-Whitney U, p = 0.3, Z = -1, Figure 5-2). 
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Figure 5-2. Aged Type I neurons have a more depolarised resting membrane 
potential. A) Resting membrane potential (RMP), B) Rheobase of cells which 
did not fire action potentials in initial minute of recording (pA), C) Sample cell 
firing spontaneously (i), sample cell not firing at rest (ii) and a sample current 
injection (iii). 
 
 
Holding cells at a set membrane potential was achieved by application of 
suitable level of “steady state” bias current. The amount of current required to 
hold cells at -70 mV (Young 5.5 ± 6 pA, n = 18, Aged 23.6 ± 5 pA, n = 7) and -
80 mV (Young -27 ± 7 pA, n = 19, Aged 4 ± 3 pA, n = 7) was dependent on age 
(repeated measure two way ANOVA, age p = 0.03, F = 5).  
Once cells were held at a set membrane potential a series of depolarising and 
hyperpolarising steps were injected. Injection of -40 pA of current was used to 
assess passive membrane properties of the cells; the averages of these traces 
are shown in Figure 5-3. From a holding potential of -70 mV the cells from the 
Young population charged with a mean membrane time constant of 31 ± 4 ms 
(n = 18) which is significantly faster than those from the Aged population (48 ± 4 
ms, n = 8, Mann-Whitney U p = 0.005, Z = -2.5, Figure 5-3). This was also 
faster from a prestimulus potential of -80 mV averaging 29 ± 3 ms in the young 
cohort (n = 19) and 35 ± 4 ms in the aged cohort (n = 8) which was not 
significantly different (Mann-Whitney U, p = 0.14, Z = -1.6, Figure 5-3).  
There was no statistically significant effect of age on input resistance (-70 mV 
Young: 413 ± 37 MΩ, n = 18, Aged 539 ± 61 MΩ, n = 8; -80 mV Young 352 ± 32 
MΩ, n = 18, Aged: 420 ± 69 MΩ, n = 8, repeated measure two-way ANOVA, 
age p = 0.14, F = 2.4 Figure 5-3) or capacitance (-70 mV Young: 79 ± 9 pF, n = 
18, Aged: 97 ± 15 pF, n = 8, Mann-Whitney U, p = 0.16, Z = -1.4; -80 mV 
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Young: 90 ± 9 pF, Aged : 90 ± 8 pF, Mann-Whitney U, p = 0.6, Z = 0.56, Figure 
5-3). All Type 1 neurons exhibit some degree of hyperpolarization activated 
“sag” at -80 mV. Sag was not age dependent averaging 16 ± 2 % in the Young 
neurons (n = 18) and 15 ± 3 % in the Aged (n = 8) neurons (Mann-Whitney U, p 
= 0.7, Z = -0.4, Figure 5-3). 
The relationship between current injected and proportion of cells firing one of 
more spikes is shown in figures 5-4B and C for prestimulus potentials of -70 mV 
and -80 mV, respectively. Examples of current injections from both age cohorts 
are shown in Figure 5-4. As expected less current was required to generate 
spiking from the more depolarized holding potential.  From both prestimulus 
potentials, age had no effect on the likelihood of spike generation (Figure 5-4). 
Figure 5-4 C describes the total spike outputs generated during the 500 ms 
depolarizing stimuli (including traces with zero spikes) related to stimulus 
amplitude, this also did not differ with age at either -70 mV (Two way ANOVA p 
= 0.2, F = 1.4) or -80 mV (Two way ANOVA p = 0.6, F = 0.4).  
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Figure 5-3. Passive membrane properties of type I cells.  A) Averaged traces of 
voltage response to a -40 pA current step in the Young and Aged cohort from a 
holding potential of -70 mV (i) or -80 mV (ii) (the shaded areas are the standard 
error of the mean), B) Input resistance (R
in
) from -70 mV (i) and  -80 mV (i) C) 
membrane time constant (tau) from -70 mV (i) and -80 mV (i), D) Capacitance 
from -70 mV (i) and -80 mV (ii) E) % sag from -80 mV. 
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 Figure 5-4. Type I neurons exhibit no age dependent changes in excitability in 
response to depolarising stimuli. A) For -40 pA, +20 pA and +80 pA stimuli 
applied at a prestimulus voltage of -80 mV the applied current injection (i) and 
observed voltage response from an example Young cell (ii) and Aged cell (iii) 
are presented. B) Fraction of cells which fired at least 1 action potential in 
response to each amplitude of depolarising current injection applied from 
holding potentials of -70 mV (i) and -80 mV (i). C) Mean number of action 
potentials for each level of current injection from holding potentials of -70 mV (i) 
and -80 mV (ii),(error bars SEM) D) Rheobase from a holding potential of -70 
mV (i) and -80 mV (ii). 
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Although no differences were observed in firing properties from set membrane 
potentials the rheobase was significantly higher from the prestimulus potential 
of -80 mV in the Young neurons (44 ± 5 pA, n= 16) than in the Aged cohort (28 
± 4 pA, n = 8) (Mann-Whitney U p = 0.04, Z = -2.047, Figure 5-4). From a 
prestimulus membrane potential of -70 mV the mean rheobase was ~8 pA 
higher in Young cohort (16 ± 3 pA, n = 16) in comparison to the Aged neurons 
(7.5 ± 2 pA, n = 8) but was not statistically different (Mann-Whitney U, p = 0.08, 
Z = -1.8, Figure 5-4).  
The action potential properties were measured from the 1st action potential 
generated in response to depolarising current injections. Average APs from the 
Young and Aged groups are presented in Figure 4. The threshold (-70 mV, 
Young -53 ± 1 mV, n = 18, Aged -54 ± 2 mV, n = 8; -80 mV, Young  -54 ± 1 mV, n 
= 18, Aged -56 ± 1 mV, n = 8, repeated measure two-way ANOVA, age p = 0.9, 
F = 0.3, Figure 5-6), maximum rate of rise (dV/dt max; -70 mV, Young 269 ± 18 
mV/ms, n = 18, Aged 259 ± 27 mV/ms, n = 8; -80 mV Young 297 ± 16 mV/ms, n 
= 18, Aged 271 ± 26 mV/ms, n = 8, repeated measure one-way ANOVA, age p 
= 0.6, F = 0.4, Figure 5-5) and action potential zenith (70 mV, Young 17 ± 2 mV, 
n = 18, Aged 22 ± 4 mV, n = 8 Unpaired t-test, p = 0.1, t = -1.7; -80 mV, Young 
19 ± 2 mV, n = 18, Aged 23 ± 4 mV, n = 8, Mann-U-Whitney, p = 0.1, Z = -1.6, 
Figure 5-6) did not differ with age.  
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Figure 5-5. dV/dt of first action potential generated, A) averaged dV/dt of action 
potentials plotted against the average voltage of aforementioned action 
potentials from a holding current of -70 mV (i) and -80 mV (ii). B) dV/dt max 
from a holding potential of -70 mV (i) and -80 mV (ii).  
The action potential width measured at the threshold was a mean of >0.4 ms 
wider in the Aged cohort in comparison to the Young cohort (-70 mV, Young 1.5 
± 0.1 ms, n = 18, Aged: 2 ± 0.2 ms, n = 8; -80 mV, Young 1.6 ± 0.1 ms, n = 18, 
Aged, 2 ± 0.2 ms, n = 8, repeated measure one-way ANOVA, age p = 0.04, 
Figure 5-6). From a set measurement of -20 mV there was no differences in 
action potential width (-70 mV, Young: 0.8 ± 0.05 ms, n = 18, Aged: 0.9 ± 0.08 
ms, n = 8; -80 mV, Young: 0.8 ± 0.05 ms, Aged: 1 ± 0.1 ms, repeated measure 
one-way ANOVA, age p = 0.07, Figure 5-6).  
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Figure 5-6. Aged Type I neurons have wider action potentials. The properties of 
the first action potential produced by a 500 ms duration depolarizing pulse A) 
averaged action potential for 1st Action potential from -70 mV (i) and -80 mV (ii). 
B) action potential Zenith from holding potential of -70 mV (i) and -80 mV (ii), C) 
action potential width from holding potential of -70 mV (i) and -80 mV (ii), D) 
action potential width at threshold from holding potential of -70 mV (i) and -80 
mV (ii), E) threshold from holding potential of -70 mV (i) and -80 mV (ii). 
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Finally I examined the delay between the injection of the current and the 
generation of an action potential. This was examined on 2 steps the first was a 
measurement of the first action potential generated during this protocol. There 
was no difference in the latency to the first action potential generated at either 
holding potential (-70 mV, Young: 137 ± 30 ms, n = 18, Aged 168 ± 58 ms, n = 
8, Mann-Whitney U, p = 0.5, Z = -0.7; -80 mV, Young: 166 ± 33 ms, n = 18, 
Aged: 245 ± 55 ms, n = 8, Mann-Whitney U, p = 0.2, Z = -1.2, Figure 5-7). 
Secondly I looked at the latency to the first action potential generated following 
the injection of 80 pA, no age-dependent differences were observed (-70 mV, 
Young 11 ± 1 ms, n = 18, Aged: 11 ± 2 ms, n = 8, Mann-Whitney U p = 1, Z  = 
0; -80 mV, Young: 57 ± 22 ms, n = 18, Aged: 85 ± 28 ms, n = 8, Mann-Whitney 
U, p = 0.5, Z = -0.7 Figure 5-7).  
 
Figure 5-7. Latency to generation of first Action potential of Type I neurons A, 
B) Latency to the 1st Action potential generated in response to depolarising 
current injections from a holding current of -70 mV and -80 mV, respectively. C, 
D) Latency to the first action potential generated in response to the injection of 
80 pA of current from a holding potential of -70 mV  and -80 mV, respectively.  
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5.3.2.  Type II neurons  
I began by examining spontaneous synaptic events while clamping the voltage 
at -70 mV.  Similar to Type I neurons these cells receive a large quantity of 
spontaneous inward going synaptic events. The frequency of these events did 
not differ with age (Young: 13 ± 3 Hz, n = 16, Aged: 7 ± 2 Hz, n = 14, Mann-
Whitney U, p = 0.3, Z = -1.2 Figure 5-8), however the average amplitude of 
these events was a mean of 2.5 pA larger in the Young cohort (-16 ± 1 pA, n = 
16) in comparison to the Aged (-13 ± 1 pA, n = 14, Mann-Whitney U p = 0.02, Z 
= -2.3 Figure 5-8). The holding potential required to hold Type II cells at -70 mV 
in voltage clamp mode did not differ with age (Young: -6 ± 5 pA, n = 16, Aged -9 
± 3pA, n = 14, Mann-Whitney U, p = 0.5, Z = -.07, Figure 5-8). 
 
Figure 5-8 Spontaneous inward post-synaptic current properties of Type II 
neurons A) The holding current required to hold cells at -70 mV, B) Inward 
postsynaptic current frequency from 60 s voltage clamp recordings at -70 mV C) 
Corresponding mean inward postsynaptic current amplitudes D) Sample trace 
from a typical BNST neuron showing numerous spontaneous inward-going 
postsynaptic currents and a zoomed in image of a single spontaneous synaptic 
events.  For all graphs in this figure Young n = 16, Aged n = 14.  
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Following these recordings I switched into current clamp mode and examined 
the cells at their resting membrane potential. The resting membrane potential 
was ~5 mV more depolarised in the aged cohort however this was not 
statistically significant (Young: -74 ± 2 mV, Aged: -69 ± 2 mV, unpaired t-test p 
= 0.1, t = -1.7, Figure 5-8). The proportion of cells spontaneously firing was far 
greater in the aged cohort with 10/16 aged cells firing while only 4/17 cells fired 
in the Young cohort (Chi squared p = 0.02). While this may be partly mediated 
by the RMP it could also be down to changes in cells excitability such as action 
potential threshold. Of the cells which were spontaneously firing there was no 
age effect on the firing frequency (Young 3 ± 2 Hz, n = 10, Aged 4 ± 2 Hz, n = 4, 
Mann-Whitney U, p = 0.8, Z = -0.3, Figure 5-9); equally of the cells which did 
not fire there was no age-dependent effect on the rheobase (Young 27 ± 4 pA, n 
= 10, Aged 18 ± 8 pA, n = 5, p = 0.2, t = 1.2, Figure 5-9).  
 
Figure 5-9 The Resting membrane potential properties of Type II neurons do not 
differ with age. A) Resting membrane potential (RMP) B) Sample cell firing 
spontaneously with current injection bellow, C) Firing frequency of cells which 
fired at RMP D) Rheobase at RMP. 
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From the -40 pA step of the current injection protocol (averages shown in Figure 
5-10A) the input resistance, membrane time constant (tau), sag and 
capacitance were calculated. Input resistance (-70 mV Young 482 ± 56 MΩ, n = 
18, Aged 582 ± 69 MΩ, n = 16, Mann-Whitney U p = 0.3, Z = -1.1; -80 mV, 
Young 433 ± 56 MΩ, n = 18, Aged 467 ± 68 MΩ, n = 16, Mann-Whitney U, p = 
0.8, Z = -0.3), membrane time constant (-70 mV, Young 35 ± 4 ms, n = 18, Aged 
32 ± 4 ms, n = 16, unpaired t-test  p = 0.7, t = 0.4; -80 mV, Young 30 ± 4 ms, 
Aged 28 ± 4 ms, Mann-Whitney U p = 0.9, Z = -0.2) and were not age-
dependent at either holding potential (Figure 5-10). Sag also did not differ with 
age (-80 mV, Young 17 ± 2 %, n = 18, Aged 21 ± 3 %, n = 16, unpaired t-test, p 
= 0.2, t = -1.3, Figure 5-10). Capacitance was a mean of over 10pF higher in the 
young cohort however this was not statistically significant (-70 mV, Young: 74 ± 
6 pF, n = 18, Aged: 57 ± 3 pF, n = 16; -80 mV, Young 70 ± 6 pF, n = 18, Aged 
60 ± 3 pF, n = 16, repeated measure one-way ANOVA, age p = 0.054 Figure 
5-10).  
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Figure 5-10. Passive membrane properties of Type II cells. A) Averaged traces 
of voltage response to a -40 pA current step in the Young and Aged cohort from 
a holding potential of -70 mV (i) and -80 mV (ii) respectively. The shaded areas 
are the standard error of the mean. B) Input resistance (R
in
) from a holding 
current of -70 mV (i) and -80 mV (ii), C) membrane time constant from a holding 
potential of -70 mV (i) and -80 mV (ii), D) Capacitance from a holding potential 
of -70 mV (i) and -80 mV (ii), E) Sag from a holding potential of -80 mV.  
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The first action potential generated in response to the depolarising current 
injections was used to examine action potential properties. The averages for 
these action potentials are represented in Figure 5-12. No differences were 
observed in action potential zenith (-70 mV, Young 18 ± 2 mV, n = 18, Aged 17 ± 
2 mV, n = 16; -80 mV, Young 17 ± 2 mV, Aged 18 ± 2 mV, repeated measure 
one-way ANOVA, age p = 0.97, t = 0.1, Figure 5-12) or action potential width at 
-20 mV from either holding current (-70 mV, Young 0.8 ± 0.02 ms, n = 18, Aged 
0.8 ± 0.03 ms, n = 16; -80 mV, Young 0.7 ± 0.03 ms, Aged 0.8 ± 0.02 ms, 
repeated measure one-way ANOVA, age p = 0.14, F = 2.3, Figure 5-12). There 
were no differences in the maximum rate of rise of the action potential (-70 mV, 
Young 260 ± 18 mV/ms, n = 18, Aged 254 ± 20 mV/ms, n = 16; -80 mV Young: 
283 ± 19 mV/ms, n = 18, Aged: 290 ± 17 mV/ms, n = 14, repeated measure 
one-way ANOVA, p = 0.12, F = 2.5, Figure 5-11) at either holding potential. 
Threshold was more depolarised in the young cells when examined from either 
holding potential (-70 mV, Young: -52 ± 1 mV, n = 18, Aged: -56 ± 1 mV, n = 16; 
-80 mV, Young: - 55 ± 1 mV, n = 18, Aged: -58 ±1 mV, n = 16, repeated 
measure one-way ANOVA, p = 0.03, F = 5.5, Figure 5-12). Interestingly, this 
shift in threshold appears to have no effect on the rheobase of the cells with no 
differences observed at either holding potential (-70 mV, Young 14 ± 2 pA, n = 
16, Aged 15 ± 5 pA, n = 13, Mann-Whitney U, p = 0.3, Z = -1; -80 mV, Young 35 
± 3 pA, n = 15, Aged 34 ± 8 pA, n = 14. Mann-Whitney U p = 0.4, Z = -0.9, 
Figure 5-13). 
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Figure 5-11. dV/dt of Type II neurons A) averaged dV/dt of cells plotted against 
the average action potential from a holding potential of -70 mV (i) and -80 mV 
(ii), B) dV/dt max of cells from a holding potential of -70 mV (i) and -80 mV (ii). 
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Figure 5-12. Aged Type II neurons have a more depolarised threshold. The 
properties of the first action potential produced by a 500 ms duration 
depolarizing pulse A) averaged action potential for 1st action potential from -70 
mV (i) and -80 mV (ii). B) action potential Zenith from holding potential of -70 
mV (i) and -80 mV (ii), C) action potential width measured at -20 mV from 
holding potential of -70 mV (i) and -80 mV (ii) D) Threshold from a holding 
potential of -70 mV (i) and -80 mV (ii).  
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Given the more hyperpolarised threshold in the aged animals I would have 
expected to see an increase in excitability of the aged neurons. Excitability was 
measured using the depolarising current injections. Sample traces containing 
components of these protocols can be seen in Figure 5-13; firstly I examined 
weather or not the cell fired in response to injections of depolarising currents 
(Figure 5-13). From a holding current of -70 the first step (5 pA) caused a higher 
proportion of Aged cells to fire with 11/16 aged cells firing while only 2/19 Young 
ones did (chi-squared p = 0.0004). There was no difference in the likelihood of 
firing in any other steps from this holding potential. This is most likely due to the 
fact that at the 20 pA injection the majority of both populations generated at 
least 1 spike, 15/19 Young cells and 13/16 Aged cells generated action 
potentials, by the 50pA step all cells in both cohorts were firing. From -80 mV 
the likelihood of firing did not differ on any of the current steps. Another 
measure of excitability is the frequency of action potentials in each of the 
current steps. From both prestimulus potentials there was significantly higher 
rates of firing in the aged cohort in comparison to the Young (repeated measure 
2 way ANOVA p = 0.02, F = 6.7, Figure 5-13).  
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Figure 5-13. Type II neurons exhibit hyperexcitability in aged neurons in 
response to depolarising stimuli. A) For -40 pA, +20 pA and +80 pA stimuli 
applied at a prestimulus voltage of -80 mV the applied current injection (i) and 
observed voltage response from an example Young cell (ii) and Aged cell (iii) 
are presented. B) Fraction of cells which fired at least 1 action potential in 
response to each amplitude of depolarising current injection applied from 
holding potentials of -70 mV (i) and -80 mV (ii), significance based on chi 
Squared tests. C) Mean number of action potentials for each level of current 
injection from holding potentials of -70 mV (i) and -80 mV (ii), respectively (error 
bars SEM), D) rheobase from a holding potential of -70 mV (i) and -80 mV (ii).   
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When examining the latency in action potential generation, I found no 
differences in latency in the first action potential generated (-70 mV, Young 90 ± 
15 ms, n = 18 Aged 82 ± 14 ms, n = 16, Mann-Whitney U, p = 1, Z = -0.07; -80 
mV, Young 67 ± 9 ms, n = 18, Aged 89 ± 23 ms, n = 16, Mann-Whitney U, p = 
0.8, Z = -0.3, Figure 5-14), however following the injection of 80 pA from both 
holding potentials there was a significant difference with the aged neuron 
generating spikes earlier (-70 mV, Young 9 ± 0.7 ms, Aged 6 ± 0.4 ms; -80 mV, 
Young 15 ± 1 ms, Aged 10 ± 0.7 ms, repeated measure one-way ANOVA, p = 
0.002, F = 12, Figure 5-14).  
 
 
Figure 5-14. Latency to action potential A) Latency to the first action potential 
generated from depolarising steps from a membrane prestimulus of -70 mV (i) 
and -80 mV (ii) B) Latency to the first action potential generated in response to 
injection of 80 pA from a prestimulus potential of -70 mV (i) and -80 mV (ii). 
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5.4. Discussion       
The data presented here represents differences in the intrinsic properties of 
BNST neurons observed when comparisons were made between patch clamp 
recordings performed in brain slices obtained either from post-pubescent Young 
(3-4 months) or very Aged (29-30 months) female C57BL/6 mice in the 
BNSTALG. There are three Types of cells located within this area, due to the low 
numbers of Type III neurons their physiological role in aging was not addressed 
here. Overall, our data points to an intrinsic hyper-excitability associated with 
normal aging in Type II neurons and a more hyperpolarised resting membrane 
potential of Type I neurons with aging.  
In Type I neurons the mean resting membrane potential of the Aged neurons 
was >10 mV more hyperpolarised. In theory this would drive the cells away from 
threshold making them less likely to fire, indeed only 12.5 % of the Aged cells 
fired at rest vs 47% of the Young, however this was not statistically significant. 
The change in holding current for both the voltage clamp recordings and the 
current clamp recording can be accounted for by these differences in resting 
membrane potential along with the changes in rheobase. The opposite was 
found in the Type II neurons with a higher proportion of aged cells firing, in this 
population these changes can be attributed to the differences in intrinsic 
excitability rather than changes in resting membrane potential.  
The spontaneous action potential firing seen in these neuronal populations of 
the BNST suggest this area may be able to provide a substantial tonic synaptic 
drive to their various downstream synaptic targets, which included the CRF 
releasing cells of the PVN as well as the CRF circuit within the BNST. This does 
assume, however, that the intrinsic properties seen in acute brain slices are 
truly reflective of those present in vivo. This commonly made assumption is one 
that has certainly been questioned previously; intrinsic properties can be readily 
and persistently modified by “neurophysiological experiences” (e.g. periods of 
tonic depolarization) that might be expected to occur during the process of 
preparing acute brain slices (Brown & Randall, 2009).  
In Type II neurons the average inward-going synaptic event is a mean of ~ 2.5 
pA larger in the Young cohort. A higher average amplitude of synaptic events 
affect the probability of firing; given that I am unsure of the excitatory / inhibitory 
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nature of such inputs the effect of these events on firing rates could be either 
inhibitory or excitatory. Once the cells were switched into current clamp there 
was higher excitability in the aged cohort. This is unexpected as in my gender 
study (chapter 4) I found that the largest of the synaptic events were 
glutamatergic as such I would expect the large amplitude events seen here to 
be excitatory.  
The use of brain slices will also impact on the “functional” connectivity of the 
BNST. Thus, although excitatory and inhibitory synapses onto BNST neurones 
remain (as evidenced by the spontaneous synaptic activity (Figure 5.1), their 
afferent axons are for the most part detached from their cell-bodies and, thus 
are highly likely to be silent. Consequently, one must also consider the level of 
spontaneous neural activity in the light of this functional denervation. For 
example, the preparation of slices and the use of a high chloride intracellular 
solution could have disrupted or truncated some form of strong inhibitory 
synaptic tone that in vivo holds BNST cells more negative or shunts their 
membrane potential reducing electrogenesis of spikes. Having said this, some 
of the very first neurophysiological studies of the BNST, in vivo recordings in 
anaesthetized female rats, revealed that the majority of BNST neurones that 
exhibited any activity fired at  >1 Hz, and this activity may have to some degree 
been affected by oestrogen status (Bueno & Pfaff, 1976). More recently in vivo 
recordings from ventral BNST in male, awake mice indicate that, although 
hetrogenous, firing rates in active cells that project to VTA average around 5 Hz 
(Jennings et al., 2013), this finding is similar, albeit slightly higher, than the 
spontaneous firing rates observed in firing Type II neurons.  
When the membrane potential was pre-set to fixed levels of either -80 mV or -
70 mV prior to application of current stimuli, the depolarization-induced action 
potential frequency was higher in Type II Aged animals. Theoretically such age-
associated increase in excitability could result from a number of underlying 
sources. These include, but are not limited to, a negative shift in AP threshold 
(akin to that reported in hippocampal neurons (Randall et al. 2012), changes to 
the kinetics of Na+ channel repriming, altered AHPs, or differences in 
membrane conductances active near threshold, that either promote (e.g. low 
threshold Ca2+ channels) or resist (low threshold K+ channels) AP genesis. 
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Furthermore, quite subtle changes in combinations of these factors could 
synergize to promote enhanced excitability. In this cohort, action potential 
threshold undoubtedly played a key role in increasing excitability, in cells held at 
-80 mV the AP threshold was a mean of 3 millivolts more negative in the Aged 
animals. While this was not significant it undoubtedly contributed to the 
increased excitability observed in these cells. With regards to the actions of the 
cells at -70 mV, the depolarised threshold of the young cohort played a key role 
in the observed increases in frequency. Given the resting membrane potential 
of both cohorts was close to -70 mV, this shift in threshold most likely played a 
key role in the increases in proportion of cells firing at rest.  
This increase in excitability in the Type II neurons could contribute to changes in 
anxiety with age. As this cell type is thought to act as an ‘anxiety off’ switch 
(Daniel & Rainnie, 2016) its increased excitability could lead to an inhibition of 
the CRF cells both in the PVN and within the BNST. Dami et al (2005) found a 
decrease in glucocorticoid in the morning in male C57BL/6 male mice in healthy 
aging; given that the animals used in this study were culled in the morning the 
behaviour of these Type II neurons could be contributing to decreases in 
glucocorticoid production. Given the anxiety off switch that has been attributed 
to this population it would make sense that increases in their excitability could 
contribute to decreases in glucocorticoid. 
BNST originating GABAergic projections innervate multiple areas of the CNS, 
for example those involved in reward, feeding and stress. One key pathway is 
that monosynaptically linking BNST neurons to CRF producing cells of the PVN. 
It is likely that this pathway is predominant in mediating reductions in plasma 
glucocorticoid levels in response to BNST stimulation. Furthermore, BNST cells 
that are activated by excitatory inputs from limbic structures, such as the medial 
prefrontal cortex and hippocampal formation can, in turn, mediate a direct 
inhibitory, GABAergic drive to CRF-releasing neurons in the PVN (Cullinan et 
al., 1993, 2008; Boudaba et al., 1996).  
 Lesion of this system leads to exaggerated HPA activation by stressors 
(Radley & Sawchenko, 2011) suggesting that the mPFC inputs to the BNST can 
act as a brake on activity in the HPA axis. Afferent inputs to the BNST from the 
central amydala, in contrast, are inhibitory and thus relieve the influences of the 
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BNST (and consequently afferent inputs from mPFC) on PVN activity. To my 
knowledge no one has assessed whether these cells are Type I, Type II or Type 
III, given their inhibitory nature one would assume they are Type I or Type II.  
Therefore, in aging the increased excitability of Type II BNST neurons might be 
expected to increase the inhibitory influence of BNST on the PVN and thus 
reducing overall HPA activity by limiting CRF output from parvocellular neurons. 
An interesting observation seen in Type I neurons was a widening of action 
potentials with age.  If this outcome, seen here at the cell body, translated to 
similar changes in spike width at the presynaptic terminals formed by BNST 
neurons a substantial increase in release probability might be expected, and 
thus a corresponding increase in drive to down-stream synaptic targets of BNST 
neurons. 
Although it can be proposed that neurophysiological changes in BNST neurons 
develop as a consequence of what might be regarded as autonomous aging-
related processes within the BNST itself,  another possibility is that the altered 
excitability I report represents an adaptive change in respond to an altered 
afferent synaptic drive from, for example, other limbic structures. Certainly other 
components of the limbic system with established BNST connectivity have been 
previously shown to exhibit significant neurophysiological changes associated 
with aging  (Chang et al., 2005b; Bodhinathan et al., 2010; Coskren et al., 
2014).  
Notably the BNST is well known for its sexually dimorphic nature as discussed 
in chapter 3. Due to their availability for this first study of BNST neurophysiology 
in Aged animals I focussed entirely on females. An interesting extension to this 
work would be to compare how aging alters the neurophysiological properties of 
male mice. This data provides no indication of when the neurophysiological 
changes I report develop within the mouse lifespan. A more detailed longitudinal 
study would be required for this, preferably sampling multiple age points from a 
large cohort of littermate animals raised throughout life in the same facility.  
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6. Changes in excitability of Type I and Type II neurons in the BNST of the 
CHMP2B mouse model of frontotemporal dementia 
 
In the previous chapter I addressed the influence of healthy aging on the 
intrinsic properties of neurons located within the BNSTALG. A key risk factor for a 
number of different dementias is aging, here I plan to examine weather 
expected changes in frontotemporal dementia differed from those observed 
during heathy aging.  
6.1. Introduction  
6.1.1. The CHMP2B model of frontotemporal dementia 
 
Frontotemporal dementia (FTD) is the second most common form of young 
onset dementia following Alzheimer’s disease (Ratnavalli et al., 2002; Harvey et 
al., 2003). A number of genes have been linked with familial FTD, the most 
common of which are those encoding tau (MAPT), C9orf72 and progranulin 
(GRN). There are also a number of rarer  genetic causes of the disease, one 
such gene encodes the charged multivesicular body protein 2B (CHMP2B) 
(Clayton et al., 2015).  
The CHMP2B mutation causes an inheritable form of frontotemporal dementia 
in a Danish family (Skibinski et al., 2005; Isaacs et al., 2011). These patients 
display less concern for others, an unkempt appearance, disinhibition, 
inappropriate emotional responses and restlessness sometimes along with 
increased aggression often followed by progressive aphasia (Isaacs et al., 
2011).  
 When this mutation was introduced into mice they displayed a progressive 
axonopathy, APP-positive swellings indicative of altered axonal function, this 
takes place through a gain of function mechanism (Ghazi-Noori et al., 2012b). 
These mice also display both social and motor deficits in the later stages of the 
disease (Clayton et al., 2015).  
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6.1.2. The role of the BNST in frontotemporal dementia  
 
The impact of chronic stress on neurological function is unquestionable and 
greatly increases ones risk of developing various forms of dementia (Peavy et 
al., 2009; Johansson et al., 2010; Greenberg et al., 2014b). One study has 
found a strong correlation between PTSD in veterans and the onset of 
dementia, with the biggest correlation observed in patients that developed 
frontotemporal dementia (Yaffe et al., 2010; Greenberg et al., 2014a). The 
BNST plays a key role in both chronic stress and PTSD as discussed in the 
introduction. Given this correlation, alongside the central role of BNST in stress, 
I propose that the BNST could be implicated in this disease and further study is 
required to identify altered functionality within this region.  
A number of mouse models of frontotemporal dementia have shown a decrease 
in anxiety in various mazes. These include the V337M, THY-Tau22, PS19 
mouse models which display decreases in anxiety on the elevated plus maze 
and the P301S model which had an increase in the amount of time spend in the 
middle of the open field. The R406W model found no differences in anxiety 
using the light dark box. Unlike these mouse models patients suffering from 
frontotemporal dementia often display increases in anxiety (Porter et al., 2003; 
Koss et al., 2016). 
Patients in this Danish family also display an increase in aggression; impulse 
aggression is partly mediated by the BNST, this type of aggression often seen 
in PTSD patients has been attributed to feeling of helplessness. It is possible 
that the BNST is playing a role in this aggression observed in patients.  
To my knowledge no one has assessed any aspect of BNST properties in any 
mouse model of frontotemporal dementia. At the time this research was carried 
out no studies examining changes in anxiety levels of this model had been 
published. Here I plan to address the effects of the CHMP2B mutation on 
anxiety levels of unstressed mice alongside the examination of the 
electrophysiological properties of BNST neurons within this novel model of 
frontotemporal dementia. 
Hypothesis  
 
179 
 
Increased in anxiety observed in the human FTD may be associated with 
changes in excitability of neurons located within the BNSTALG. 
 
Aims 
To determine if changes in excitability exist within the CHMP2B model of 
frontotemporal dementia.  
 
6.2. Methods 
 
CHMP2B mice were initially breed at UCL and transported to the University of 
Exeter and allowed to acclimatise for a week prior to commencing experiments. 
The animals had ad lib access to food and water for their entire lifespan. This 
experiment focused entirely on male animals.  
Anxiety levels were tested on the elevated zero maze as previously described in 
the methods chapter. Ten animals from each cohort were tested twice on 
successive days and percentage time in the open portion was averaged across 
animals.  
Brain slices containing the BNSTALG were prepared as previously described. A 
K-gluconate solution containing biocytin was used to carry out recordings. A 
series of electrophysiological characterisations were carried out as previously 
described in the methods chapter.  
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6.3. Results 
 
6.3.1. Behavioural tests  
Anxiety levels were assed using the elevated plus maze. I examined the 
percentage time spent in the open arm in 10 animals from each cohort 
averaged over two days. The wild type (WT) cohort spent an average of 16 ± 2 
% (n = 10) in the open arm while the transgenic (TG) cohort spend an average 
of 13 ± 2 % (n = 10) in the open arm (unpaired t-test, p = 0.1, t = 1.6, Figure 
6-1).  
 
Figure 6-1 Percentage time spent in open arm of elevated zero maze  
 
6.3.2. Electrophysiological characterisation of cells located in the anterolateral 
area of the BNST  
 
In the WT cohort a total of 39 cells were recorded from the BNSTALG while 35 
were recorded from the TG cohort. These cell types were then classified based 
on the electrophysiological properties as highlighted in the methods chapter. 
The WT cells comprised 15 Type I cells from 10 animals with a maximum of two 
cells per animal, 16 Type II cells from 11 animals with a maximum of two cells 
per animal and 6 Type III cells from four animals with a maximum of two cells 
per animal; the TG cohort was made up of 16 Type I cells from 10 animals with 
a maximum of 4 cells per animal, 12 Type II cells from nine animals with a 
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maximum of two cells being recorded from each animal and five type III cells 
from five animals with only one cell per animal being recorded. The other cells 
did not contain high enough numbers of any one population for valid 
comparison so were not included in this study.  
6.3.2.1. Type I cells  
 
Once whole cell acess to a cell was obtained the properties of the synaptic 
events were examined in voltage clamp mode while holding the cells at -70 mV. 
The amount of current required to hold these cells at -70 mV also did not differ 
averaging approxomitly 21 pA for each cohort (WT 22 ± 12 pA, n = 9, TG 21 
±13 pA, n =13, Mann-Whitney U, p = 0.9, Z = -0.1, Figure 6-2). There was no 
difference in eitheir the frequency (WT 4.5 ± 1.5 Hz, n = 9, TG 4.6 ±1.2 Hz, n = 
13, Mann-Whitney U, p = 1, Z = -0.3) or averaged amplitude (WT -14 ± 0.8 pA, 
n = 9, TG -15 ± 0.9 pA, n = 13, Mann-Whitney U, p = 0.8, Z = -0.3 A) of these 
events (Figure 6-2).  
 
Figure 6-2. Synaptic events in type I cells. A) Current required to hold cells at -
70 mV, B) frequency of post synaptic currents, C) average amplitude of post 
synaptic events, D) sample trace with a zoomed in voltage synaptic event.  
 
182 
 
 
Following this I switched into current clamp mode and looked at the resting 
membrane potential; genotype had no effect with both cohorts resting at ~ -76 
mV (WT -77 ± 4 mV, n = 15, TG -75 ± 4 mV, n = 16, unpaired t-test, p = 0.6, t = 
-0.5, Figure 6-3). This was unsurprising given the similar holding currents 
observed in voltage clamp mode. The proportion of cells which generated at 
least 1 action potential in this 1 minute recording was not different with 5/15 WT 
cells firing and 2/16 TG cells firing (chi-squared p = 0.2).Cells were then held at 
a set potential of -80 mV for examination of intrinsic properties; the amount of 
current required to hold cells at -80 mV  was not different between the cohorts 
(WT -6 ± 13 pA, n = 15, TG -23 ± 25 pA, n = 16, unpaired t-test, p = 0.6, t = 
0.6).  
 
 
Figure 6-3. Resting membrane potential of type I cells A) Resting membrane 
potential, B) sample trace of cell firing at rest with current trace below.  
  
The passive membrane properties were examined from the -40 pA current 
injection, the averages of these current injections is shown in Figure 6-4. No 
genotype specific differences were observed in input resistance (WT 305 ± 27 
MΩ, n = 15, TG 247 ± 21 MΩ pA, n = 16, unpaired t-test, p = 0.1, t = 1.7), sag 
(WT 11 ± 1.5%, n = 15, TG 15 ± 2%, n =16, unpaired t-test, p = 0.2, t = -1.3) 
and capacitance (WT 82 ± 7 pF, n = 15, TG 81 ± 9 pF, n = 16, unpaired t-test, p 
= 0.9, t = 0.1) (Figure 6-4). From a holding potential of -80 mV the membrane 
time constant in the WT cohort was over 5 ms faster than in the TG cohort, 
however this was not statistically significant (WT 23 ± 1.3 ms, n = 16, TG 19 ± 2 
ms, n = 15, unpaired t-test p = 0.07, t = 1.9, Figure 6-4).  
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Figure 6-4. Passive membrane properties of Type I neurons A) Average of cells 
response to injection of -40 pA of current from a holding potential of -80 mV,  B) 
input resistance, C) membrane time constant, D) % sag  and E) Capacitance. 
 
I then examined the action potential properties of the first action potential 
generated in each cell, these are averaged in Figure 6-5A. No differences in AP 
zenith (WT 22 ± 1 mV, n = 15, TG 19 ± 2 mV, n = 16 unpaired t-test, p = 0.2, t = 
1.5), AP width (WT 0.9 ± 0.06 ms, n = 15, TG 0.8 ± 0.05 ms, n = 16, unpaired t-
test, p = 0.15, t = 1.5) or Threshold (WT -55 ± 2 mV, n = 15, TG -54 ± 2 mV, n = 
16,  Mann-Whitney U, p = 0.7, Z = -0.4) were observed between the populations 
(Figure 6-5). Following this the first derivative of the action potentials were 
examined and the peak compared as shown in Figure 6-5, in the TG population 
the maximum rate of rise was ~60 mV/ms lower than its WT counterpart (WT 
320 ± 23 mV/ms, n = 15, TG 258 ± 19 mV/ms, n = 16, unpaired t-test p = 0.04, t 
= 2.1). 
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Figure 6-5. Action potential properties of Type I neurons A) Average of first 
action potential generated in response to depolarising current injections, B) AP 
zenith C) AP width at -20 mV, D) averaged dV/dt of cells plotted against the 
average voltage change of the action potential, E) maximum dV/dt and F) 
Threshold.  
 
I then examined the excitability of neurons using two protocols, in the step 
protocol I examined the proportion of cells firing in each step and the frequency 
of said firing; in the Rheobase protocol I looked at the amount of current 
required to generate an action potential; no differences were observed in 
rheobase (WT 34 ± 6 pA, n = 6, TG 30 ± 2 pA, n = 7, unpaired t-test, p = 1, t = -
0.2, Figure 6-6). Some differences were observed in the proportion of cells firing 
in response to the injection of depolarising current specifically following the 
injection of 35 pA of current where the TG cohort was more likely to fire action 
potentials (Table 6-1, Figure 6-6). A final measure of excitability is the delay 
between the onset of the current injections and the generation of the action 
potential referred to as latency. No differences in latency were observed when 
examining either the first action potential generated in response to depolarising 
current  (WT 14 ± 2 ms, n = 15, TG 15 ± 3 ms, n = 16 Mann-Whitney U test, p = 
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0.6, Z = -0.5, Figure 6-6) or latency following the injection of 80 pA of current 
(WT 6 ± 3 ms, n = 14, TG 6 ± 2 ms, Mann-Whitney U, p = 0.8,  Figure 6-6).   
 
 
Figure 6-6. Excitability of Type I neurons. A sample trace of a WT (ii) and TG 
(iii) cell, i) sample current injections. B) Fraction of cells firing at least 1 action 
potential in response to a series of depolarising, C) frequency of firing in 
response to each depolarising current injection D) Rheobase, E) Latency to the 
first action potential generated in response to depolarising current injection and 
F) Latency to first action potential generated in response to the injection of 80 
pA of current.  
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Current 
injected 
Firing frequency following 
injection of depolarising 
current  
Fraction of cells generating 
action potentials  
 WT (Hz) TG (Hz) 
 
WT  TG  P value 
5 pA 0.1 ± 0.1  0 ± 0 0.07 0 0.3 
20 pA 2.5 ± 1.5 0.1 ± 0.1 0.27 0.6 0.1 
35 pA 6.8 ± 2.8 1.1 ± 0.5  0.67 0.25 0.02 
50 pA 9.6 ± 4.2 4 ± 1.1 0.73 0.56 0.06 
65 pA 12.3 ± 5.4 8 ± 1.6 0.8 0.82 0.9 
80 pA 15.6 ± 6 12.5 ± 2.4 1 0.88 0.2 
Table 6-1 Firing of frequency in response to each current injection and 
proportion of Type I cells firing in response to each current injection from both 
holding potentials. P values based on chi squared performed in Excel 
 
 
6.3.2.2. Type II cells  
A similar series of protocols was used to examine Type II cells. While holding 
these cell at -70 mV in voltage clamp mode there was no difference in the 
amount of current required, averaging 4 pA in each cohort (WT 4 ± 5 pA, n = 14, 
TG 4 ± 4 pA, n = 5, unpaired t-test, p = 0.9, t = -0.05); a sample trace is 
depicted in Figure 6-7. With regards to the frequency (WT 6.2 ± 2 Hz, n = 14, 
TG 3.4 ± 1, n = 5, Mann-Whitney U, p = 0.4, Z = -0.8) and average amplitude of 
synaptic events (WT -13 ± 0.6 pA, n = 14, TG -14 ± 1.4 pA, n = 5, unpaired t-
test, p = 0.5, t = 0.6) there was no significant differences between the cohorts 
(Figure 6-7).  
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Figure 6-7. Synaptic events in type II cells A) Current required to hold cells at -
70 mV, B) frequency of post synaptic currents, C) average amplitude of post 
synaptic events, D) sample trace with a zoomed in voltage synaptic event. 
 
Cells were then switched into current clamp mode. There was no difference in 
the resting membrane potential with both cohorts resting at ~-71 mV (WT -72 ± 
3 mV, n = 16, TG -71 ± 3 mV, n = 12, unpaired t-test, p = 0.7, t = -0.4, Figure 
6-8). A similar proportion of cells were firing in each group with 7/16 TG cells 
firing and 6/12 WT cells firing (chi-squared, p = 0.7). Of the cells which were not 
firing the Rheobase was the same in the different populations with an average 
of 26 pA being required to generate an action potential in each group (WT 26 ± 
7 pA, n = 6, TG 26 ± 6 pA, n = 5, unpaired t-test, p = 1, Figure 6-8). Of the cells 
which did fire in the TG cohort they fired at 2 ± 1 Hz while in the WT cohort they 
fired at 6 ± 2 Hz (Figure 6-8), this was not significantly different (Mann-U-
Whitney, p = 0.1, Z = -1.6). 
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Figure 6-8. Type II cells at their Resting membrane potential. A) resting 
membrane potential of cells, B) frequency of cells which fired at their resting 
membrane potential, C) Rheobase of cells which did not fire at their resting 
membrane potential, D) sample cell firing at rest (i), sample cell not firing at rest 
(ii). 
 
When examining the passive membrane properties of these cells I found no 
differences in input resistance (WT 429 ± 69 MΩ, n = 16, TG 317 ± 36 MΩ pA, n 
= 12, Mann-Whitney U, p = 0.4, Z = -0.9), membrane time constant (WT 27 ± 2 
ms, n = 16, TG 24 ± 2 ms, n = 12, unpaired t-test, p = 0.3, t = 1), capacitance 
(WT 75 ± 7 pF, n = 16, TG 79 ± 7 pF, n = 14, unpaired t-test, p = 0.7, t = -0.396 
) or sag (WT 14 ± 3%, n = 16, TG 19 ± 3%, n = 12, Mann-Whitney U, p = 0.2, Z 
= -1.4,). The averages of the -40 pA step from each holding current for each 
genotype and the graphs are depicted in Figure 6-9.  
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Figure 6-9. Passive membrane properties of type II BNST neurons A) Average 
of cells response to injection of -40 pA of current from a holding potential of -80 
mV,  B) input resistance, C) membrane time constant, D) % sag  and E) 
Capacitance. 
 
I then addressed the action potential properties from the first action potential 
generated in response to depolarising current injections shown in Figure 6-10. I 
found no differences in the width of the action potential at -20 mV (WT 0.8 ± 
0.04 ms, n = 16, TG 0.9 ± 0.03 ms, n = 12, Mann-Whitney U, p = 0.3, Z = -1, 
Figure 6-10), zenith of the action potential (WT 20 ± 2 mV, n = 16, TG 18 ± 2 
mV, n = 12, unpaired t-test, p = 0.5, t = 0.6, Figure 6-10) or the maximum dV/dt 
(WT 302 ± 17 mV/ms, n = 16, TG, 316  ± 27 mV/ms, n = 12, unpaired t-test, p = 
0.6, t = -0.5, Figure 6-10). The mean threshold was significantly more 
depolarised in the WT cohort than in the TG cohort (WT -54 ± 1 mV, n = 16, TG 
-60 2 mV, n = 12, unpaired t-test, p = 0.02, t = 2.6, Figure 6-10).  
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Figure 6-10. Action potential properties of Type II neurons. A) Average 
waveform of first action potential generated in response to depolarising current 
injections, B) AP zenith C) AP width at -20 mV, D) averaged dV/dt of cells 
plotted against the average voltage change of the action potential, E) maximum 
dV/dt and F) threshold.  
 
A more depolarised threshold often leads to increases in excitability, however 
when I looked at firing frequency in each step (Table 6-2) and the proportion of 
cells firing in each step, I observed no differences (Figure 6-11,Table 6-2). 
Equally, genotype showed no effect on Rheobase (WT 24 ± 5 pA, TG 30 ± 7 
pA, Mann-Whitney U, p = 1, Z = -0.1, Figure 6-11).  
Finally, I examined the latency of action potential generation in the step protocol 
beginning with the first action potential generated. The TG cohort fired 
significantly earlier than the WT cohort (WT 12 ± 3 ms, n = 16, TG 7 ± 2 ms, n = 
12, Mann-U-Whitney p = 0.047, Z = -2, Figure 6-11). No difference in latency 
were observed following the injection of 80 pA of current (WT 2 ± 0.5 ms, TG 2 
± 0.7 ms, Mann-Whitney U, p = 0.3, Z = -1, Figure 6-11).  
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Current 
injected 
Firing frequency following 
injection of depolarising 
current  
Fraction of cells generating 
action potentials  
 WT (Hz) TG (Hz) 
 
WT (%) TG (%) P value 
5 pA 1 ± 1 1 ± 1 0.1 0.1 0.6 
20 pA 6 ± 3 6 ± 4 0.2 0.2 0.7 
35 pA 10 ± 4 11 ± 5 0.7 0.7 0.9 
50 pA 15 ± 5 14 ± 6 0.9 0.8 0.09 
65 pA 21 ± 5 18 ± 6 1 0.9 0.2 
80 pA 24 ± 4 22 ± 6 1 1  
Table 6-2. Proportion of Type II cells firing in response to each current injection 
from both holding potentials. P values based on chi squared performed in Excel 
 
 
Figure 6-11. Firing properties of Type II neurons A sample trace of a WT (II) and 
TG (III) cell, i) sample current injections depicting the injection of -40 pA, +20 pA 
and +80 pA. Fraction of cells firing at least one action potential in response to a 
series of depolarising, C) frequency of firing in response to each depolarising 
current injection, D) Rheobase, E) Latency to the first action potential generated 
in response to depolarising current injection and F) Latency to first action 
potential generated in response to the injection of 80 pA of current. 
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1.1.1.1 Type III neurons  
 
In type III cells the synaptic activity in voltage clamp was not included due to low 
n numbers; only 3 of each cohort had recording with low enough levels of noise 
to be included. Therefore I begin by looking at the resting membrane potential 
of these cells. Despite the TG cohort (-63 ± 6 mV) being a mean difference of 
12 mV more depolarised then the WT (-75 ± 7 mV) population they did not 
significantly differ (unpaired t-test, p = 0.2, t = 1.3, Figure 6-12). Of the WT 
population 4/6 cells fired at least 1 action potential in the 1 minute while 2/5 TG 
cohort fired (chi-squared, p = 0.4). The firing frequencies here has n numbers 
too low for a valid comparison.  
 
 
Figure 6-12 Resting membrane potential of Type III cells A) Resting membrane 
potential, Bi) Sample cell firing at rest, ii) sample cell not firing at rest.   
 
The amount of current required to hold cells at -80 mV (WT -47 ± 16 pA, TG -9 
± 31 pA) was not genotype specific. Once cells were at their holding potentials 
the passive membrane properties of the cells were examined. I found no 
differences in input resistance (WT 545 ± 82 MΩ, n = 6, TG 358 ± 101 pA, n = 
5, unpaired t-test, p = 0.2, t = 1.5), membrane time constant (WT 25 ± 5 ms, n = 
6, TG 17 ± 3 ms, n = 5, unpaired t-test, p = 0.2, t = 1.4) or capacitance (WT 46 ± 
4 pF, n = 6, TG 62 ± 16 pF, n = 5, unpaired t-test, p = 0.3, t = -1).  
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Figure 6-13 Passive membrane properties of Type III neurons A) Average of 
cells response to injection of -40 pA of current. B) Input resistance, C) 
membrane time constant and D) Capacitance. 
 
Next I examined the action potential properties; no differences in action 
potential zenith (WT 13 ± 3 mV, n = 6, TG 13 ± 4 mV, n = 5, unpaired t-test, p = 
0.9, t = 0.1, Figure 6-14 C, D), peak width at -20 mV (-80 mV, WT 0.8 ± 0.1 ms, 
n = 6, TG 0.9 ± 0.1 ms, n = 5, unpaired t-test, p = 0.7, Figure 6-14 E, F) or dV/dt 
max (-80 mV, WT 235 ± 24 mV/ms, TG 236 ± 24 mV/ms, unpaired t-test, p = 1, 
t = -0.2) were observed. While a mean difference of 6 mV existed in threshold 
(WT -62 ± 3 mV, n = 6, TG -56 ± 3 mV, n = 5, unpaired t-test p = 0.2, t = -1.3) a 
large amount of variability meant this was not statistically significant.  
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Figure 6-14 Action potential properties of type III neurons A) Average of first 
action potential generated in response to depolarising current injections. B) AP 
zenith, C) AP width at -20 mV, Averaged dV/dt of cells plotted against the 
average voltage change of cells, E) dV/dt max of cells and F) Threshold of cells 
from a holding potential of -70 mV and -80 respectively.  
 
In examining excitability using the step protocol no differences in either 
proportion of cells firing (Table 6-3) or the frequency (Table 6-4) at which cells 
fire were observed.  
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Figure 6-15 firing properties of Type III neurons A sample trace of a TG (II) and 
WT (III) cell, i) sample current injections. Fraction of cells firing at least 1 action 
potential in response to a series of depolarising pulses from a holding potential 
of -70 mV (B) and -80 mV (C). D, E) frequency of firing in response to each 
depolarising current injection from a holding potential of -70 mV and -80 mV 
respectively.  
Current 
injected  
WT (%) TG (%) P value 
5 pA 17 0 0.4 
20 pA 67 40 0.2 
35 pA 83 40 0.1 
050 pA 100 60 0.1 
65 pA 100 80 0.2 
80 pA 100 80 0.2 
Table 6-3 Proportion of Type III cells firing in response to each current injection 
from both holding potentials. P values based on chi squared performed in Excel 
 
Current 
injected  
WT (Hz)  TG (Hz) 
5 pA 2 ± 2 Hz 0 ± 0 Hz 
20 pA 8 ± 6 Hz 5 ± 3 Hz 
35 pA 8 ± 3 Hz 12 ± 7 Hz  
50 pA 15 ± 5 Hz 16 ± 9 Hz  
65 pA 21 ± 7 Hz 12 ± 8 Hz  
80 pA 25 ± 8 Hz 16 ± 9 Hz 
Table 6-4 Average frequency in response to each current injection from -70 mV 
and -80 mV of Type III cells  
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6.4. Discussion 
This study examined the anxiety levels in the CHMP2B model of frontotemporal 
dementia, along with the electrophysiological properties of neurons located 
within the BNSTALG. Overall, we found no differences in anxiety levels but 
observed some increases in excitability in the TG cohort in Type II neurons and 
a decrease in the maximum rate of rise in the action potential of type I neurons 
in the TG cohort.  
TG Type II neurons display a hyperpolarised threshold, this would indicate that 
these cells would require less depolarising stimuli to generate an action 
potential and thereby lead to an increase in excitability. This was observed in 
decreased latency of these cells. Given the fast nature of synaptic events the 
differences in the period of time required for a cell to spike can be quite 
significant with regards to the cells response to synaptic input. With the 
assumed role of Type II neurons as anxiety off cells this increased excitability 
would in theory lead to a decrease in anxiety (Daniel et al., 2017). However, the 
subtle nature of this increase, ie. that only 1 parameter appears to be affected 
while other measures of excitability like rheobase or firing frequency remain 
unaltered, may account for why this increase did not lead to decreases in 
anxiety in the maze. The opposing changes in excitability of the two populations 
may be cancelling out any behavioural effect.  
The action potential waveform can have impact on various neurological 
functions; in Type I neurons the maximum rate of rise was significantly slower in 
the TG cohort. Changes in the maximum rate of rise can have effects on the 
action potential waveform leading to alterations in neurotransmitter release.  
While statisitically significant differences in action potential width or action 
potnetial zenith were not observed a trend towards a shorter thinner action 
potnetial was seen in the Type I neurons of the TG cohort. These two 
measurements would have opposing actions on neurotransmitter release; often 
a wider action potential would lead to increases in neurotransmitter release 
while a shorter action potential would lead to a decrease in neurotransmiter 
release. As the action potential width in this example is measured from a set 
potential of -20 mV the thinner aspect is most likely down to the fact that in the 
TG cohort the measurement was taken closer to the tip of the action potential 
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where it is most likely to be the thinnest. Unfortunatly due to large ADPs in a 
proportion of these cells AP width at threshold was not a viable measure.  
These cells are classified using only their electrophysiological properties. The 
degree to which these forms of cell classification can be applied to dementia 
models is debatable. It is difficult to determine whether changes observed are 
down to changes in how the different cell types are behaving in the disease 
state or if changes within populations lead to misclassification of cells. For 
example classification of type II cells is based mostly on the hump observed in 
the depolarising step before the generation of an action potential thought to be 
driven by T-type calcium channels (Hammack et al., 2007a). If these channels 
expression or function are changed by the dysfunction of the CHMP2B gene 
then there may be a resulting misclassification of the cell leading to potential 
differences in both the type II cells and in the other populations where the type II 
cells are misclassified.  
While some of the electrophysiological properties differ in the different 
populations there is no effect on the anxiety levels of the animals, there is a 
number of possible reasons for this; it could be down to the fact that these 
animals were unstressed. This finding is consistent with the literature with 
Clayton et al 2017 finding no differences in anxiety levels in these mice using 
both the open field and the elevated plus maze. This finding is interesting as in 
the human population frontotemporal dementia is often associated with 
increases in anxiety(Clayton et al., 2017). It may be that the mechanisms of 
dealing with stress become altered in disease state but given that all the animal 
testing so far has been carried out on unstressed models no differences have 
emerged. Of particular interest would be a PTSD model of stress in these 
animals given the strong correlation of PTSD and frontotemporal dementia in 
humans (Greenberg et al., 2014b). This hypothesis was not tested as part of 
this project but it would be interesting to consider in the future.  
This study has higlighted differences in intrinsic properties of neurons located 
within the anterolateral area of the BNST. These changes have no effect on 
anxiety in an unstressed model, however they highlight the potential for 
changes in stress processing which need to be adressed further. 
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7.  General discussion 
7.1. Summary and general discussion  
Physiological manifestations of fear and anxiety appear to be conserved across 
mammalian species (Zhu et al., 2014; Sotnikov et al., 2014; Koch et al., 2016). 
As the mouse’s response to stress mimics a number of those observed in 
humans they are often used as a model to examine responses to stress and 
anxiety levels. A number of behavioural tests exist to determine anxiety in 
mouse models, this includes the elevated zero maze as used in this study. 
Further to these behavioural studies the use of mouse models allow numerous 
more invasive tests to be performed than cannot be carried out in a human, 
including electrophysiological characterisations of key brain regions associated 
with stress and anxiety such as the BNSTALG. In vitro patch clamp recording is a 
robust way to gather real time electrophysiological information on neurons. The 
intrinsic electrophysiological properties of BNSTALG neurons have been 
characterised in the mouse, rat and non-human primate with similar populations 
being observed (Daniel et al., 2017). This would indicate that the populations 
are conserved into higher mammalian species. 
Overall, this thesis shows that a number intrinsic electrophysiological properties 
of neurons in the BNSTALG differ with gender, age and in the CHMP2B model of 
frontotemporal dementia. However the impact of the estrus cycle on BNST 
properties was minimal. I began by examining the effect of the estrus cycle on 
intrinsic properties in the BNSTALG. A trend was observed in the dV/dt max of 
Type II neurons which was only significant in post hoc analysis: diestrus was 
slower than metestrus and proestrus. The trend observed in maximum rate of 
rise did not lead to any changes in either the shape of the action potential or the 
excitability of the different groups. The minimal effect of the estrus cycle on 
neurons located in the BNST meant that each of the stages of estrus could be 
grouped together for comparisons with an aged matched male cohort.  
There were a number of intrinsic electrophysiological properties which were 
affected by gender; Type II cells showed an increased excitability in males 
driven by changes in passive membrane properties specifically input resistance. 
Progesterone or rather its metabolite ALLO plays a key role in regulating the 
expression of extrasynaptic GABAA receptors. These receptors can modulate 
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input resistance through tonic inhibition. In female mice, ALLO is 8-10 fold 
higher than in male mice and while progesterone is thought to be anxiolytic, the 
effects of fluctuations in ALLO are far more variable; the effect mediated can be 
both anxiolytic or anxiogenic (Dong et al., 2001a; Gulinello et al., 2003; Lovick, 
2006; Matsumoto et al., 2007; Shen et al., 2007; Smith et al., 2007; Jiang et al., 
2014; Nagaya et al., 2015a). This increase in excitability in the Type II male 
neurons may lead to anxiolytic behaviour; Type II neurons are thought to be 
anxiolytic mediating their action through inhibition of the HPA axis (Daniel & 
Rainnie, 2016).  
The differences in excitability and passive membrane properties of Type II 
neurons may contribute to changes in susceptibility to anxiety related disorders. 
The BNST is involved in a feedback mechanism of stress modulation between 
the HPA axis and the limbic system; dysregulation of this system has been 
implicated in PTSD (Lee et al., 2008; McElligott et al., 2010; Lebow et al., 2012; 
Gafford & Ressler, 2015). Also, alteration in BNST function and CRF levels 
have been observed in patients with PTSD (Bremner et al., 1997b). As the 
BNST is susceptible to modulation by stressful stimuli and mediates sustain fear 
states these changes in baseline processing may provide some basis for the 
altered susceptibility between the genders to PTSD.  
Following this, I examined the effect of age on the intrinsic properties of neurons 
in the BNST. Due to the availability of tissue, this study was carried out in aging 
females. In aged mice, Type I neurons had a hyperpolarised resting membrane 
potential and wider action potentials, while Type II  neurons from the aged 
cohort displayed smaller amplitudes of inward-going post synaptic events and 
an increase in excitability most likely due to the a more depolarised threshold. 
Increases in activity of Type II neurons are thought to decrease anxiety, if this 
hypothesis holds then in theory you would see a decrease in anxiety with aging 
in the female cohort. However, in the human population there is an increase in 
anxiety related disorders in menopausal females which has been attributed to 
decreases in sex hormones (Garrido, 2011; Ebner et al., 2014). In chapter four, 
the correlation between behaviour and intrinsic properties of BNSTALG neurons 
was addressed; while a number of correlations were observed in the male 
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cohort, there were no significant correlations in any of the parameters examined 
in the female cohort.  
An issue with the classification of this population was that it was based upon 
recordings in male rats and while most of the characteristics of these cells have 
led to similar classifications in the mouse there is a larger degree of variability in 
the female population. This may be attributable to changes in hormones leading 
to increased variability. However in chapter three this was addressed and I 
found that none of the electrophysiological properties examined displayed 
oestrous cycle dependent variations. Stress modulation changes over the 
lifespan occur in a sex specific manner (Bowman et al., 2006) therefore in the 
future it would be interesting to expand upon this and examine the effect of age 
on males and see if a similar increase exists. 
Finally I looked at the impact of frontotemporal dementia on the BNSTALG, in 
Type I neurons the TG cohort had a significantly lower maximum rate of rise. 
This however did not lead to any changes in other aspects of the action 
potential waveform examined including width or zenith. Also TG Type II neurons 
had a more hyperpolarised threshold and faster latency. Changes in threshold 
often lead to alterations in excitability, however this was not the case in this 
cohort as no changes in excitability were observed. Similar to the previous two 
studies the largest differences were observed in Type II neurons, this may 
implicate that these neurons are more susceptible to changes in physiological 
conditions.   
There is a third common cell type in these populations the Type III neurons, . 
The original classification of these cells was based upon two parameters, the 
absence of sag and the presence of an inwardly rectifying potassium current. 
The protocols used in this study did not address the presence or absence of 
inwardly rectifying potassium channels and were therefore based entirely upon 
the absence of sag. Therefore, the Type III neurons included here may be not 
accurately represent the Type III population present in these cohorts. The 
possible mixture of cells combined with low n number may be masking 
diffrences between the populations. These Type III neurons are thought to be 
CRF positive neurons and play a key role in stress modulation in the BNST as a 
whole and specifically within the BNSTALG (Sahuque et al., 2006; Lee et al., 
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2008; Sink et al., 2013; Janitzky et al., 2014; Gafford & Ressler, 2015; 
Henckens et al., 2016). To fully understand how these circuits may be affected 
by gender, age and disease Type III cells should be examined further.  
7.2. Future work 
An interesting extension of this work would be a longitudinal study examining 
the effect of healthy aging on neurons in the BNST in both genders across their 
lifespan. In the introduction the genders specific effects of aging were 
addressed and while here we focused on the gender differences in young adults 
and healthy aging in females the changes in susceptibility to anxiety related 
disorders begins before puberty (Wesselhoeft et al., 2015). In the prepubescent 
age range there is a higher incidence of anxiety related disorders in males. 
From the age of 12 onwards the incidences increase in both genders however 
they become more prevalent in females. I would propose the characterisation of 
these neurons from weening up to very aged animals at 30 months. This work 
would be carried out in conjunction with anxiety test measured on the elevated 
zero maze.  
In conjunction with this, the optogenetic stimulation of afferent projections into 
the BNST would provide a more in depth understanding of the roles of these 
different population in stress modulation. To examine the functional connectivity 
between the ventral subiculum and mPFC onto the BNST I would use the two 
new variants of channelrhodopsin, Chronos and Chrimson. They would be 
injected into the mPFC and hippocampus respectively. These variants respond 
selectively to blue and red light allowing dual activation in the same slice prep. 
While the axonal projections would be removed optic stimulation still leads to 
EPSCs in connected cells. The BNSTALG receives dense afferents from both the 
ventral subiculum and the mPFC. I would expect a large proportion of the cells 
to respond to optic stimulation.  
During the recordings I would fill the cells with biocytin. This will allow post 
recording characterisation of morphology and markers. While some initial work 
has been carried out into characterising these cells more research is needed. 
For example, no definitive markers have been found to tie electrophysiological 
characterisation to cell types. Some preliminary unpublished data (Daniel & 
Rainnie, 2015) from the Rainnie lab suggests that these different cell 
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populations do display certain markers specifically type III being CRF positive 
and type II being PCK- positive. One aspect of this project would be to address 
this post recording. This longitudinal study would provide vital insight into the 
mechanisms underlying stress processing over their lifetime. 
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